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Abbreviation 
Ab: antibody 
AI: autoinducer 
ACN: acetonitrile 
AHL (HSL): N-acylated homoserine lactone 
AOS: Aqua-Opto sensor  
Bcc: Burkholderia cepacia complex 
Bn: benzyl 
BSA: bovine serum albumin 
CBs: chlorobenzenes  
CF: Cystic Fibrosis  
CONA: conalbumin  
CR: cross reactivity 
Da: dalton 
DCC: 1,3-dicyclohexylcarbodiimide 
DMF: dimethylformamide 
RIA: radioimmunoassay 
EA: ethyl acetate 
EIAs: enzyme immunoassays  
ELISA: enzyme-linked immunosorbent assay.  
EW: evanescent wave  
GAR: goat anti-rat 
Gfp: green fluorescent protein 
HRP: horseradish peroxidase 
HS: homoserine 
IA: immunoassay 
IgG: immunoglobulin G 
IgM: immunoglobulin M 
IC50: inhibitory concentration 50%, test midpoint of the standard curve 
Kd: dissociation constant  
KLH: Keyhole limpet hecocyanin  
LC: liquid chromatography   
LOD: limit of detection 
mAb: monoclonal antibody 
NaOH: sodium hydroxide 
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NHS: N-hydroxysuccinimide 
NMR: nuclear magnetic resonance 
MS: mass spectrometry  
OD: optical density  
OVA: ovalbumin 
PBS: phosphate-buffered saline 
PQS: Pseudomonas quinolone signal  
PBST: phosphate-buffered saline with Tween 20 
Protein G: protein G from Streptococcus  
QS: quorum sensing 
QQ: quorum quenching 
RT: room temperature 
SPR: surface plasmon resonance  
TBAB: tetrabutyl ammonium bromide  
TIRF: total internal reflectance fluorescence 
TG: tyroglobulin  
TMB: 3,3’,5,5’-tetramethylbenzidine 
TSA: tyramide signal amplification 
PMMA: polymethyl methacrylate 
HSL standards  
C4-HSL: N-butyryl-L-homoserine lactone 
3oxo-C4-HSL: N-3-oxo-butyryl-L-homoserine lactone 
3OH-C4-HSL: N-3-hydroxy-butyryl-L-homoserine lactone 
C6-HSL: N-hexanoyl-L-homoserine lactone 
3oxo-C6-HSL: N-3-oxo-hexanoyl-L-homoserine lactone 
3OH-C6-HSL: N-3-hydroxy-hexanoly-L-homoserine lactone 
C8-HSL: N-octanoyl-L-homoserine lactone  
3oxo-C8-HSL: N-3-oxo-octanoyl-L-homoserine lactone  
3OH-C8-HSL: N-3-hydroxy-octanoyl-L-homoserine lactone  
C10-HSL: N-decanoyl-L-homoserine lactone  
3oxo-C10-HSL: N-3-oxo-decanoyl-L-homoserine lactone 
3OH-C10-HSL: N-3-hydroxy-decanoyl-L-homoserine lactone 
C12-HSL: N-dodecanoyl-L-homoserine lactone 
3oxo-C12-HSL: N-3-oxo-dodecanoyl-L-homoserine lactone 
3OH-C12-HSL: N-3-hydroxy-dodecanoyl-L-homoserine lactone 
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1 Introduction 
1.1  Quorum sensing  
1.1.1  Discovery of quorum sensing 
Quorum sensing has been an important topic only since a few decades. In the 300 years since 
van Leeuwenhoek’s remarkable descriptions of the teeming world of microorganisms, 
bacteria have been regarded as deaf mutes going about their business without communicating 
with their neighbours (Bassler & Losick, 2006). It was not until the 1960s and 1970s, with the 
discovery of what is now called quorum sensing (QS), that it became evident that bacteria 
possess sophisticated systems of communication that enable them to send and receive 
chemical messages to and from other bacteria. In its simplest form, quorum sensing is a cell-
cell communication mechanism by which bacteria count their own numbers by producing and 
detecting the accumulation of a signalling molecule that they export into their environment 
(Bassler & Losick, 2006). We now know that QS-mediated communication is more 
complicated than originally assumed and, furthermore, is one of several mechanisms bacteria 
use to interact with other cells. The concept of intercellular communication within a bacterial 
population originates for the discoveries of Tomasz (1965) on genetic competence in 
Streptococcus pneumoniae (then known as Pneumococcus) and Nealson et al. (1970) on 
bioluminescence in Vibrio. Competence is a physiological state in which bacteria are capable 
of taking up and undergoing genetic transformation by DNA molecules. In 1965, Tomasz 
reported that entry into the competent state is governed by an extracellular factor that is 
manufactured by Streptococcus itself (Tomasz, 1965). Thus, the competence factor, which 
was later shown to be a modified peptide, was described as a “hormone-like activator” that 
synchronises the behaviour of the bacterial population. In 1970, it was shown that two 
obscure species of bioluminescent marine bacteria, Vibrio fischeri and Vibrio harveyi, 
produced light at high cell density but not in dilute suspensions (Nealson et al., 1970). Light 
production could be stimulated by the exogenous addition of cell-free culture fluids, and the 
component responsible, called the autoinducer (AI), was later identified as an acyl-
homoserine lactone (Eberhard et al., 1981; structures present in Figure 3). The combined 
findings of Tomasz (1965) and Nealson (1970) suggested that certain bacteria use the 
production, release, exchange, and detection of signalling molecules to measure their 
population density and to control their behaviour in response to variations in cell numbers. 
For nearly 20 years, these cell-cell signalling phenomena were considered unusual 
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occurrences restricted to a few specialised bacteria. It is now clear that intercellular 
communication is not the exception but, rather, is the norm in the bacterial world and that this 
process, called quorum sensing, is fundamental to all of microbiology (Bassler & Losick, 
2006). In addition, bacterial AHL QS molecules are recognised by higher organisms, 
including plant and human. AHL-producing bacteria are associated with pathogenic, 
commensalic or even beneficial interactions (Hughes & Sprendio, 2008). 
1.1.2 Mechanism of quorum sensing  
Bacteria release a wide variety of small molecules including secondary metabolites such as 
antibiotics and siderophores (iron chelators), metabolic end products and cell-to-cell 
signalling molecules into the environment. In many instances, the latter are considered to 
provide the bacterial population with a means of determining its numerical size (or density). 
As the bacterial culture grows, signal molecules are released into the extracellular milieu and 
accumulate. Once a threshold concentration of the molecule (and consequently a specific 
population density) is achieved, a co-ordinated change in bacterial behaviour is initiated 
(illustrated in Figure 1, Williams et al., 2007). 
Figure 1 Quorum sensing 
 
 
When the bacterial density is low (left), the concentration of signal molecules is also low. When the cell density 
(also the signal molecules) reaches a critical level, the bacteria start QS regulated gene expression (right). 
  
low density high density 
 
Signal molecule 
Signal producer 
Signal receptor 
Gene expression 
Bacteria cell 
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Fuqua et al. (1994) firstly introduced the term ‘quorum sensing’ to describe this phenomenon. 
The term QS does not, however, adequately describe all situations where bacteria employ 
diffusible chemical signals. The size of the quorum, for example, is not fixed but will vary 
according to the relative rates of production and loss of signal molecule, i.e. it is dependent on 
the prevailing local environmental conditions (Hense et al., 2007). It is also possible for a 
single bacterial cell to switch from the ‘non-quorate’ to the ‘quorate’ state as has been 
observed for Staphylococcus aureus trapped within an endosome in endothelial cells (Qazi et 
al., 2001). In this context, ‘diffusion sensing’ or ‘compartment sensing’ are more appropriate 
terms since the signal molecule is supplying information with respect to the local environment 
rather than cell population density (Redfield, 2002; Winzer et al., 2002) Quorum sensing 
might therefore be better considered as a special category of diffusion sensing where, in a 
given environment, the threshold concentration of signal molecule required to trigger a 
response can only be achieved by more than one cell (Redfield, 2002; Winzer et al., 2002). 
Furthermore, it should be remembered that quorum sensing, as the determinant of cell 
population density, is only one of many different environmental signals (e.g. temperature, pH, 
osmolarity, oxidative stress, nutrient deprivation) which bacterial cells must integrate in order 
to determine their optimal survival strategy (Qazi et al., 2001). Thus, QS is an integral 
component of the global gene regulatory networks which are responsible for facilitating 
bacterial adaptation to environmental stress (Hense et al., 2007; Williams et al., 2007).  
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Figure 2 Simplified quorum sensing mechanisms 
 
Mechanism 1 for quorum sensing in Gram-positive bacteria using polypeptide autoinducer; Mechanism 2 for Gram-positive bacteria employ N-acylated-homoserine lactones as 
signal molecules; Mechanism 3, quorum sensing in both Gram-positive and Gram-negative bacteria using autoinducer 2; Mechanism 4 describes quorum sensing beyond bacteria 
borders: autoinducer 3. Ref: (Boyen et al., 2009) 
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1.1.3 Gram-negative bacteria and AHL (HSL) quorum sensing molecules 
AHLs (HSLs) were the initially introduced QS molecules. However, they are not the only 
class of QS signal molecules. In Gram-negative bacteria, 4-quinolones, fatty acids and fatty 
acid methyl esters have been identified as QS signal molecules (Figure 3). Apart from γ-
butyrolactones such as Khoklov’s A-factor produced by Streptomyces (Figure 3), Gram-
positive bacteria employ unmodified (e.g. the competence stimulating factors of S. 
pneumoniae) or post translationally modified peptides such as the staphylococcal cyclic 
peptides (not shown). Although no ‘universal’ bacterial quorum sensing system or signal 
molecule family has yet been discovered, many Gram-negative and Gram-positive bacteria 
produce ‘autoinducer-2’ (Figure 3), a collective term for a family of interconvertible furanone 
compounds (Williams et al., 2007). 
Figure 3 Structures of some representative signal molecules 
3-oxo-AHL, 3-OH-AHL, and AHL (R ranges from C1 to C15). The acyl side chains may also contain one or 
more double bonds: A-factor, 2-isocapryloyl-3-hydroxymethyl-g-butyrolactone; AI-2, autoinducer-2, furanosyl 
borate ester form; PQS, Pseudomonas quinolone signal, 2-heptyl-3-hydroxy-4(1H)-quinolone; DSF, ‘diffusible 
factor’, methyl dodecenoic acid; PAME, hydroxyl-palmitic acid methyl ester. Ref: (Williams et al., 2007). 
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Some examples of LuxR/LuxI/AHL-dependent quorum sensing systems in Gram-negative 
bacteria have been reviewed in (Williams et al., 2007). The individual bacteria use different 
QS mechanism, different QS molecules and have different biological function. The details are 
listed in Table 1.  
Table 1 Quorum sensing bacteria and their signal molecules (an incomplete list) 
 
Ref: (Williams et al., 2007) 
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1.1.3.1 Burkholderia cepacia and quorum sensing 
The Burkholderia cepacia complex (Bcc) consists of seventeen closely related species 
(Vanlaere et al., 2009), which were isolated from different natural habitats, such as plant 
rhizosphere, soil and river water (Chiarini et al., 2006; Jha et al., 2009). They were also found 
in some urban environments like playgrounds and athletic fields (Fries et al., 1997; Bevivino 
et al., 2000; Heungens & Parke, 2000; Fiore et al., 2001; Miller et al., 2002; Lee, 2003; 
Vermis et al., 2003). Furthermore, they are able to promote plant growth, enhance plant 
disease resistance (Bevivino et al., 1998; Peix et al., 2001; Jha et al., 2009) and were applied 
for bioremediation (Master et al., 2002; Jiang et al., 2008). However, the genus also contains 
primary pathogens for animals and humans. Disease in humans normally occurs in individuals 
who are frequently exposed to contaminated sites through bacterial infection of minor cuts or 
abrasions or inhalation of dusts (Dance, 2002). Bcc strains can cause life-threatening lung 
infections in patients requiring mechanical ventilation and in individuals with chronic 
granulomatous disease or cystic fibrosis (CF) (Eberl, 2006). In fact, over the past two 
decades, the number of human infections caused by Burkholderia-like bacteria has increased 
markedly. Polyphasic-taxonomic studies revealed that these organisms comprise a very 
heterogeneous group of strains, collectively referred to as the Bcc (Coenye & Vandamme, 
2003). The Bcc species employ quorum sensing, using AHLs as autoinducers. Most members 
of the Bcc were found to use the CepIR QS system (Lewenza et al., 1999). Numerous AHLs 
with different side chain length and functional groups at the C3 position were confirmed as 
AIs for Bcc species (Sokol et al., 2007). Furthermore, the evidence of interspecies 
communication between B. cepacia and Pseudomonas aeruginosa in CF patients was also 
suggested to be related to QS and this correlation may cause a higher risk for the infected 
patients (McKenney et al., 1995; Eberl, 2006). 
Initial evidence for the production of signal molecules by a Bcc strain was obtained from 
cross-feeding experiments, which showed that AHL-containing culture supernatants of P. 
aeruginosa stimulated production of siderophores, protease and lipase in B. cepacia 10661 
(McKenney et al., 1995). The first QS genes in a Bcc strain were identified in a screen for 
transposon insertion mutants that hyperproduced siderophores on chrome azurol S agar 
(Lewenza et al., 1999). This work showed that the QS system of B. cenocepacia K56-2 
consists of the AHL synthase CepI, which directs the synthesis of N-octanoyl-homoserine 
lactone (C8-HSL) and, as a minor by-product, N-hexanoyl-homoserine lactone (C6-HSL), and 
the transcriptional regulator CepR. CepR was shown to tightly control expression of cepI, 
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likely through binding to a lux box-like sequence that partially overlaps the -35 region of the 
putative cepI promoter (Lewenza & Sokol, 2001). This positive feedback loop ensures that a 
very rapid increase in target gene expression occurs once the system has been triggered. 
Interestingly, CepR negatively controls its own regulation, i.e. is auto-regulated. A highly 
similar QS system was identified in a screen for mutants defective in biofilm formation of B. 
cenocepacia H111 (Gotschlich et al., 2001; Huber et al., 2001). Moreover, systematic surveys 
revealed that in fact representatives of all Bcc species contain the CepI/CepR QS system and 
produce mostly C8–HSL and the amount of AHLs produced by different Bcc strains varies 
dramatically with concentrations ranging from 10 nM to 1 mM for the abundant C8-HSL 
(Gotschlich et al., 2001). Given that most B. multivorans and several B. cenocepacia strains 
produce extremely low amounts of C8-HSL (less than 1 nM), it has been suggested that 
additional regulatory factors may be present in these strains that silence cepI expression 
(Eberl, 2006). 
B. cepacia LA3, an isolate from rice rhizosphere, produces mainly C10-HSL among C8-HSL 
at published concentration of 1.61 μM (Li et al., 2006). Using single drop microextraction 
(SDME), Malik et al. (2009) reported that both optical isomers of C10-HSL (D and L) were 
determined from the cell-free supernatant, while L-C10-HSL was dominant. The HSL 
detection of the B. cepacia LA3 supernatant with immunoassay and the in situ experiment 
with B. cepacia biofilm on ibidi slides will be introduced below. 
1.1.3.2 Pseudomonas aeruginosa and quorum sensing 
P. aeruginosa is an opportunistic human pathogen that causes chronic infection in CF 
patients. The pathogenicity of P. aeruginosa depends on multiple cell-associated factors such 
as alginate, pili, and lipopolysaccharide, and on extracellular virulence factors including 
proteases (elastase, alkaline protease, and LasA protease), hemolysins (rhamnolipid and 
phospholipase), and toxins (exoenzyme S and exotoxin A, Geisenberger et al., 2000). 
P. aeruginosa possesses two N-acylhomoserine lactone (AHL) dependent QS systems 
consisting of two pairs of LuxRI homologs, LasRI and RhlRI, respectively. LasR and RhlR are 
both LuxR-type transcriptional activators that are activated by AHLs synthesized via LasI (N-
3-oxo-dodecanoyl-homoserine lactone) and RhlI (N-butanoyl-homoserine lactone), 
respectively (Diggle et al., 2007). The P. aeruginosa las and rhl regulatory circuitry is linked 
to a second QS signalling system, which employs 2-heptyl-3-hydroxy-4(1H)-quinolone, the 
Pseudomonas quinolone signal (PQS; for structure, see Figure 3) (Pesci et al., 1999; Diggle et 
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al., 2006). In common with the AHLs, PQS regulates the production of virulence 
determinants including elastase, rhamnolipids, the galactophilic lectin, LecA, and 
phycocyanin (a blue-green phenazine pigment) and have an influence on biofilm development 
(Pesci et al., 1999; Diggle et al., 2003). In contrast to the AHLs, when supplied exogenously, 
PQS overcomes the cell-population density-dependent production of P. aeruginosa 
exoproducts (Diggle et al., 2003). 
1.1.3.3 Interspecies communication between P. aeruginosa and B. cepacia  
During chronic co-infection, P. aeruginosa and B. cepacia form mixed biofilms in the lungs 
of CF patients. Given that both bacteria utilize AHL signal molecules to control biofilm 
formation and expression of virulence factors, it appears likely that the two strains are not 
only capable of communicating with each other, but that these interactions may be of 
profound importance for the virulence of the mixed consortium (Geisenberger et al., 2000). 
Using gfp-based biosensors it was possible to visualise AHL-mediated communication in 
mixed biofilms, which were cultivated either in artificial flow chambers or in alginate beads 
in mouse lung tissue (Riedel et al., 2001). These investigations revealed that in both model 
systems B. cepacia is capable of perceiving the AHL signals produced by P. aeruginosa, 
while the latter strain did not respond to the molecules produced by B. cepacia, supporting the 
view of unidirectional communication between the two strains. The clinical importance of 
AHL-mediated cross-communication for the virulence of the mixed consortium during co-
infection is subject of on-going investigations (Eberl, 2006). 
1.1.3.4 Pseudomonas putida and quorum sensing 
Another member of Pseudomonas family, Pseudomonas putida strains are frequently isolated 
from the rhizosphere of plants and many strains promote plant growth, exhibit antagonistic 
activities against plant pathogens and have the capacity to degrade pollutants (Arevalo-Ferro 
et al., 2005). As previously described Pseudomonas species, P. putida also employs AHLs as 
QS molecules. Recent work demonstrated that the tomato rhizosphere isolate P. putida IsoF 
produces a wide spectrum of signal molecules including AHLs with side chain length from 
C6 to C14 with different substitutions (Steidle et al., 2002; Fekete et al., 2010). Therein, the 
3oxo-decanoyl-homoserine lactone (3oxo-C10-HSL) was the most dominant HSL followed 
by 3oxo-dodecanoyl-homoserine lactone (3oxo-C12-HSL) and 3oxo-octanoyl-homoserine 
lactone (3oxo-C8-HSL). The remaining HSLs, e.g. the 3oxo-tetradecanoyl-homoserine 
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lactone (3oxo-C14-HSL), were determined in quite low amount (Fekete et al., 2010). The QS 
system of this strain consists of PpuI, which directs the synthesis of AHL signal molecules 
and PpuR, which binds to the AHLs and regulates the ppuI expression in a positive feedback 
loop. While the wild type P. putida IsoF formed very homogenous unstructured biofilms that 
uniformly cover the surface, a ppuI mutant formed structured biofilms with characteristic 
microcolonies and water filled channels. When the medium was supplemented with AHL 
signal molecules, the mutant biofilm lost its structure and converted into an unstructured 
biofilm similar to the one formed by the wild type IsoF. These results suggest that the QS 
system influences biofilm structural development (Steidle et al., 2001). For comparison, an 
AHL-negative mutant of P. putida IsoF, P. putida F117 and P. putida strain KT2440 were 
often used as negative controls of AHL-production. The mutant F117 is unable to produce 
AHLs but able to be activated by AHL autoinducers. Therefore, the mutant F117, which is 
deleted in AHL production, is used as AHL bioreporter using a green fluorescent protein (gfp) 
gene function (Steidle et al., 2002). Consequently, the P. putida KT2440 is neither HSL 
producer nor AHL consumer (Steidle et al., 2002). 
Figure 4 Dynamics of 3oxo-C10-HSL and 3oxo-C10-HS in P. putida culture supernatant 
 
The graph shows a comparison of the time-resolved concentrations of 3oxo-C10-HSL and 3oxo-C10-HS (as 
hydrolyzed product, being further degraded itself) from the beaker experiment. Ref: (Fekete, et al., 2010). 
Interestingly, Fekete et al. (2010) have recently demonstrated the dynamic regulation of AHL 
production and degradation in P. putida IsoF, which described the stage dependent HSL 
production and degradation process. Briefly, as showed in Figure 4, the concentration of the 
main autoinducer 3oxo-C10-HSL increased rapidly at the beginning of growth and reached its 
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maxima at 35 nM in 11 h followed by a rapid decline. A very similar dynamic was observed 
by 3oxo-C10-HS, the hydrolysed product of 3oxo-C10-HSL, just with a time delay of about 4 
hours (Fekete et al., 2010). The biological reason of the parallel production and degradation 
of HSL and HS is probably the occurrence of an AHL-hydrolysing enzyme, which is a very 
interesting aspect for further understanding of the QS (see also section 1.2). 
1.1.3.5 Quorum sensing in biofilm communities and 1,2,4-trichlorobenzene 
(TCB) biomineralisation 
Chlorobenzenes (CBs) are important basic materials and additives in the production of 
pesticides, dyes, pharmaceuticals, disinfectants, rubbers, plastics, and electric goods. Their 
occurrence in the environment is widespread and they were found in the atmosphere, water, 
soil sediments, vegetables, and biota (Wang et al., 2007). Since CBs can be accumulated in 
the food chain, the elimination of these pollutants from the environment and from polluted 
sites is of great public interest. As chemical and photochemical degradation of CBs is very 
slow, biological degradation could be considered as a feasible process to eliminate these 
compounds from soil ecosystems (Wang et al., 2007). 
Biodegradation of 1,2,4-TCB in natural samples occurs in very low rates due to insufficient 
degradation capacity and slow adaptation of the indigenous microorganisms. In some cases, 
the biodegradation of 1,2,4-TCB in soil could be enhanced by inoculation with adapted 
bacteria like Pseudomonas sp. P51, Burkholderia sp. PS12 and Burkholderia sp. PS14 under 
laboratory conditions. Schroll et al., (2004) showed an applicable method to considerably 
enhance the biodegradation of 1,2,4-TCB in a soil with low native degrading capacity by 
inoculating this soil with an adapted microbial community from a contaminated site via soil 
inoculum (Schroll et al., 2004). Wang et al., (2007) demonstrated that soil inoculation with a 
microbial community attached on clay particles resulted in a higher efficiency of 1,2,4-TCB 
mineralisation as compared with inoculating soil with the isolated key degrader or the 
microbial community in free liquid medium. Futhermore, the key organism Bordetella sp. of 
this degrading community was successfully isolated and identified (Wang et al., 2007). The 
mechanism behind the very effective function of these “microbe-clay-particle complexes” is 
therefore very interesting but not understood yet. Since QS is widely employed by bacteria of 
intra- and inter- species’ communication, regulating their gene expressions, 1,2,4-TCB 
degradation might also be regulated by QS bacteria, e.g. Pseudomonas spp. or Burkholderia 
spp.. It was suggested, that biofilm forming bacteria on the clay particles may have several 
advantages that are not enjoyed by single cell bacteria. For example, organisms within 
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biofilms can withstand shear forces, nutrient deprivation, pH changes and antibiotics in a 
more pronounced manner; cells in biofilms have a better chance of survival especially in 
periods of stress as they are protected within a matrix and can utilize cooperative benefits in a 
community. However, this idea is so far only a hypothesis and up to date, no literature has 
been found to confirm the presence of QS in this particular community. 
1.2 Quorum quenching 
The term “quorum quenching” (QQ) was coined to describe all processes that interfere with 
QS (Dong et al., 2001). QQ strategies do not aim to kill bacteria or limit their growth. Rather, 
they affect the expression or activity of a specific function. This is an important feature 
because these strategies exert a different selective pressure for microbial growth as compared 
to antibiotic/biocide treatments. This is a valuable trait for the development of sustainable 
biocontrol or therapeutic procedures in the present context of rising antibiotic resistance. 
Three steps of the AHL-based QS regulation mechanism could be targets for QQ procedures: 
1) the production of signal molecules, 2) the signal molecule itself, and 3) sensing of the 
signal molecule by the cognate regulatory protein. The mechanisms that are involved could be 
either of abiotic or biotic origins (Uroz et al., 2009).  
1.2.1  Inhibition of AHL signal sensing 
The first example of natural inhibition of AHL signal sensing involves AHLs themselves. N-
decanoyl-HSL (C10-HSL) and N-3oxo-tetradecanoyl-HSL (3oxo-C14-HSL) were reported to 
inhibit the production of the antibiotic pigment violacein by Chromobacterium violaceum, a 
QS-dependent function controlled by N-hexanoyl-HSL (C6-HSL) (McClean et al., 1997). 
Similarly, the acyl length and the substitution of the acyl chain can perturb QS-regulated 
functions such as V. fischeri luminescence (Schaefer et al., 1996) or conjugal transfer in 
Agrobacterium tumefaciens (Zhu et al., 1998). Other natural compounds are capable of 
interfering with QS-regulated functions in vivo (Figure 5).  
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Figure 5 Quorum sensing inhibitors  
 
A) Halogenated furanonen from Delisea pulchra; B) Pennicillic acid from Penicillium; C) Cyclic sulphur 
containing compound that was isolated from garlic; D) Patulin from Penicillium and E) L-canavanine from 
Medicago truncatula. Ref: (Uroz et al., 2009) 
Their mode of action and chemical structure frequently remain unknown. These compounds 
often compete with AHL for binding to the LuxR like receptor. This prevents QS regulation 
from occurring (Uroz et al., 2009). 
1.2.2 Limitation of signal accumulation-HSL degradation 
1.2.2.1 Abiotic degradation 
N-acyl homoserine lactones are very sensitive to elevated temperatures. Yates et al., (2002) 
reported that C4-HSL and C6-HSL were 3 and 1.5-times more rapidly degraded at 37°C than 
at 22°C, respectively. As they contain lactones, these molecules are also sensitive to alkaline 
pH. Schaefer et al., (2000) estimated that the half-life (in days) of 3oxo-C6-HSL was 1/ 
(1 10
7
[OH
-
])
23
. More recently, Byers et al., (2002) demonstrated that the half-life of this 
molecule was 30 min at pH 8.5, while it was seven hours at pH 7.8. The mechanism involved 
in this degradation is chemical lactonolysis, which leads to the generation of acyl-homoserine. 
This reaction can be partially reversed by acidification of the medium, which allows the 
restoration of the QS signal molecule. In addition, AHL can undergo a spontaneous Claisen-
like alkylation of the ß-ketoamide moiety, which leads to the formation of tetramic acids. 
Tetramic acid derivatives of AHL do not function as QS signal molecules, but might act as 
antibiotics against Gram-positive bacteria (Kaufmann et al., 2005). 
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Figure 6 HSL-degradation pathways and degradation products. 
 
Degradation pathways: 1. lactone ring hydrolysis, 2. amidohydrolysis; or modification pathways: 3. oxido-
reductase, 4. oxidase. Ref: (Uroz et al., 2009) 
1.2.2.2 Enzymatic degradation 
Aside from abiotic factors, AHL stability is also affected by biotic activities. The enzymatic 
degradation of the AHL molecules appears to occur in a very broad range of organisms. 
Degradation of AHLs was first demonstrated in bacteria, and has been reported in members of 
nearly 20 genera. Several plants, including clover, lotus and yam bean were proven to prevent 
accumulation of AHLs with acyl chain length from C6 to C10 in their environment 
(Delalande et al., 2005; Götz et al., 2007). Three main enzymatic mechanisms have been 
discovered and were clearly described: lactone hydrolysis, amido hydrolysis (Figure 6.2) and 
oxido reduction (Figures 6.3 and 6.4). 
AHL-lactonases catalyse the hydrolysis of the homoserine lactone ring of the AHLs; this 
leads to the generation of acyl homoserine. This hydrolysis is identical to the pH mediated 
lactonolysis, and as such, the reaction can be partially reversed by acidification of the 
medium. Lactonase activities have been demonstrated in several bacterial genera and also in 
eukaryotic cells (Uroz et al., 2009). 
AHL-acylases catalyse the complete and irreversible degradation of the AHLs through the 
hydrolysis of their amide bond; this releases homoserine lactone and the corresponding fatty 
acid (Figure 6.2). All of these AHL-acylases degrade long-chain AHLs more efficiently than 
short-chain forms.  
To date, two occurrences of AHLases with oxidative or reducing activities have been 
reported, but only in bacteria. In contrast to the previous QQ enzymes, these activities do not 
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lead to the degradation of the AHL molecules into QS-inactive molecules. Instead, they 
catalyse a modification of the chemical structure of the signal.  
1.2.3 The biological functions of the AHLases  
A recent study revealed that rearrangement compounds arising from 3oxo-AHLs generated 
tetramic acids that are toxic to several Gram-positive strains, including Bacillus sp. 
Interestingly, numerous Bacillus sp. strains harbour on genes encoding AHL lactonases that 
are able to degrade AHLs. As a consequence, one role of the AiiA lactonase in Bacillus might 
be to detoxify the 3oxo-AHL derivatives, as proposed by Kaufmann et al. (2005).  
Remarkably, degradation of AHLs also occurs in bacterial strains that produce these 
molecules. The best-described example is that of the plant pathogen Agrobacterium 
tumefaciens, for which Ti plasmid transfer and copy number are regulated by QS via the 
expression of the attKLM operon (Chevrot et al., 2006). It was suggested that AHL 
degradation by bacteria and eukaryotes might not be the primary function of AHL 
degradation enzymes, but might play an important role in AHL turnover (Uroz et al., 2009). 
1.3 Current HSL analytical methods 
Currently, arrays of different methods have been introduced for the detection and 
characterisation of AHL molecules. Generally speaking, one approach uses conventional 
analysis applying chromatography and mass spectrometry and the other was bioassays and  
bioreporters, which are inducible by AHL. Both of them have their advantages and 
disadvantages. 
1.3.1 Conventional chemical analysis  
The concentration of naturally produced AHL molecules can be quite low and they are 
difficult to be detected by conventional techniques. Furthermore, AHLs are difficult to 
analyse by liquid chromatography using traditional detectors, because their absorbance 
maxima are at low wavelengths and contain high background absorbance of solvents. Thus, 
the applicability of ultra violet (UV) detectors for AHLs analysis is very limited (Cataldi et 
al., 2004). However many different analytical methods of AHLs have been developed and 
optimised in the last years. Shaw et al. (1997) developed detection method for AHLs in 
bacteria cultures using thin-layer chromatography (TLC). Frommberger et al. (2003) 
conducted partial filling micellar capillary electro-chromatography and nano LC with mass 
spectrometric detection.  
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Table 2 Conventional AHL analytical methods 
Clean-up and pre-concentration  
 
AHL structure identification 
 
Quantification of AHLs 
 
Liquid-Liquid Extraction (LLE) 
 
Mass 
Spectrometry 
(MS) 
Time Of Flight 
MS (TOF-MS) 
Gas Chromatography (GC) 
Liquid 
Chromatog
raphy (LC) 
 
Normal Phase Liquid 
Chromatography (NPLC) 
 
Fourier Transform 
Ion Cyclotron 
Resonance MS 
(FT-ICR-MS) 
Reversed Phase Liquid 
Chromatography (RPLC) 
 
Nuclear Magnetic Resonance 
Spectroscopy (NMR) 
High Performance Liquid 
Chromatography (HPLC) 
Ion Exchange 
Chromatography (IEC) 
 
Thin Layer 
Chromatography (TLC) 
 
Ultra high Performance 
Liquid Chromatography 
(UPLC) 
(Semi) Preparative Liquid 
Chromatography 
UV-VIS spectrophotometer 
Solid Phase Extraction (SPE) 
Capillary Electrophoresis 
(CE) 
Ref: (Fekete et al., 2010) 
Direct analysis of AHLs by gas chromatography (GC)/ mass spectrometry (MS) was 
demonstrated by Cataldi et al. (2004). Li et al. (2006) combined solid-phase extraction (SPE) 
and ultra high performance liquid chromatography (UPLC) detection methods. Conventional 
chemical analyses are the most accurate methods for identification of individual molecule 
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structures, though very resource and time consuming. Fekete et al. (2010) have recently 
reviewed the analytical methods for AHL molecule identification (listed in Table 2). 
In summary, AHL containing samples need to be extracted, pre-concentrated and separated 
with chromatography and further identified with mass spectrometry. The quantification of the 
individual AHL needs a combination of chromatography and mass spectrometry (Table 2). 
Additionally, internal standards are always necessary for both identification and 
quantification; these are not always available. 
1.3.2 Bioreporters  
The principle of bioassay is that most of the autoinducer reporter strains are mutants that 
cannot synthesise their own AHLs; the wild type phenotype is only expressed upon the 
addition of exogenous AHLs. When the gene expression is induced, the production could be 
visualised directly or indirectly by the reaction of a reporter gene producing visible (light or 
fluorescence) signals. Brelles-Mariño & Bedmar, (2001) and Williams et al., (2007) reviewed 
bioassays with different functions. Many autoinducer sensors are dependent upon the use of 
lacZ reporter fusions in an E. coli or A. tumefaciens genetic background or on the induction or 
inhibition of the purple pigment violacein in Chromobacterium violaceum. lux-based reporter 
assays include the recombinant reporter plasmid pSB315 that lacks a functional luxI homolog. 
E. coli cells transformed with pSB315 are dark unless supplied with an exogenous AHL and a 
long-chain fatty aldehyde such as dodecanal, which is an essential substrate for the light 
reaction (Swift et al., 1993). In addition, a refined construct is available, pSB401, which does 
not require the addition of exogenous aldehyde and responds to a wide range of AHLs 
(Winson et al., 1995). E. coli harbouring pSB401 responds most sensitively to 3oxo-C6-HSL, 
which is the natural inductor, but it is less sensitive to AHLs with acyl side chains from 4 to 
10 carbons in length, irrespective of the substituent at the 3-position. Other lux-based 
biosensors such as pSB406, are available in which luxR and the luxI promoter region are 
replaced with the P. aeruginosa luxR homolog. lux-based reporters detect most of the 3-oxo 
and alkanoyl standards, but do not detect N-butanoyl homoserine lactone or any of the 3-
hydroxy forms. A broad range of AHLs (or AHL-like activities) can be detected by a set of 
lux-based reporters that differ in their sensitivity for specific AHLs (Winson et al., 1998). 
Some microorganisms may produce signals that are not detected by one of the reporters or 
they may produce molecules at levels below the threshold of sensitivity of the reporter (Shaw 
et al., 1997). Thus, the utilisation of several bioreporters with different sensitivities and 
specificities is highly recommended (Williams et al., 2007).  
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1.4 Immunochemistry 
1.4.1 Introduction of immunochemical techniques 
Immunochemical techniques are analytical methods based on the interaction of antibodies 
(Abs) with antigens (Ags). Antibodies are polymers containing hundreds of individual amino 
acids arranged in a highly ordered secondary and tertiary structure sequence. These 
polypeptides are produced by immune system cells (B lymphocytes when exposed to 
antigenic substances or molecules). Abs contain in their structure recognition/binding sites for 
specific molecular structures of the Ag (see Figure 7). According to the ‘key-lock’ model an 
Ab interacts in a highly specific way with its unique Ag. The interaction is reversible, as 
determined by the law of mass action, and is based on electrostatic forces, hydrogen bonding 
and hydrophobic and Van der Waals interactions. This feature constitutes the key to the 
immunochemical techniques (Marco et al., I, 1995).  
Immunoassay technology originated in the late 1950s when Yalow and Berson (Nobel Prize 
awarded) published the development of a quantitative immunological assay which could 
detect human insulin at the pictogram level in small samples of body fluid. In the following 
years this technology found wide application in biochemistry, endocrinology and clinical 
chemistry. The reasons for these developments include the selectivity and sensitivity 
exhibited by the antibodies and the simplicity of performing the immunoassays (Marco et al., 
I, 1995). Other immunochemical techniques like immunosensors are widely developed and 
used in different areas as well. However, small molecules are not able to produce an immune 
response, thus the small molecules need to be linked to a carrier, usually a protein, see also 
(1.4.2.3.). 
1.4.2 Production of antibody 
1.4.2.1 Antibody introduction  
Antibodies are large proteins produced by vertebrates and play an important role in 
identifying and eliminating foreign objects. The basic structural unit is composed of two 
heavy chains and two light chains, as shown in Figure 7. Antibodies bind other molecules 
known as antigens. Binding occurs in a small region near the ends of the heavy and light 
chain called the hypervariable region (labelled only on one arm in the figure). As the name 
implies, this region is extremely variable, which is why vertebrates can produce millions of 
antibodies that can bind many different antigens. The part of the antigen that is recognised by 
the antibody is known as an epitope. 
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There are five classes of immunoglobulins (Igs)—IgA, IgD, IgE, IgG, and IgM—defined by 
the amino acid sequence of the heavy chain. The Igs have different roles in immune responses 
(www.virology.ws). 
Figure 7 Structure of IgG monoclonal antibody molecule 
 
Ref: (www.virology.ws)  
1.4.2.2 Target molecule selection 
A good knowledge of the analytical target, its chemical structure, its stability and its 
degradation routes are required before assay development starts. Another important 
requirement is to establish the purpose of the analysis: is it to be class-selective or analyte 
selective? For use on an immunoaffinity column for some screening IAs a class-specific 
antibody may be more convenient than a very selective Ab, particularly with regard to the fact 
that many substances suffer degradation for biotransformation to other chemically related 
compounds. Finally, it is also important to know the kind of matrix to which the 
immunochemical analysis is going to be applied. Thus, metabolites or protein adducts may be 
the targets for Ab development when the aim of the analysis is biological monitoring of 
exposure to toxicants and/or pollutants (Marco et al., II, 1995). 
If the target compound contains functional groups such as NH2, COOH, OH, SH, CO or 
CHO, direct covalent coupling to the carrier molecule can be performed. However, to avoid 
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masking essential groups for the Ab recognition, a hapten should be usually prepared. A 
hapten is a derivative of the target molecule that contains an appropriate group (linker or 
spacer arm) for attachment at a convenient place in the molecule (Marco et al., II, 1995). 
1.4.2.3 Hapten design  
The term hapten is originally from Greek haptein and means to grasp. In immunochemistry, 
hapten is substance that acts as an antigen by combining with particular bonding sites on an 
antibody. A hapten conjugated to a carrier protein may cause an immune response (Mosby, 
2009). Unlike a true antigen, it does not induce the formation of antibodies.  
The design of a hapten is the most crucial step in the development of an immunochemical 
technique for all low-molecular-mass substances. The specificity and selectivity of 
immunochemical techniques are mainly determined by the Ab. A hapten should preserve as 
much as possible the chemical properties of the target molecules. However, characteristic 
portions of the molecules are sometimes sufficient to generate valuable antibodies. Exposure 
of the molecule to the immune system is greater for these sites placed further from the 
attachment point, thus determining the selectivity of the resulting antibodies. Using important 
functional groups of the target analyte leads to a reduction of the sites that could potentially 
help to stabilize the Ab-analyte immunocomplex. Antibodies with lower affinity may thus be 
obtained, leading to less sensitive assays. The length and structure should be chosen to reduce 
spacer recognition while maximising target exposure to the immune system. However, 
usually different haptens are used as immunogen and competitor. The length, size or/and 
chemical structure of the spacer arm is different in the immunogen and competitor. An 
optimal competitor hapten must be tested for every assay (Marco et al., II, 1995). 
1.4.2.4 Hapten synthesis and conjugation to carrier molecules 
Haptens could be purchased commercially or synthesized in house. Table 3 shows a summary 
of some common coupling strategies. The functional group of the hapten governs the 
selection of the conjugation method to be used (Marco et al., II, 1995). Keyhole limpet 
hemocyanin (KLH), tyroglobulin (TG), conalbumin (CONA), bovine serum albumin (BSA) 
or ovalbumin (OVA) are the carrier proteins most frequently used as either immunogens or 
coating Ags. As competitors, enzymes are the most commonly used labels in IA, but a variety 
of fluorescent labels are also available and increasingly being used. 
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Table 3 Principal strategies for protein conjugates 
 
Ref: (Marco et al., II, 1995) 
In this context, the effect of the resulting hapten-protein ratio in the conjugates should be 
noted. Usually it is considered that a high ratio of hapten per protein increases the strength 
and specificity of the immune response, but for competitors (an enzyme, protein or 
derivatised solid surface) a moderate value is more desirable, favouring the sensitivity of the 
resulting competitive immunoassay (IA). Theoretically, when the amount of hapten in the 
competitor is limited, less analyte in solution is needed to compete for the specific Ab. There 
is also a risk that a high degree of substitution could affect the activity of enzymes or 
antibodies when these are the labelled immunoreagents (Marco et al., II, 1995).  
1.4.2.5 Immunisation, fusion and hybridoma  
For obtaining antibodies, essentially any vertebrate can be used. Sheep, goats and cows offer 
the possibility of obtaining larger amounts of Ab; but rabbits, mice and rats are used because 
they are easy to care for and produce moderate amounts of serum. 
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Figure 8 Monoclonal antibody production 
  
Ref: (Vanderlaan et al., 1988) 
The production of polyclonal Abs is relatively simple but monoclonal antibodies offer the 
advantage of containing a defined Ab type and being produced by established cell lines, 
yielding unlimited quantities of antibodies as long as the hybridoma line is stable. However, 
for both research and commercial purposes, polyclonal antibodies are often sufficient and 
reduce costs of the research. Nevertheless, the quality of the antibodies (either polyclonal or 
monoclonal) depends mainly on the animal’s immune system, the immunogen, and the 
immunisation schedule or protocol used. A number of immunisation procedures has been 
described but, because of animal variability and the diversity of immunogens used, no 
conclusion can be drawn on which are the more efficient methods (Marco et al., II, 1995). 
In 1975 George Köhler and Ceasar Milstein revolutionised the production of antibodies by 
developing a method for culturing the particular lymphocytes that secrete antibodies (Figure 
8) (Köhler & Milstein, 1975). Briefly, after several weeks of immunisation, a rat/mouse is 
sacrificed and its spleen cells are used as the source of antibody-secreting lymphocytes. Even 
Doctoral thesis, Xiao Chen, 2011 
 
36 
 
though these cells normally do not grow in culture, antibody secreting cell lines could be 
created by fusing them with cells that do grow in culture-in this case, myeloma tumor cells. 
Spleen cells and tumor cells are mixed in the presence of polyethylene glycol, where they fuse 
into a new cell type, called a hybridoma, which grows in culture like the tumor cell and 
produces antibodies like the spleen cells. Hybridomas are seeded at roughly one colony per 
well in multi-well plates for cloning (Vanderlaan et al., 1988). 
The greatest task in making monoclonal antibodies is the rapid screening of hybridomas to 
find the 1-10 per spleen that produce the best antibodies. Each hybridoma secrets its own 
monoclonal antibody in to the cell culture medium of its well, and medium samples are 
screened by immunoassay. Once selected, the clones are expanded into the larger wells of a 
24-well plate and then to bulk spinner flasks. There is at least a three month period from the 
time of fusion until large quantities of antibodies are available. During this time, there are 
continuous rounds of subculturing the cells, assaying the media from wells, selecting the 
desired clones, and expanding the culture to ensure that, in the end, the cells are stable and 
uniform and each cell is secreting the best antibody. These antibodies are called monoclonal 
antibodies (mAbs) because they are produced from a single strain of B-cells. Before Köhler 
and Milstein, the only means of obtaining monoclonal antibodies was to purify them from the 
polyclonal serum of immunized animals (Vanderlaan et al., 1988). 
Antibodies can be used as serum or ascites fluid, or well purified. The most commonly used 
purification methods include ammonium sulphate purification and affinity purification. Once 
the affinity of the resulting sera or ascites fluid for the target analyte has been proven by 
titration experiments, the purified antisera can be used directly for the preparation of 
immunoaffinity columns or direct immunosensors (Marco et al., II, 1995). 
1.4.3 Immunoassay and different formats 
Immunoassay (IA) is based on the use of labels to detect the immunological reaction. 
Although fluorescent and chemiluminescent labels have become more popular, enzyme labels 
such as horseradish peroxidase or alkaline phosphatase are still the most popular non-isotopic 
labels, alongside the use of radioisotopes in radioimmunoassay formats. Among the enzyme 
immunoassays, those based on heterogeneous conditions are most commonly employed and 
are referred to as enzyme-linked immunosorbent assays (ELISAs). For ELISAs, either Abs or 
Ags are immobilised on a solid phase to facilitate the separation of free and bound fractions.  
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1.4.3.1 Enzyme-tracer format ELISA 
An equilibrium is established between the Ab bound to the solid surface (either directly or 
through orientating reagents such as anti-IgG or protein G, protein A), the analyte, and the 
analyte-enzyme tracer which are in solution. After the main incubation step the unbound 
reagents are washed away and the amount of enzyme bound to the solid phase by the Ab is 
measured.  
1.4.3.2 Coating antigen format ELISA  
This format is based on the competition between the immobilised Ag (or surface derivatised 
analyte) and the analyte for a fixed small amount of labelled Ab. The concentration of the 
analyte is measured indirectly by the quantification of bound Ab with a second Ab which is 
covalently labelled with an enzyme or other markers (Marco et al., II, 1995).  
The coating antigen and enzyme-tracer format ELISAs are both competitive assays thus the 
signals are inversely proportional to analyte concentration.  
1.4.3.3 Sandwich ELISA 
In this case, an excess of labelled Ab is used to detect the analyte captured by another Ab 
bound to the solid surface. This configuration is restricted by the fact that the analyte must 
have multiple Ab binding sites (Marco et al., II, 1995). This assay format is very commonly 
used in the clinical field for big molecules detections like proteins or peptides. Differently to 
competitive assays, sandwich ELISAs present proportional signals to analyte concentration. 
1.4.4 Optimisation of immunoassays  
The final goal of an immunoassay development is to establish a specific, sensitive and stable 
assay, which fulfils the demand of target analyte detection. Due to the multiple steps of assays 
and their variability of material and methods, many aspects have to be considered for assay-
optimisation. 
1.4.4.1 Test sensitivity 
A plenty of test systems require a very high sensitivity of assays, because the natural 
occurrence of some targeting substances is in a very low concentration range, e.g. in nano 
molar or pico molar. If the working range of assays could not reach the demanding sensitivity, 
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the assays are then not able to detect the required analytes in samples. Thus the different assay 
conditions should be tested to obtain more sensitive assays. 
1.4.4.2 Reagents  
Generally for ELISA tests, all buffers, blocking solutions and standards are strongly 
recommended to be prepared freshly. The chemical or biological reagents should be carefully 
stored to avoid the changing or losing of their chemical or biological activity. To minimise the 
freeze-thaw process, it is recommended to aliquot the reagents. A high quality assay can be 
achieved only, when the antibody and antigen could perform the best binding. For this 
purpose, the assay format, coating of microtiter plate, e.g. the antigen-conjugates, must be 
tested. Also the blocking of the plate, the buffers for reagents set up, the different incubation 
times should be considered.  
Besides the conditions described above, a correct dilution of antibody plays an essential role 
on assay sensitivity. The antibody dilutions are only appreciated, if they could show the 
concentration dependent signals. A zero (only buffer) and a high concentration of analyte 
should be compared for the same antibody concentration and a decreased optical signal must 
be seen with the addition of high amount of analytes if the antibody dilution is in dynamic 
range. Thus, a two dimensional titration is very useful to obtain the best dilution combinations 
of antibodies, coating antigen, enzyme-tracer, secondary antibodies or analytes dependent on 
assay formats. 
1.4.4.3  Hapten conjugates 
It was discussed in the previous section (1.4.2.4) that the hapten-conjugates have strong 
influence on immunoassays because they directly affect the resulting antibody properties. In 
assays the hapten-protein and the hapten-tracer conjugates would have an effect on the 
performance of assays in different formats. Despite the selection of haptens, the hapten 
density, which means the hapten amount on one carrier macromolecule, is essential for assays 
sensitivity. It was mentioned that a high conjugation density (many epitopes) is required for 
the hapten-protein conjugates for immunisation purpose. However, for coating antigen assays, 
a reduced hapten density is preferred due to the binding competition with analytes to 
antibodies. But the hapten amount could not be too low that there is no more binding of 
antigen to antibodies. Similarly, a low hapten density of hapten-tracer conjugation was 
recommended for more sensitive enzyme-tracer assay. Therefore, different conjugation rates 
should be compared to get most sensitive assays. 
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1.4.4.4 Buffers and blocking systems   
Not only the primary antibody, the secondary antibody, coating antigen and enzyme-tracer 
influence the assay sensitivity, the buffers and blocking solutions also have drastic effect on 
ELISAs. The important buffers are standard buffer, buffer for sample and conjugation 
dilution, wash buffer, coating and blocking buffer. A correct physiological condition is very 
important for ELISAs according to the biological natures of the antibodies and enzymes. The 
buffer must fulfil the criteria like pH, salt content, buffer range, viscosity, etc. 
correspondingly to the assays. The goal of buffer selection is to obtain stable and sensitive 
assays with low standard deviation and low background. In order to reduce unspecific binding 
on coated plate, a blocking was very often performed with addition of different kinds of 
proteins or protein mixtures. Albumin is commonly used as blocking substance and also 
smaller proteins like casein for example were used for blocking. Effective blocking could 
significantly reduce the unspecific binding but a blocking could also cause increased 
background. In general, the blocking substance should not interfere with the ELISA system. 
For example, BSA should not be used as blocking agent, if the antibody was generated with 
hapten-BSA conjugate. 
Not only the in-lab prepared but also the commercially purchased buffers should always be 
controlled, because a small change of the buffer composition could have huge effect on 
assays.  
1.4.4.5 Immobilisation on the surface of microtiter plate 
Depending on ELISA format, the surface of microtiter plate can be immobilised (coated) with 
antigens, antibodies, hapten-protein-conjugates or some other materials like streptavidin. 
There are different kinds of specialised mitrotiter plates available, using optimised adsorptive 
surface. Lipophilic substances, proteins or sugars could be immobilised on the surface. A high 
purity of the coating substance is required because the biological products might contain other 
proteins in matrix, which could also bind on the plate surface besides the target coating 
substance. 
1.4.5 Immunoassay evaluation 
Accuracy describes the exactness of the assay to measure a known, true value of analyte and 
to measure it repeatedly. Accuracy is expressed as the per cent error between the assay-
determined value and the assigned value for that sample. A per cent error of ≤20% is an 
Doctoral thesis, Xiao Chen, 2011 
 
40 
 
acceptable level of accuracy for an enzyme immunoassay (O'Connell et al., 1993). Precision, 
a measure of the degree of repeatability of an assay under normal operating conditions, is 
expressed as the coefficient of variation of the concentrations calculated for the standard 
reference curve dilutions within a single assay plate (intra-assay precision) and between 
different assay plates (inter-assay precision) determined over time and controlling for 
different operators. Acceptable levels of intra-assay and inter-assay precision are 10% and 
20%, respectively (O'Connell et al., 1993), and these can be used to define the range of the 
assay and the upper and lower limits of determination (LOD). The working range of the assay 
is the interval between the upper and lower levels of analyte that have been demonstrated to 
be determined with these levels of precision and accuracy. 
The “goodness of fit” of the assay is, for comparative purposes, an indication of how closely 
the data points of the reference serum standard curve fit the four parameter model. Goodness 
of fit is expressed as the regression coefficient (R
2
) of the standard curve. An R
2
 value is 
indicative of a good fit for the data to the curve (Quinn et al., 2002). 
1.4.6 Fluorescence in immunochemistry 
1.4.6.1 Fluorescence  
Fluorescence is the emission of visible light from fluorophore substance at electronic excited 
states after excitation with shorter wavelength light. It includes excitation and emission 
process of fluorophores, which means receiving and releasing of energy. There are different 
kinds of fluorescent substances and the typical structures of fluorescent dyes are shown in 
Figure 9. Fluorescence phenomena have been widely applied in the chemical and biological 
sciences, e.g. fluorescence immunoassay, fluorescence microscopy, confocal laser scanning 
microscopy (LSM), fluorescence in situ hybridisation (FISH) etc. The measurement of 
fluorescence can provide information on a wide range of molecular processes, including the 
interactions of solvent molecules with fluorophores, conformational changes, and binding 
interactions (Lakowicz, 2006).  
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Figure 9 Chemical structures of typical fluorescent dyes  
 
Ref: (http://www.dyespigments.com/fluorescent-dyes.html) 
The invention of water soluble cyanine fluorescent dye is a revolutionary step of the 
fluorescent technology, and now the cyanine dyes are becoming the most popular fluorescent 
dyes for biological science. Commercially, cyanine dyes are differently termed, which include 
CyDye, Cy2, Cy3 and Cy5 from Amersham Bioscience UK Ltd., Alexa Fluor and Texas red 
from Molecular Probes Inc., and Oyster from Denovo Biolabels GmbH (Raem & Rauch, 
2007). 
1.4.6.2 Fluorescent dye conjugation to antibody 
For fluorescence immunoassays a dye-antibody conjugation is normally required, and the 
carrying Ab can then serve as primary antibody or secondary antibody. Numerous companies 
offer ready to use fluorescent labelled antibodies. But for many primary antibodies, the users 
have to do the labelling themselves. A serious consideration must be taken to choose the 
suitable method for labelling due to the big amounts of commercially available dyes and 
variable conjugation methods. The conjugation of dyes using activated ester residues on NH2-
(lysine) of proteins is a very commonly used method (scheme see Figure 10). In this study, all 
conjugation experiments were performed using this reaction.  
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Figure 10 Fluorescent dye conjugation using activated amino groups on lysine residues of proteins  
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As discussed previously, due to the change of fluorescence through conjugation to protein, 
optimising steps must be processed to achieve the aimed applications. To check the quality of 
fluorescent dye conjugation, a determination of label degree, which indicates the molar ratio 
of dye and protein, is recommended. The label degree over 10 is reachable, however, in praxis 
a label degree between one and five is preferred. The high amount of protein bound dyes 
might modify the lysine in antigen binding domains and consequently reduce the antibody 
antigen binding affinity (Raem & Rauch, 2007). 
1.4.6.3 Tyramide Signal Amplification (TSA)  
TSA signal amplification, also named CARD, was introduced by Bobrow  et al., (1989, 1991, 
1992) for use in immunoblotting
 
and ELISAs and is based on the deposition of a large number
 
of haptenised tyramine molecules by peroxidase activity. Tyramine is a phenolic compound 
and HRP can catalyse the dimerisation of such compounds when they
 
are present at high 
concentrations, probably by the generation
 
of free radicals (Zaitsu & Ohkura, 1980). If 
applied in lower
 
concentrations, such as those used in the signal amplification
 
reaction, the 
probability of dimerisation is reduced, whereas
 
the binding of the highly reactive 
intermediates to electron-rich
 
moieties of proteins, such as tyrosine, at or near the site
 
of the 
peroxidase binding site is favored (Speel et al., 1999). Visualisation of deposited tyramides 
can be performed
 
either directly after the TSA reaction with fluorescence microscopy,
 
if 
fluorochrome-labelled tyramides are used, or indirectly with
 
either fluorescence or brightfield 
microscopy, if biotin, digoxigenin,
 
or di- or trinitrophenyl are used as haptens. This can act
 
as 
further binding sites for anti-hapten antibodies or (strept)avidin
 
conjugates (in the case of 
biotinylated tyramides, Speel et al., 1999). 
1.4.7 Aqua-Optosensor (AOS) 
Aqua-Optosensor is an optical immunosensor based on total internal reflectance fluorescence 
(TIRF). The sensor system consists of a disposable sensor chip and an optical readout device 
Doctoral thesis, Xiao Chen, 2011 
 
43 
 
(Sensor device see Figure 18, page 69). The chip is built up from a ground and cover plate 
with in- and outlet and, between, of an adhesive film with a capillary aperture of 50 µm. The 
ground plate serves as a solid phase for the immobilisation of bio-components e.g. the capture 
antibody or hapten conjugate. In the readout device, an evanescent field is generated at the 
surface of the ground plate by total internal reflection of a laser beam (principle see Figure 
11). This field is used for the excitation of fluorophore markers. The generated fluorescence 
light is detected by a simple optical setup using a photomultiplier tube and the voltage signal 
increase in time is directly proportional to the amount of fluorophore bound to the surface of 
the flow channel (Schult et al., 1999). 
Figure 11 Principle of the Aqua-Optosensor  
 
Principle of total internal reflectance fluorescence, figures supplied from Karin Wöllner (presentation file, 2010) 
For the excitation of the fluorophores the evanescent field of the laser light is used which is 
generated by total internal reflection of the laser beam at an interface between the high-
refractive (n1, PMMA, poly- (methyl methacrylate)) and the low-refractive (n2, liquid 
sample) material. The intensity of this field decreases exponentially with increasing distance 
from the interface in the half-space of the low refractive (n2) medium. Theoretical prediction 
and experimental results show that this increase is linear in the case of small analyte 
concentration and/or short times which always hold for the sensor setup presented here. 
Consequently, the slope of the linear increase is directly proportional to the concentration of 
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the analyte. From the increase of the fluorescence signal the initial slope (sensitivity), as 
mV/s, is calculated. In general, every kind of immunochemical assay can be performed with 
this setup (Schult et al., 1999).  
1.5 Outline of goal and tasks for this work 
Reviewing the current AHL detection methods, both of bioreporter assays and conventional 
chemical analyses have the advantages and disadvantages. According to this background, the 
development of a new sensitive AHL molecule detection system, based on anti-AHL 
antibodies, was set to be the goal of this study. The idea was to offer an additional AHL 
analytical method, which might also be possible for in situ detection of AHLs.  
As noticed in section 1.4, the key of an immunochemical technology is the antibody quality, 
which has direct influence on the assay sensitivity. Therefore the antibody establishment was 
the focus of this study. The tasks consisted of four main steps. A) The preparation of the 
immunisation, which contained the selection, synthesis of the AHL hapten and further 
conjugation to protein carriers. B) Production and screening of anti-AHL antibodies. C) 
Further characterisation of the antibodies and optimising of the immunoassays. D) 
Application of the assays for detection of QS molecules in biological samples from different 
biological origins. 
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2 Materials and methods 
2.1 Chemicals, standards and proteins 
Adipic acid, adipic acid dichloride, aluminium oxide, potassium hydroxide, toluene, benzyl 
bromide, tetrabutyl ammonium bromide, sebacid acid, Meldrum's acid, dichloromethane, 
4-dimethylaminopyridine, triethylamine, acetonitrile, (S)-2-amino-4-butyrolactone 
hydrobromide and sodium cyanoborohydrid were purchased from Sigma-Aldrich 
(Taufkirchen, Germany). Ethyl acetate, cyclohexane, ammonium chloride and acetonitrile 
(chromasolv) were purchased from Riedel-de-Haën (Seelze, Germany). Dimethylformamide, 
pyridine, hydrochloric acid, sodium hydroxide, sodium chloride, and sodium hydrogen 
carbonate were purchased from Merck (Darmstadt, Germany). Hexane was purchased from 
Promochem (Wesel, Germany). 
Table 4 Commercially purchased HSL standards  
 
HSLs Company  
C4-HSL Cayman chemical ,  USA 
3oxo-C4-HSL Not t ingham Universi ty,  UK  
3OH-C4-HSL Not t ingham Universi ty,  UK  
C6-HSL  Cayman chemical ,  USA 
C6-HSL (DL isomer)  Sigma Aldrich,  Germany  
3oxo-C6-HSL Sigma Aldrich,  Germany  
3OH-C6-HSL Not t ingham Universi ty,  UK  
C8-HSL Cayman chemical ,  USA 
3oxo-C8-HSL Sigma Aldrich,  Germany  
3OH-C8-HSL Not t ingham Universi ty,  UK  
C10-HSL Cayman chemical ,  USA 
3oxo-C10-HSL Sigma Aldrich,  Germany  
3OH-C10-HSL Not t ingham Universi ty,  UK  
C12-HSL Sigma Aldrich,  Germany  
3oxo-C12-HSL ( in ethanol)  Cayman chemical ,  USA 
3oxo-C12-HSL  Cayman chemical ,  USA 
3OH-C12-HSL Not t ingham Universi ty,  UK  
All substances in powder form and L isomer if not noticed. 
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The haptens N-(11-carboxy-3-oxoundecanoyl)-L-homoserine lactone (HSL1), N-(5-
carboxypentanoyl)-L-homoserine lactone (HSL2), N-(11-carboxy-3-hydroxyundecanoyl)-L-
homoserine lactone (HSL3), and N-(9-carboxynonanoyl)-L-homoserine lactone (HSL4) were 
synthesised in house.  
The HSL standards were purchased from different companies (Table 4). The homoserine 
molecules (HS), the hydrolysis products of HSLs, were prepared in house. Briefly, 1 mg of 
HSL substances was solved in 900 µL ACN and 100 µL 1M NaOH was added to the solution 
at room temperature and shaken for 15 min. The homoserine lactone rings were supposed to 
be completely opened according to (Engelmann et al., 2007) and ready for use as stock 
solution for assays. 
For conjugations, N-hydroxysuccinimid (NHS), 1,3-dicyclohexylcarbodiimide (DCC), N,N-
dimethylformamide 99% (DMF), ovalbumin from chicken egg white (OVA), albumin from 
bovine serum (BSA), and sodium tetraborate were purchased from Sigma-Aldrich 
(Taufkirchen, Germany). Horseradish peroxidase (HRP) was purchased from Serva 
Electrophoresis (Heidelberg, Germany). Boric acid was from Riedel-de-Haën (Seelze, 
Germany). SuperFreeze peroxidase stabilizer was purchased from Pierce/Perbio (now Thermo 
Fisher Scientific, Bonn, Germany). 
For ELISAs, protein G from Streptococcus and slim milk powder, hydrogen peroxide (H2O2) 
and 3,3’,5,5’-tetramethylbenzidine (TMB) were purchased from Sigma-Aldrich (Taufkirchen, 
Germany). Mouse anti-rat IgGs (TIB170, TIB 172, TIB 173 and TIB 174) are in house clones 
(E. Kremmer, IMI, HMGU). They are commercially available from ATCC (American Type 
Culture Collection, Manassas, USA). Goat anti-rat antibody (GAR) conjugated with HRP was 
obtained from Dianova (Hamburg, Germany). Dimethylsulfoxide (DMSO), 99%, was 
purchased from Fluka (now Sigma-Aldrich). Buffer salts (sodium dihydrogen phosphate 
monohydrate, disodium hydrogen phosphate dehydrate and sodium chloride, sodium acetate, 
sodium carbonate, citric acid mono hydrate), Tween 20 and sulphuric acid, 95-97%, were 
purchased from Merck (Darmstadt, Germany).   
2.2 Instruments for hapten syntheses 
NMR spectra were acquired on solutions containing 0.4-0.7 mg HSL substances in 0.5-0.75 
mL CDCl3. 
1
H and 
13
C NMR spectra were obtained at 303 K with a 5mm z-gradient 
13
C/
1
H 
dual cryogenic probe using 90° excitation pulses on a Bruker DMX 500 spectrometer 
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(Rheinstetten, Germany) operating at 500 MHz. Chemical shifts (ppm) were reported relative 
to internal CDCl3 (
1
H, 7.24 ppm and 
13
C, 77.00 ppm). 
UPLC-MS measurements were carried out with a NanoAcquity UPLC system (Waters, 
Milford, USA) coupled to a Q-TOF2 mass spectrometer (Waters-Micromass, Manchester, 
UK) using negative electrospray ionisation. After injection of 0.5 µL sample volume, the 
analytes were trapped for preconcentration on a symmetry C18 column (5 µm, 180 µm x 20 
mm) for 4 min at a flow rate of 4 µL min
-1
 and separated subsequently at 0.4 µL min
-1 
and 
30°C on an Atlantis C18 nano-column, (3 µm, 75 µm x 150 mm, both Waters, Milford, USA) 
with an initial mobile phase composition of 95% of eluent A (methanol/water 10:90 v/v, 2 
mM ammonium acetate and 5% eluent B (methanol, 2 mM ammonium acetate). The eluent 
gradient started after a delay of 2 min increasing to 30% B within 5 min. A final gradient 
increase to 100% B followed by further 15 min holding this composition for 4 min. Then 
immediate switching to initial conditions was done followed by an equilibration time of 9 min 
until the end of the cycle after 35 min in total. Thus the retention time of 17.6 min for HSL3 
and 18.2 for the co-product was measured. Voltage of PicoTip electrospray emitter (10 µm 
orifice, New Objective, USA) was set to 1.8 kV, MS cone voltage 17 V, collision energy 8 
eV, MCP detector 2.3 kV and scan time was 2 sec from m/z 120 – 500. The analytes were 
detected as mono-deprotonated (M-1)-molecular ions with m/z 328.2 and m/z 360.2. 
2.3 Synthesis of HSL haptens 
2.3.1 Synthesis of sebacic acid monobenzyl ester (1) 
 
Sebacic acid (HOOC-(CH2)8-COOH, MW=202) [20 mmol] was reacted with a potassium 
hydroxide solution (KOH, MW=56 [20 mmol] in 40 mL distilled water under stirring for 1 h 
at 40°C. Ethanol was added and the azeotrope was evaporated to dryness. 60 mL of toluene 
were added and mixed with 2 mmol tetrabutyl ammonium bromide (TBAB, MW=322) and 20 
mmol of benzyl bromide (MW=171). The reaction was stirred under reflux for 5 h. After 
cooling down to RT, the solvent was removed.  
HOOC
COOH
Br
TBAB 
HOOC
COOBn
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The residue was purified on silica gel column chromatography using a gradient of 
CH2Cl2/CH3OH/CH3COOH=99.5/0.47/0.03 (Begin) 
CH2Cl2/CH3OH/CH3COOH=95/4.5/0.5 (after seeing the first molecule) 
as eluent. 
2.3.2 Synthesis of N-(9-benzylcarboxyl-1-hydroxy)-Meldrum’s acid (2) 
 
4.05 mmol of the purified sebacic acid monobenzyl ester (MW=292, 1 Eq), Meldrum’s acid 
(MW=144, 1 Eq), and dimethyl aminopyridine (DMAP, MW=122, 1.05 Eq) were dissolved 
in 47 mL dry CH2Cl2. The reaction mixture was cooled down with an ice bath (4°C) and EDC 
(MW=191, 1.1 Eq) was added. The mixture was stirred for 1 h at 4°C then overnight at RT. 
The solvent was evaporated off and the crude residue dissolved in 75 mL ethyl acetate (EA) 
and washed twice with 20 mL (2 x 20 mL) 2N HCl. The aqueous phases were joined and 
washed with 25 mL ethyl acetate. The EA phases were joined and dried over Na2SO4. Na2SO4 
was filtered off and the solvent was removed. The crude product was used without further 
purification.  
2.3.3 Synthesis of N-(11-benzylcarboxy-3-oxoundecanoyl)-L-homoserine 
lactone (3) 
6.86 mmol of 2 (MW=292, 1 Eq), -amino-γ-butyrolactone hydrobromide (MW=182, 1Eq) 
and 1.145 mL triethylamine (MW=109, 1.2 Eq) were dissolved in 110 mL acetonitrile and 
stirred 2 h at RT then 3 h under solvent reflux.  
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Thereafter, the solvent was removed. The residue was dissolved in ethyl acetate (50 mL) and 
washed with: 
1 x NaHCO3 sat (30 mL) 
1 x NH4Cl sat (30 mL) 
1x NaCl sat (30 mL) 
The organic phase was then dried over Na2SO4. Na2SO4 was filtered off and the solvent was 
removed.  
The crude product was purified by column chromatography on silica gel using a mixture ethyl 
acetate (80%)-cyclohexane (20%) as eluent. 
2.3.4 Synthesis of N-(11-carboxy-3-oxoundecanoyl)-L-homoserine 
lactone (HSL1) (4) 
O
N
H
O
O
O
HOOCBnOOC
O
N
O
O
O
H
H2, Pd/C
 
370 mg of 3 (MW=417, 1 Eq) and 37.4 mg Pd/C were dissolved in 11 mL absolute methanol. 
The atmosphere in the flask was purged with vacuum/N2 and placed under H2 atmosphere for 
4 h. The catalyst was filtered out and the solvent evaporated off. The dried product had a 
weight of 266 mg and was used without further purification. 
HSL1: 
13
C NMR (500 MHz, CDCl
3
): δ = 206.49; 179.67; 172.17; 163.84; 66.06; 61.16; 49.65; 40.04; 
33.98; 33.29; 29.53; 29.37; 29.14; 29.07; 24.81; 23.21. 
1
H NMR (500 MHz, CDCl
3
): δ = 9.85 (s, 2H); 4.45 (m, 1H); 4.39 (m, 1H); 4.26 (m, 1H); 3.58 
(s, 2H); 2.52 (m, 1H); 2.31 (m, 2H); 2.30 (m, 2H); 2.26 (m, 1H); 1.59 (m, 2H); 1.54 (m, 2H); 
1.52 (m, 2H); 1.28 (m, 2H); 1.27 (m, 2H); 1.23 (m, 2H). 
 
Doctoral thesis, Xiao Chen, 2011 
 
50 
 
2.3.5 Synthesis of N-(5-carboxypentanoyl)-L-homoserine lactone (HSL2) 
(5) 
 
 
 
 
 
Adipic acid (MW = 146) 643 mg and 4-dimethylaminopridine (MW = 122) 20 mg were 
solved in 0.35 mL dimethylformamide. Accordingly 0.6 mL adipic acid dichloride (4 mmol, 
MW = 183) were added and stirred for 4 days. After addition of 1.465 g (s)- -amino- -
butyrolactone hydrobromide (8 mmol, MW = 182) and 10 mL pyridine the mixture was 
stirred 2 days. After removal of the solvent with nitrogen flow, 3 mL H2O was added and the 
mixture was extracted with ethyl acetate. The extract was purified with a short aluminum 
oxide column. After recrystallization in ethyl acetate/hexane solution, 1 g of raw product was 
gained (MW = 247, circa 50%). 
HSL2: 
13
C NMR (500 MHz, CDCl3): δ =176.28; 174.3; 172.17; 66.06; 62.12; 36.77; 33.29; 33.00 
24.00; 23.87. 
1
H NMR (500 MHz, CDCl3): δ = 8.84 (s, 2H); 4.45 (m, 1H); 4.39 (m, 1H); 4.15 (m, 1H) 2.52 
(m, 1H); 2.36 (m, 2H); 2.26 (m, 1H); 2.25 (m, 2H); 1.96 (m, 2H) 1.65 (m, 2H). 
N
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2.3.6 Synthesis of N-(11-benzylcarboxy-3-hydroxyundecanoyl)-L-
homoserine lactone (6) 
BnOOC
O
N
O
O
O
H
OH
N
H
O
O
O
BnOOC
NaBH3C
MeOH
 
Sodium cyanoborohydride (2.9 mmol, MW=63, 1.5 Eq) was added to a solution of 1.9 mmol 
of 3 (MW=417, 1 Eq) in 15 mL methanol. The reaction mixture was maintained at pH 3-4 by 
addition of 3% HCl in methanol. Three further additions of sodium cyanoborohydride (3 x 2.9 
mmol) were made at 3 h intervals while the pH was kept at 3-4. The solvent was removed by 
rotary evaporation, and the residue was extracted with hot ethyl acetate (4 x 20 mL). The 
ethyl acetate extracts were combined and concentrated to yield the crude product, which was 
purified by silica column chromatography on silica gel using as eluent 10% MeOH in DCM. 
2.3.7 Synthesis of N-(11-carboxy-3-hydroxyundecanoyl)-L-homoserine 
lactone (HSL3) (7) 
 
 
587 mg of 6 and 58.7 mg Pd/C were dissolved in 17 mL absolute methanol. The atmosphere 
in the flask was purged with vacuum/N2 and placed under H2 atmosphere for 2.5 h. The 
catalyst was filtered out and the solvent evaporated off. The dried product had a weight of 446 
mg. Due to impurity of HSL3, further purification was performed by crystallization in 25% 
acetonitrile (v/v) at 4 °C over night. The purified HSL3 was characterised with NMR and LC-
MS (Figure 12). 
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Figure 12 Mass spectrum (LC-MS) of HSL3  
 
A: Purified HSL3 [(M –H) 328.175]; B: HSL3 [(M –H) 328.175]; and its containing the hydrolyzed byproduct 
[(M –H) 360.198] before purification 
2.3.8 Synthesis of N-(9-benzylcarboxy nonanoyl)-L-homoserine lactone 
(8) 
 
 
1.4 mmol of 1 (MW=292, 1.25 Eq), triethylamine (2.3 mmol, MW=101, 2 Eq), -amino-γ-
butyrolactone hydrobromide (1.1 mmol, MW=182, 1 Eq) were dissolved in 11 mL dry 
BnOOC N
H
O
O
O
BnOOC
COOH
EDC, DCM 
O
O
NH
2
*HBr
A 
B 
m/z 
300 310 320 330 340 350 360 370 380 
% 
0 
100 
328.184 
326.159 316.177 
360.198 
329.181 
359.361 
329.266 
360.313 
361.25
9 
m/z 
300 310 320 330 340 350 360 370 380 
% 
0 
100 
328.175 
327.873 
329.182 
330.185 
Doctoral thesis, Xiao Chen, 2011 
 
53 
 
dichloromethane. The reaction was cooled down with ice bath and kept under stirring for 1 h. 
EDC (1.7 mmol, MW=191, 1.5 Eq) was added and the mixture was stirred at RT for 48 h. 
DCM was removed by rotary evaporation. The residue was dissolved in ethyl acetate (30 mL) 
and washed with: 
2 x 10 mL NaHCO3 satured 
2 x 10 mL NH4Cl satured 
1 x 10 mL NaCl satured 
The organic phase was then dried over Na2SO4. Na2SO4 was filtered off and the solvent was 
removed. The crude product was purified by silica column chromatography on silica gel 
(ethyl acetate/cyclohexane: 80/20). 
HSL3: 
13
C NMR (500 MHz, CDCl3): δ = 179.05; 176.92; 172.17; 69.62; 66.06; 62.12; 41.62; 35.71; 
34.23; 33.29; 29.44; 29.14; 29.03; 28.47; 24.81; 24.62. 
1
H NMR (500 MHz, CDCl3): δ = 7.10 (s, 3H); 4.45 (m, 1H); 4.39 (m, 1H); 4.15 (m, 1H); 3.84 
(m, 1H); 2.52 (m, 1H); 2.31 (m, 2H); 2.29 (m, 1H); 2.26 (m, 1H); 2.10 (m, 1H); 1.52 (m, 2H); 
1.46 (m, 1H); 1.30 (m, 2H); 1.28 (m, 2H); 1.27 (m, 1H); 1.26 (m, 2H); 1.25(m, 2H); 1.23 (m, 
2H). 
2.3.9 Synthesis of N-(9-carboxynonanoyl)-L-homoserine lactone 8 (HSL 
4) 
 
 
 
205 mg of 7 (MW=375) and 20.5 mg Pd/C were dissolved in 7 mL absolute methanol. The 
atmosphere in the flask was purged with vacuum/N2 and placed under H2 atmosphere for 3 h. 
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Thereafter, the catalyst was filtered out and the solvent was evaporated off. The dried product 
had a weight of 139 mg and was used without further purification. 
HSL4: 
13
C NMR (500 MHz, CDCl3): δ = 179.67; 176.28; 172.17; 66.06; 62.12; 36.56; 33.98; 33.29; 
29.5; 29.18; 29.01; 26.76; 25.97; 24.81. 
1
H NMR (500 MHz, CDCl3): δ = 9.10 (s, 2H); 4.45 (m, 1H); 4.39 (m, 1H); 4.15 (m, 1H); 2.52 
(m, 1H); 2.29 (m, 2H); 2.26 (m, 1H); 2.10 (m, 2H); 1.60 (m,2H); 1.52 (m, 2H); 1.42 (m, 2H); 
1.35 (m, 2H); 1.34 (m, 2H); 1.23 (m, 2H). 
2.4 Materials and instruments for ELISA 
Ultra-pure water used for buffers and all other solutions, was prepared by Milli-Q filter 
system from Millipore (Eschborn, Germany). Nunc MaxiSorp™ 96-well microtiter plates and 
lids were purchased from Thermo Fisher Scientific (Schwerte, Germany) and Greiner 96-well 
U-shape medium binding plates were from Greiner Bio-One (Solingen-Wald, Germany). 
Washing steps in microtiter plates were performed with an automated microtiter plate washer 
from Bio-Tek Instruments (Bad Friedrichshall, Germany). Absorbance was read by a multi-
detection reader Spectra Max M5
e
 from Molecular Devices (Palo Alto, USA, now part of 
Danaher Corporation, Washington, DC, USA). A heating-shaking-mixing system, Heidolph 
incubator 1000 from Metrohm (Herisau, Switzerland), was used for incubation or shaking. 
Centrifugation for conjugate preparations was performed with a Heraeus Sepatech Biofuge 
1.5 (Hanau, Germany) in 500 µL protein low-bind tube from Eppendorf (Hamburg, 
Germany). During incubations, solutions were covered with parafilm (Pechiney Plastic 
Packaging, Menasha, USA). 
2.5 Preparation of hapten-protein conjugates for immunogens and 
coating antigens 
The haptens (HSL1, HSL2, HSL3, and HSL4) were conjugated to BSA and OVA according 
to the active ester method as described previously (Krämer, et al., 2004, 2005). For example, 
for HSL1-BSA or HSL1-OVA, for each of the conjugates 47 µmol of NHS and 51 µmol of 
DCC were dissolved in 150 µL DMF, and the solution was added to 46 µmol of the hapten 
HSL1, respectively. This activation reaction was carried out for 4 h at RT with stirring. After 
that, the white precipitate urea was removed by centrifugation with 1400 rpm for 10 min. The 
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proteins BSA and OVA were solved in 40 mM PBS, pH 7.6 (15 mg in 1.5 mL), and the 
activated hapten solution was added slowly (10-20 µL per 10 min) to the protein solutions. 
Approximately 140 µL of hapten was added to each 1.5 mL protein solution. The conjugates 
were dialysed with 1 L 20 mM PBS buffer (pH 7.8) for 3 days in Slide-A-Lyser dialysis 
cassette (0.5-3 mL; 10 kDa MW cut-off) with buffer changes twice per day. For dialysis of all 
conjugations, Slide-A-Lyser dialysis cassettes, needles and syringes were purchased from 
Pierce/Perbio (now Thermo Fisher Scientific, Bonn, Germany) 
Figure 13 Schematic protein conjugation process of HSL3. 
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Totally, eight conjugates were produced: HSL1-BSA, HSL1-OVA, HSL2-BSA, HSL2-OVA, 
HSL3-BSA, HSL3-OVA, HSL4-BSA, and HSL4-OVA for immunisations. 
For the optimisation of the coating antigen ELISA format, HSL2-BSA-r1, HSL2-BSA-r2, 
HSL2-OVA-r2, HSL3-BSA-r1 and HSL3-BSA-r1 were conjugated with the analogous 
procedure as described above, but with a reduction in HSL hapten molecules per protein 
(Table 5).  
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Table 5 Preparation of hapten-protein conjugates for immunogens and coating antigens 
 
Conjugate Hapten Protein Hapten  
[µmol] 
NHS  
[µmol] 
DCC  
[µmol] 
DMF  
[µL] 
Protein  
[mg] 
HSL1-BSA HSL1 BSA 46 47 51 150 15 
HSL1-OVA HSL1 OVA 46 47 51 150 15 
HSL2-BSA HSL2 BSA 46 47 51 150 15 
HSL2-OVA HSL2 OVA 46 47 51 150 15 
HSL2-BSA-r1 HSL2 BSA 25 25 28 200 15 
HSL2-BSA-r2 HSL2 BSA 20 25 28 300 15 
HSL2-OVA-r2 HSL2 OVA 20 25 28 300 15 
HSL3-BSA HSL3 BSA 15 10 17 50 5 
HSL3-OVA HSL3 OVA 15 10 17 50 5 
HSL3-BSA-r1 HSL3 BSA 4 3 4 13 5 
HSL3-OVA-r1 HSL3 OVA 4 3 4 13 5 
HSL4-BSA HSL4 BSA 92 93 102 300 15 
HSL4-OVA HSL4 OVA 92 93 102 300 15 
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2.6 Characterisation of hapten protein conjugates with UV 
absorbance spectra 
The haptens, proteins and conjugates were diluted in 40 mM PBS and 250 µL well
-1
 of the 
prepared solution were pipette into the wells of a UV-star 96-well plate (Greiner Bio-one, 
Monroe, USA). The absorbance of the UV spectra of the HSL1, HSL2 and HSL4 conjugates 
were determined with a SAFIRE II microplate reader (Tecan, Switzerland) from 240-500 nm. 
Differently HSL3 conjugates were performed with the Spectra Max M5
e
 microplate reader 
(Molecular Devices, USA) with the same preparation procedure described above. The spectra 
were recorded and visualised automatically with the corresponding software of the 
instruments. Additionally, coating antigen format ELISAs were also used for determination of 
the binding of antibody-conjugates. The concentrations used for UV measurement of the 
conjugates, haptens and proteins are listed in Table 6. 
Table 6 Concentration of haptens, proteins and conjugates for UV absorbance spectra 
Hapten 
[mg mL
-1
] 
Protein 
[mg mL
-1
] 
Conjugate 
[mg mL
-1
] 
HSL1 
0.1 
BSA 
2.5 
OVA 
2.5 
HSL1-BSA 
2.5 
HSL1-OVA 
2.5 
HSL2 
0.1 
BSA 
2.5 
OVA 
2.5 
HSL2-BSA 
2.5 
HSL2-OVA 
2.5 
HSL3 
0.1 
BSA 
3 
OVA 
3 
HSL3-BSA 
3 
HSL3-OVA 
3 
HSL4 
0.1 
BSA 
1.25 
OVA 
1.25 
HSL4-BSA 
1.25 
HSL4-OVA 
1.25 
2.7 Preparation of enzyme-tracers 
As enzyme-tracers, HSL1-HRP, HSL2-HRP, HSL3-HRP, and HSL4-HRP were prepared 
according to the method described by Schneider & Hammock (1992). Briefly, for each 
enzyme- tracer, 3 µmol of hapten (HSL1, HSL2, HSL3, or HSL4) were used. A solution with 
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NHS (15 µmol) and DCC (30 µmol) in 130 µL DMF was added to each hapten. The mixture 
was then stirred at RT for 4 h and further for 12 h at 4°C. The solution was then centrifuged to 
remove the precipitates and the clear supernatants of the activated haptens were slowly added 
(10 µL per 10 min) to 3 mL of HRP solution (2 mg HRP in 3 mL 40 mM PBS, pH 7.6). After 
complete addition of hapten supernatants, the hapten-HRP mixtures were stirred for 12 h at 
4°C. After that, the conjugates were dialysed for 3 days in 1 L 20 mM PBS buffer (pH 7.6), 
using Slide-A-Lyser cassette (0.5-3 mL; 10 kDa MW cut-off), with a minimum of one buffer 
change per day. Finally, the HSL-HRPs were stored at 4 °C for use or partly at -20 °C with a 
1:3 dilution in SuperFreeze peroxidase stabilizer. Only HSL1-HRP and HSL3-HRP could be 
used for enzyme-tracer format assays. That was because HSL2-HRP and HSL4-HRP showed 
either weak binding or no inhibition, thus it’s difficult to obtain sensible assays. 
Table 7 Materials for enzyme-tracer production 
Enzyme-
Tracer 
Date Hapten 
[µmol] 
NHS  
[µmol] 
DCC 
[µmol] 
DMF 
[µL] 
HRP  
[mg] 
Buffer 
[mL] 
HSL1-HRP 08022008 HSL1, 3 µmol 15  30  130  3  3 (130 mM NaHCO3) 
HSL1-HRP 05062009 HSL1, 3 µmol 15  30  130  3  3 (130 mM NaHCO3) 
HSL2-HRP 08022008 HSL2, 3 µmol 15  30  130  3  3 (130 mM NaHCO3) 
HSL3-HRP 09052009 HSL3, <3 µmol 15  30  130  3  3 (130 mM NaHCO3) 
HSL3-HRP 25042008 HSL3(inpure), 3 µmol 15  30  130  3  3 (40 mM PBS) 
HSL3-HRP 06102009 HSL3, 3 µmol 15  30  130  3  3 (40 mM PBS) 
HSL4-HRP 25042008 HSL4, 3 µmol 15  30  130  3  3 (40 mM PBS) 
2.8 Production of anti-HSL monoclonal antibodies  
Approximately 50 µg of each immunogen conjugate was injected intraperitoneally and 
subcutaneously in to LOU/C rats using CPG2006 (TIB MOLBIOL, Berlin, Germany) as 
adjuvant. After 2 months a final boost was given 3 days before fusion. Fusion of the myeloma 
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cell line P3X63-Ag8.653 with the rat (or mouse) immune spleen cells was performed 
according to standard procedure (Kremmer et al., 1995). Hybridoma supernatants were tested 
in a solid-phase immunoassay using HSL-BSA conjugates adsorbed on polystyrene microtiter 
plates. After incubation with culture supernatant for 1 h, bound mAbs were detected using 
HRP-labelled goat-anti-rat IgG+IgM antibodies (Dianova) and o-phenylenediamine as 
chromogen in the enzyme reaction. A hapten-BSA conjugate, which was prepared in the same 
way, but with an unrelated hapten structure, was used as negative control (Performed by 
Kremmer, IMI; HMGU).  
2.9 Determination of immunoglobulin type 
The immunoglobulin (Ig) type of the mAbs was determined using biotinylated mAbs specific 
for IgM, IgG subclasses, and light chains ( -IgG1, -IgG2a, -IgG2b, -kappa (ATCC), -
IgM (Zytomed, Berlin, Germany), -IgG2c, -lambda (Ascenion, Munich, Germany). HPR-
labelled avidin (Alexis, Grünberg, Germany) was used to visualize the bound biotinylated 
mAbs. The mAbs present in this study were all IgG2a,κ antibodies (determined by Kremmer, 
IMI, HMGU). 
2.10  Purification of monoclonal antibodies and determination of 
protein concentration 
Protein G or protein A was used for purification of mAbs. A culture supernatant was added to 
protein G-Sepharose 4 Fast Flow (Amersham Pharmacia Biotech, Uppsala, Sweden), and the 
antibodies were eluted from the column with 0.1 mol L
-1
 citrate buffer, pH 2.7. Dialysis was 
performed against 40 mM PBS, pH 7.6, three times, each time with 100 times the antibody 
volume. Antibody solutions were sterile filtered with a 0.2-µm filter and stored at 4°C until 
used. The determination of protein concentrations of the antibodies was carried out with a 
spectrophotometer, on the basis of absorbance measurements at 235 nm and 280 nm  
(Whitaker & Granum, 1980) (performed by Kremmer, IMI, HMGU). 
2.11 Characterisation of HSL antibodies (anti-HSL mAbs) with 
enzyme-linked immunosorbent assay (ELISA) 
The antibody binding was determined against numerous HSL substances using coating 
antigen and enzyme-tracer format. Further antibody selection and application were all based 
on the characterisation of the antibodies. 
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2.11.1 Standard procedure of coating antigen format ELISA  
For antibody screening, HSL2-BSA was diluted to 2 µg mL
-1
 in 50 mM carbonate buffer, 
(100 µL per well, pH 9.6) for coating on MaxiSorp microtiter plate at 4°C, overnight. The 
next day, the plate was washed, 200 µL per well slim milk powder solution were added (1% 
in 40 mM PBS, 1 h) to block the unsaturated plate surface. During the time for blocking, 75 
µL analyte per well (commercially purchased HSL analogues in 40 mM PBS, pH 7.6) and 75 
µL mAb per well
 
(in 40 mM PBS) were pre-incubated in Greiner Bio-One U-shape plate 
(concentrations please see Table 14). The U-shape plates, containing 150 µL per well of 
analyte-mAb mixture, were covered with lids and shaken by Heidolph incubator 1000 for 1 h. 
Then the analyte-mAb (100 µL per well) mixture was transferred from U-shape plate to the 
blocked MaxiSorp plate after washing. The mixture was incubated for 1 h on the coated 
MaxiSorp plate. After the plate was washed again, 100 µL well
-1 
of a
 
mixture of biotinylated 
mouse anti-rat mAbs (named TIBmix: biotinylated TIB 172 (mouse anti-rat kappa light 
chain), TIB173 mouse anti-rat IgG2a (Fc)), TIB174 (mouse anti-rat IgG2b (Fc)), TIB 170 
(mouse anit-rat IgG1 (Fc)) mixed with same portion of each, provided by E. Kremmer, IMI, 
HMGU) was added to plate for 1 h. After another washing step, 100 µL per well of 
streptavidin-HRP was used for the biotin-streptavidin reaction with 1 h incubation. The plate 
was washed and 100 µL TMB substrate (200 µL of 1% H2O2 and 800 µL of 6 mg mL
-1
 TMB 
(in DMSO) per well
 
dissolved in 50 mL 100 mM sodium acetate buffer, pH 5.5) was added 
for the enzyme reaction. Finally, the reaction was stopped by the addition of 50 µL of 2 M 
H2SO4 per well
 
after 5-25 min, depending on the color intensity on the plate. Alternatively, 
the steps of TIB mix and streptavidin could be replaced with the labelled secondary antibody 
GAR-HRP (100 µL well
-1
, in 40 mM PBS, 1 h) while the rest of the procedure remained 
unchanged (Figure 15). In optimised coating antigen format assays HSL2-BSA-r1 and HSL2-
BSA-r2, which contained reduced number of HSL2 molecules on BSA, were used for 
coating. The concentrations of antibodies, coating antigen, and the labelled secondary 
antibody are given in Table 14 (Page 92). 
The optimising of the coating antigen format assay was including different tests of buffers 
(Hepes, PBS), incubation surfaces (glass, low bind tube et.), blocking solutions (BSA, Tween 
20 etc.) incubation time etc. The details and results of the assay optimising can be found in 
the master thesis of Mandy Starke (Starke, 2009, unpublished study). 
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 Figure 14 Scheme of coating antigen format ELISA 
Microtiter plate
Coating antigen
HSL molecule
Substrate
Anti-HSL mAb
Product
GAR-HRP
 
2.11.2 ELISA in the enzyme-tracer format 
For coating on MaxiSorp plate, 200 µL well
-1 
 of Protein G solution with a concentration of 2 
µg mL
-1 
in 50 mM carbonate buffer (pH 9.6) was used (4°C, overnight, Figure 15). The next 
day, the plate was washed and 150 µL well
-1 
of mAb solution was added for 2 h. Then, the 
plate was washed again, and 100 µL well
-1
 of analyte solution was added (1 h). As a 
competitor and enzyme-tracer, 50 µL well
-1 
of the prepared HSL1-HRP or HSL3-HRP 
solution was directly added to the plate wells, which still contained analyte solutions. The 
mixture was incubated with shaking for 1 h and the plate was washed (the concentrations of 
antibodies and dilutions of HSL-HRP tracers are summarised in Table 15). As described for 
the coating antigen format, TMB substrate (150 µL well
-1
) was used for the enzymatic 
reaction. Finally, the reaction was stopped after 5-25 min with the addition of 50 µL well
-1
 
2M H2SO4. 
The wash programme for both formats was the same, and it included 3 times washing with 
200 µL well
-1
, 4 mM PBST (40 mM PBS 1:10 diluted plus 0.05% Tween 20, pH 7.2) buffer. 
The incubation temperature was 25±3°C. The optimised concentrations of all described 
solutions were determined by 2D titrations (results not shown). All ELISA absorbance 
Legends 
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measurements were performed with a Spectra Max M5
e
 microplate reader (Molecular 
Devices) at 450 nm (reference 650 nm).  
Figure 15 Scheme of enzyme-tracer format ELISA 
Microtiter plate
HSL molecule
HSL-HRP
Substrate
HSL mAb
Product
Protein G
 
2.11.3 Titration and screening against HSL substances 
To obtain the most sensitive assays, a titration process is necessary to find out the best 
combination of the assay relevant substances and concentrations. In coating antigen format, 
the HSL conjugates, anti-HSL antibody, HSL analyte and secondary antibody need to be 
tested. While in enzyme tracer format, coating protein (e.g. Protein G), anti-HSL antibody and 
HSL enzyme-tracer should be taken into consideration. For better understanding, an example 
of the template (experiment design in 96-well microtiter plate) is given in Figure 16. This is a 
coating antigen format assay for titration of HSL2-BSA concentration and the antibody 
dilutions. Three HSL2-BSA concentrations at 1 µg mL
-1
, 2 µg mL
-1
 and 4 µg mL
-1
 were 
coated, and 2 dilutions of antibody supernatants (1:50, 1:200) were applied, but only GAR-
HRP dilution of 1:20000 was used for the assay. The variations are dependent on the factors, 
which are needed to be optimised for certain assays. 
Legends 
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Figure 16 A template example for titration in coating antigen format  
 
Employing the optimal combination of the assay from titration, a series of selected HSL 
substances were tested to each single HSL antibody in both assay formats. The % control was 
calculated, using the formula below: 
Control (%) = (A/A0) x 100,  
where A is the value of the absorbance for each standard or sample and A0 is the value of 
absorbance for the zero standard (only 40 mM PBS). The less the % control values the higher 
is the binding affinity of the tested HSL to the antibody, because the ELISAs in this study are 
both competitive assays. The determination of % control values are the important process for 
the antibody characterisation because these results indicate how good the binding is between 
the antibody and HSL molecules. The screening of the first antibody supernatants was only 
performed with this method and standard curves were additionally tested for the second 
antibody screening. 
2.11.4 Binding test to a few possible HSL degradation substances 
Due to the high recognition to HSs of the mAbs, it was considered if the antibodies showed 
affinities to other possible HSL degradation products, e.g. serine. A few serine analogues and 
HSL acyl side chain similar esters (see Figure 17) have been selected for specific binding test. 
The 1 mg mL
-1
 stock solutions were prepared in ACN or methanol and then further diluted to 
1000 µg L
-1
 in 40 mM PBS for immunoassay. The substances were determined with enzyme-
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tracer format using mAb HSL1/2-2C10 in 200 ng mL
-1
 and enzyme tracer HSL1-HRP 1:1000. 
The % control was calculated using the formula described in last paragraph (2.11.3).  
Figure 17 Tested HSL/HS analogues 
HSL fragment analogues Molecular structure 
Serine  
 
Adipic acid 
 
Methionine  
 
Dodecanoicacid 
 
Dodecandiacid  
 
Glycine 
 
2.11.5 Standard curves 
The standard curves for the HSL analytes were set up in 40 mM PBS, ranging from 0 (only 
PBS) to 20000 or 50000 µg L
-1
. Both the coating antigen and the enzyme-tracer format are 
competitive formats, which reveal (absorbance) signals that are inversely proportional to the 
analyte concentration. A blank, consisting of all buffers, was subtracted from all values, and 
was used in the corresponding reagents, addition of substrate for the enzyme reaction, and the 
stop solution. Usually, the blank value was in the same absorbance range as the highest HSL 
standard concentration of the standard curve.  
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Curve fitting of the standard curve was performed with SOFTmax Pro 5.2 (Molecular 
Devices) or SigmaPlot 11 (Systat Software, Inc., Chicago, IL, USA), using the four-
parameter curve fit according to: 
D
C
x
DA
y
B)(1
  
Where A is the y-value corresponding to the asymptote at low values of the x-axis and D is 
the y-value corresponding to the asymptote at high values of the x-axis. The coefficient C is 
the x-value corresponding to the midpoint between A and D (e.g. μg L−1; test midpoint 
(IC50)). The coefficient B describes how rapidly the curve makes its transition from the 
asymptotes in the centre of the curve.  
Standard curves were normalised to % control as described above (Section 2.11.3). From 
these normalised standard curves, the limit of detection (LOD) of the assays was determined 
between 15- 85 % or 10-90 % of control (Harrison et al., 1989). 
2.11.6 Determination of cross reactivity 
Using the optimised immunoassays, cross reactivities (CR) of 16 substances were determined, 
including twelve HSLs and four HSs (hydrolysed compounds of HSLs). In addition, all four 
haptens used in immunogens and/or enzyme-tracers were tested as cross-reactants. Usually, 
on each microtiter plate, the main analyte (3oxo-C10-HSL or C8-HSL) was used as reference 
in duplicate determination, whereas cross-reactants were determined in duplicate or triplicate. 
Standards for the cross reactants were set up in 40 mM PBS, pH 7.6, ranging from 0 (only 
PBS), and 0.5 to 20000 or 50000 µg L
-1
, according to their expected CR. 
CR% was calculated by use of the formula: 
CR (%) = (IC50 for the main analyte)/ (IC50 for the compound tested) x 100  
2.12  Detection of HSLs in biological samples with ELISA 
After full characterisation of the HSL mAbs, the application of the developed antibodies was 
followed by the detection of HSLs in different biological samples with ELISA. Since the 
operation procedure is very similar between different samples, the method will be described 
below using the example of HSL detection in B. cepacia LA3 culture supernatant (Chen et. 
al., 2010b).  
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2.12.1 Standard curves in matrix: determination of matrix effects  
The B. cepacia LA3 was growing in ABC medium (components given in Attach. 2, page 
144), thus the OD and IC50 values of the main analyte were compared in PBS or in ABC 
medium. Only enzyme-tracer format with mAb HSL1/2-2C10 and HSL1/2-4H5 was used for 
detection of HSLs in real samples (only HSL1/2-2C10 was used for other biological samples), 
because of the higher sensitivity in this format than coating antigen format. The assays were 
carried out as described in section (2.11.2). For the determination of the matrix effect, 
standard solutions of the main analyte (3oxo-C10-HSL) were set up in ABC medium though, 
ranging from 0 (only ABC medium), 0.5 to 20000 µg L
-1
. For better comparison of both 
assays (with mAbs HSL1/2-2C10 and HSL1/2-4H5, respectively), the same enzyme-tracer, 
namely HSL3-HRP was used here, diluted 1:600 and 1:400, respectively. As mentioned 
above, the change of OD, and the shifting of IC50 and working ranges between immunoassays 
in PBS and in different media indicate the matrix effect of the assays (Chen et. al., 2010b). 
2.12.2 Standard curves in ABC Medium: determination of HSL in B. 
cepacia LA3 supernatants 
As described in the previous section (2.12.1), different concentrations of 3oxo-C10-HSL in 
ABC medium were used for the set-up of the standard curve for B. cepacia LA3 supernatant 
measurements. Concentrations of 3oxo-C10-HSL and each LA3 supernatant sample were at 
least determined in duplicate wells on one plate, and the mean values with standard deviations 
were taken for final results. Depending on the working range of the assays, the samples were 
used undiluted or prepared in a dilution of 1:5, 1:10, or 1:20 before and after hydrolysis to 
obtain the best reliable results. For control purpose, 50 µg L
-1
 (and 25 µg L
-1
) of 3oxo-C10-
HS were spiked to each hydrolysed sample. The biological samples were calculated by 
SOFTmax Pro and results were expressed as 3oxo-C10-HSL equivalents (Chen et. al., 
2010b). 
2.13  Preparation of biological samples 
All the biological samples in this study were prepared in vitro using the corresponding 
developed standard procedures. The preparation procedures will be thus described separately 
below. 
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2.13.1 Preparation of Burkholderia cepacia culture supernatants 
B. cepacia strain LA3, a bacterial isolate from the rhizosphere of rice (Jha et al., 2009), was 
cultivated in ABC minimal medium (Clark & Maaloe, 1967) (A and B modified using 20% 
glucose as C-source) with a pH of 6.8 (pH meter, pH 523, WTW, Weilheim, Germany). Two 
baffled flasks A and B (100 mL, Schott AG, Mainz, Germany), each contained 50 mL of the 
medium, were separately inoculated 1:1000 with an overnight culture. The flasks were 
incubated and shaken at 30°C and 175 rpm using an incubator shaker (Innova 4200, New 
Brunswick Scientific, Edison, NJ, USA). Cell cultures were sampled directly after inoculation 
and after 4, 8, 12, 24, 32 and 48h from flasks A and B in parallel. The OD436nm was measured 
with a spectrophotometer (CE3021, Cecil Instruments Ltd., Cambridge, UK) at the sampling 
time points. To obtain cell free supernatants, samples were centrifuged at 4°C and 15000 g for 
30 minutes (Sorvall Evolution RC, Thermo Fisher Scientific, Bonn, Germany). Subsequently, 
the supernatants were filtered through nitrocellulose filters (filter type 0.22 µm GSWP, 
Millipore, Schwalbach, Germany), frozen at -80°C for 1h and stored at -20°C until 
measurement. All chemicals were purchased from Sigma-Aldrich (Taufkirchen, Germany). 
The hydrolysis of B. cepacia culture supernatant samples was performed by addition of 
NaOH. Briefly, 100 µL of 1M NaOH was added to 800 µL sample in a glass tube, which then 
was shaken for 15 min at RT. The solution was neutralized to pH 7 by titration of 1M HCl 
and ABC medium was added to get a final volume of 1 mL, taking the amount of HCl used 
for titration into consideration. The control sample did not receive the NaOH but was instead 
dissolved in ABC medium (Chen et. al., 2010b). 
2.13.2 Preparation of Pseudomonas putida culture supernatants 
Preparation of culture supernatant of P. putida strains IsoF (Steidle et al., 2001), F117 (an 
AHL-negative ppuI mutant of IsoF) and KT2440 (Steidle et al., 2002) were grown in ABC 
minimal medium (Clark & Maaloe, 1967) (A B medium modified using the only carbon 
source C of 10 mM sodium citrate). The medium was buffered to a pH of 6.8 to avoid abiotic 
degradation of AHLs (Englmann et al., 2007). The pH was measured after each sampling and 
was never found to be above 7.2. Cells were shaken at 30 °C and 175 rpm in 500-mL baffled 
flasks with 200 mL of medium. The medium was inoculated 1:1000 with an overnight grown 
bacterial culture and samples were taken 24h after inoculation. The bacterial culture samples 
were centrifuged at 15000 g at 4 °C for 15 min and the supernatant was filtered through 
Millipore nitrocellulose filters (0.22 mm, type GSWP) with a vacuum pump to remove the 
bacterial cells. Then the samples were quenched by shock frosting with liquid nitrogen and 
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stored at -20 °C until measured. The samples were measured undiluted or diluted with factors 
of 1:2 and 1:5.  
2.13.3 Preparation of 1,2,4-TCB-mineralising bacterial biofilm 
community samples  
The TCB degrading bacteria commnity and clay were prepared as described in (Wang et al., 
2010). Totally 4 treatments in three replicates were performed:  
 
Blank (B): medium+clay+TCB;  
Community (C): medium+community+TCB;  
Sterilised clay (S): medium+sterilised clay+TCB; 
Established biofilm (E): medium+biofilm on clay+ TCB.  
 
Three replicates were examined on days 1, 4, 7, 14, 21 and 28. The clay particles and the 
liquid medium were separated. The liquid medium was centrifuged at 6000 rpm for 30 min. 
2×0.5 mL of the supernatant was taken for immunoassay analysis of AHLs, 45 mL for AHLs 
extraction and the left for pH measurement (Wang, unpublished manuscript). 
The prepared supernatants and the extraction from clay were directly used to measure HSLs. 
The hydrolysis of the samples was performed using 0.1 M NaOH as prepared for B. cepacia 
LA3 samples. Considering the detection range of the immunoassay, the original and 
hydrolysis treated samples were prepared undiluted or diluted with factors of 1:5, 1:10, and 
1:20 in TCB containing mineral medium. 
2.14  HSL antibody characterisation with Aqua-Optosensor (AOS)  
Alternatively to the coating antigen format ELISA, an immunosensor, called Aqua-
Optosensor (Siemens AG, München, Germany), which uses TIRF as transduction principle, 
was applied for the characterisation of HSL mAbs. Due to the limited number of available 
chips in lab, only HSL1/2-2C10 was characterised with AOS for standard curves. The chips 
were coated with a polymethyl methacrylate (PMMA) matrix.  
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Figure 18 Aqua-Optosensor instruments 
(A)
(D)
(E)
(C)
(B)
 
A: prism in spotter; B: PMMA prism chip with spots; C: sensor chip; D: reader; E: laptop with evaluation 
software. Pictures from Petra Krämer (Presentation file). 
The coating-antigen HSL2-BSA-r2 was spotted via Microarray-Spotter Microgid II 
(BioRobotics, UK, now Genomic Solutions, Ann Arbor, USA) onto the prism. Through 
Contact-Spotting method three accurate spots (each  1 µL) of HSL2-BSA-r2 with 
concentrations of 3, 2 and 1 mg mL
-1
 were transferred from a 384-well microtiter plate 
(Greiner Bio-One GmbH, Frickenhausen, Germany) to the prism. A 50 mM carbonate buffer 
with 0.05% (v/v) Tween 20 (pH 9.6) was used for spotting. To enhance the immobilisation of 
the coating antigen, the spotted chips were further incubated over night at 4°C. 
For determination of antibody-analyte binding on AOS, 150 µL of mAb HSL1/2-2C10-
Oyster645 (48 µg mL
-1
) and the same volume of analyte (3oxo-C10 HS or C10-HS) were 
prepared. The mAb HSL1/2-2C10-Oyster645 was firstly diluted in 40 mM PBS, which also 
contained 0.05% (v/v) Tween 20 (pH 7.6) and 1% BSA up to 75 µL as total amount. Then an 
additional 75 µL of Low Cross-buffer (CANDOR Bioscience GmbH, Weißensberg, 
Germany) was added to the antibody solution with a final mAb concentration of 48 µg mL
-1
. 
The analytes standards were prepared in the similar way as antibodies with concentrations 
ranging from 0 (only buffer) to 5000 µg L
-1
, only the buffer was 40 mM PBS without Tween 
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or BSA. After 300 µL antibody-analyte mixture was incubated in a vial for 20 min at 27°C, 
280 µL of the it was pipetted into the chip container. The incubation step was performed on a 
shaker. The fluorescent signal was measured automatically by AOS at 35.5°C. The results 
were evaluated with the provided AOS software (Wöllner et. al., 2010).  
2.15  Optimisation of fluorescent labelling  
The conjugation and label degree determination methods were optimised according to the 
protocol of labelling of antibodies from Denove Biolabels (Biolabels, 2005) (now Luminartis, 
Münster, Germany). A serial of conjugates with label degrees (moles fluorophore or dye per 
mol protein, D/P) of 1, 2, 5, 10 and 20 were produced.  
2.15.1 Antibody-dye conjugation 
The ester activated dye Oyster645-NHS was dissolved by addition of N,N-
dimethylformamide (DMF) in original packed plastic tube. The purified mAbs were prepared 
in 40 mM PBS buffer (pH 7.6) with a concentration of about 1.5 mg mL
-1
 in Eppendorf 
protein lowbind tubes. The antibodies were diluted if their original concentrations were higher 
than 1.5 mg mL
-1
. Then the diluted Oyster645-NHS (1 eq.) was added to the antibody solution 
(1 eq./label ratio) and incubated with shaking for 10, 20 or 40 min at room temperature. 
Figure 19 Chemical structure and fluorescent spectra and of Oyster-645  
A B
 
A: molecular structure of Oyster-645; B: fluorescent spectra of Oyster 645. Ref: (www.biolabels.com) 
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The amount of antibody and dye was calculated with the formulas: 
*label degree= 
antibody
dye
n
n
 
*n=
M
CV
 
IgG antibody has a molecular weight of 150 kD and Oyster645-NHS has a molecular weight 
of 1 kD. The corresponding concentrations of mAbs were determined after purification.  
To block the activated ester on fluorophohre, a 10 % glycine solution (≥1 eq. Oyster645-NHS 
solution) in MilliQ water was added to the antibody-dye mixture. For purification of the 
antibody-dye conjugation, a dialysis was performed in 20 mM PBS buffer with Slide-A-Lyser 
cassette (0.5-3 ml; 10 kDa MW cut-off, Thermo Fisher Scientific, Bonn, Germany) for 3 
days. Finally, the labelled mAbs were removed from slides to brown glasses with syringes 
and stored at -4°C. The final concentrations of labelled antibodies were calculated 
correspondingly to their final volumes after dialysis. 
2.15.2 Determination of the label degree 
For the determination of the label degree, the conjugates were diluted to a concentration of 
0.2 mg mL
-1
 in 20 mM PBS. The solution was filled in 96-well UV-plate with 70 µL per well 
and the absorbance was measured by a multi-detection reader Spectra Max M5
e
 at λ=280 nm 
and λ=650 nm. The label degree was calculated by the formulas below: 
* Cprotein =
protein
ACfA )( max280280 * Cfluorophore= 
dye
Amax  
* Label degree (D/P) =
protein
fluorophor
C
C
 
A280 is the absorbance at λ=280 nm; Amax is the absorbance of the dye at its absorbance 
maximum (λmax); ε is extinction coefficient (cm
-1
 ×M
-1
), protein = 210000 cm
-1
×M
-1
 for a 
typical IgG (which corresponds to A280 of 1.4 for a 1 mg mL
-1
 solution and Cf280 is expressed 
as correction factor by the absorbance of the fluorophore at λ=280 nm. The spectra factors of 
Oyster
®
-645 is listed below in Table 8. 
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Table 8 Spectra characteristics of the Oyster-645, Ref: www.biolabels.com 
Dye ε (cm-1×M-1) Amax (nm) Em (nm) Cf280 
Oyster-645 250000 649 666 0.08 
2.15.3 Affinity test of fluorophore labelled antibodies  
The fluorophore labelled antibodies were tested with AOS and coating antigen format ELISA 
to determine their affinities after conjugation. The processes were described above in the 
sections (2.11.1 and 2.14). 
2.16  In situ experiments 
2.16.1 B. cepacia biofilm in flow chamber system-ibidi slide 
The B. cepacia LA3 was transferred from NB (rich medium) plate to M9 medium (minimal 
medium) with a cell density of 10
9
 cells per mL and 150 µL of bacterial suspension  was filled 
to ibidi slide per channel (6 channels, 1 µ-Slide VI ibiTreat, from ibidi, Munich, Germany). 
The slide was covered in petri dish with moisturised tissue under the slide and the whole petri 
dish was sealed with parafilm and incubated for 24h at 30°C. After incubation the autoclaved 
plastic tubes were connected to the ibidi slide device and M9 medium was pumped with a 
flow rate of 3 mL per hour per channel with peristaltic pump (Ismatec IPC-12, Glattbrugg, 
Switzerland) for 24 h at 30°C. Then the plastic tubes were taken off, sterilised, and the slides 
were ready for further antibody treatment. 
Figure 20 Antibody treatment of biofilm on ibidi slide 
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The optimised antibody treatment of the biofilm on ibidi slide is illustrated in (Figures 20 and 
21). First, the ibidi slide was washed twice and incubated with 100 µL per channel 1M BSA 
for 30 min at RT for blocking. The slide was washed twice and 100 µL per channel of 
fluorescent labelled antibody solution was added and incubated for 45 min. Finally the slide 
was washed twice and filled with 50 µL 40 mM PBS per channel for microscopy. The wash 
steps were performed with 100µL 40 mM PBS using pipette and the in- and outlet sides 
remained unchanged during the whole process. The fluorescent labelled mAbs HSL1/2-2C10, 
HSL1/2-4H5 with concentration from 0.05 to 0.2 µg mL
-1
 were used for this experiment. To 
avoid unspecific binding activated NHS on the Oyster-645 during fluorescent conjugation, 5 
µL of 10% glycine was added to each 100 µL antibody solution and incubated for 10 min. 
The experiment was obtained at 25±3°C. Using the 6 separate channels, different treatments 
were able to be performed. 
Figure 21 In situ experiment design with Oyster-645 labeled HSL antibody and Cy3-TSA  
 
A (top): experiment design with Oyster-645 labelled mAb; B (below): experiment design with Cy3-TSA 
Instead of fluorescent labelled HSL mAbs, the Cy3 labelled TSA was applied to enhance the 
fluorescent signal. In this case, unlabelled HSL mAbs were used and followed with 
incubation with GAR-HRP for 30 min and addition of TSA solution for 5-10 min. The 
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channels were washed twice with 100 µL 40 mM PBS. The principle of the in situ experiment 
is presented in Figure 22. 
Figure 22 Antibody treatments of roots 
 
Left procedure: treatment with Oyster645 labelled antibody; right procedure: treatment with Cy3-TSA. 
The fluorescence of Oyster-645 and Cy3 were detected using a confocal laser scanning 
microscope (LSM510 Meta, Zeiss, Oberkochen, Germany). An argon ion laser supplied the 
wavelength of 488 nm for excitation of Oyster-645. Two helium neon lasers provided 
excitation wavelengths of 543 nm and 633 nm, producing only unspecific autofluorescence of 
the root material enabling visualisation of the root structure. The three signals were combined 
and depicted as RGB (red green blue)-image. Additionally, specific Oyster-645 fluorescence 
could be verified by scanning the characteristic wavelength spectrum of a signal in question 
with the implemented function of the LSM510 Meta system. An optical sectioning of the 
biofilm was achieved by moving the focus position deeper into the sample in 1 µm steps 
producing z-stacks of individual pictures from the same xy-area with a penetration depth of up 
to 60 µm. The resulting set of pictures was displayed as an orthogonal view with the help of 
the LSM510 software package provided by Zeiss (the ibidi-slides were prepared by M. 
Rothballer). 
Doctoral thesis, Xiao Chen, 2011 
 
75 
 
2.16.2 Pseudomonas putida IsoF on the root of barley 
2.16.2.1 Preparation of the plant roots inoculated with P. putida IsoF 
The gfp-tagged P. putida strain IsoF (Steidle et al., 2001) harbouring the plasmid pJBA28 
(Andersen et al., 2001) was inoculated to summer barley cultivar Barke seeds and the plants 
were grown in sealed glass tubes filled with quartz sand. Two weeks after planting, whole 
barley plants were taken out of the glass tubes. Roots were carefully shaken to remove 
adhering quartz sand particles, gently washed in sterile 1 x PBS in Petri dishes and separated 
from the shoot. For antibody treatment 2 cm root pieces were removed from the older basal 
part of the root close to the seed and then briefly air-dried on glass slides. The process is 
shown in the Figure 22.  Washing with 40 mM PBS was performed between all steps before 
Citifluor addition (the plant roots were prepared by Buddrus-Schiemann). 
2.16.2.2 HSL antibody treatment on the barley root 
The principle of the experiment was introduced in Figure 21. Different from ibidi slide 
system, plant roots were more complex surfaces, which contained multiple proteins, 
carbohydrate polymers, lipid compounds and salts from plant origin or from the environment. 
The treatment procedure is shown in Figure 22 and the root was rinsed once with ca. 2 mL 40 
mM PBS using injector between all the steps. 
After the washing step, the root pieces were transferred to glass slides, air-dried, embedded in 
Citifluor (Citifluor Ltd., Canterbury, United Kingdom) and then covered with a cover slip. 
Bacterial root colonization and antibody treatment were followed using a confocal laser 
scanning microscope LSM510 Meta (same as for ibidi slide) that was equipped with two 
helium neon lasers for excitation of the fluorophores Cy3 and Cy5 at wavelengths of 543 and 
633 nm, and an argon laser for excitation of the gfp-signal at a wavelength of 488 nm. 
Bacterial cells were localized with a 63x water immersion objective. 
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3 Results  
3.1 Selection of hapten for immunisations 
Considering the structural similarity and the homoserine lactones of interest, four haptens 
named HSL1, HSL2, HSL3 and HSL4 were chosen for the development of anti-HSL mAbs. 
As shown in Figure 23, HSL1 and HSL3 have the same side chain length, but differ in the C3 
position: HSL1 contains an oxo functional group whereas HSL3 contains an OH group. In 
comparison, both HSL2 and HSL4 contain only a hydrogen atom at the C3 position. HSL2 
has the shortest chain length, while HSL4 has a chain length between HSL1/HSL3 and 
HSL2. For immunisations, all four haptens were conjugated to BSA and OVA, resulting in 
the following conjugates: HSL1-BSA, HSL1-OVA, HSL2-BSA, HSL2-OVA, HSL3-BSA, 
HSL3-OVA, HSL4-BSA and HSL4-OVA. These eight immunogens were used for the 
immunisation of rats and for assay development. During the first screening, anti-HSL1/2 
mAbs recognised both hapten-protein conjugates equally well and were named therefore 
HSL1/2. All other mAbs had a preference to only one hapten-protein conjugate. 
Figure 23 HSL hapten structures (detailed chemical names see section 2.3, page 47-53) 
 
Published results (Chen et al., 2010 a) 
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3.2 Hapten-protein conjugate characterisation with UV absorbance 
spectrum 
The shift of the absorbance peak and its slope change could generally be observed from all 
conjugates (see Figures 24-26). HSL1 was the only hapten, which showed slight UV 
absorbance at a wavelength of 277 nm with OD of 0.1516 (Figure 25 top left) and no peak 
was shown in the spectra of HSL2, HSL3 and HSL4 haptens (top right of Figure 24, top of 
Figure 26 and top of Figure 25). The 2.5 mg mL
-1
 BSA and OVA presented absorbance peaks 
at 279 nm and 280 nm with ODs >0.9 (Figure 24 middle left and right). After conjugation, the 
HSL1-BSA shifted the peak to 277 nm and HSL1-OVA had a peak at 269 nm (Figure 24 
bottom left and right) and the slope of both left peak shoulders reduced significantly 
compared to pure BSA and OVA. Thus the conjugations of HSL1 to BSA/OVA were 
confirmed to be successful. 
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Figure 24 UV spectra of HSL1 and HSL2 conjugates 
 
HSL1 [0.1 mg mL-1]
277nm; 0.1516
314nm; 0.0772
HSL2 [0.1 mg mL-1]
BSA [2.5 mg mL-1]
279nm; 0.9739
OVA [2.5 mg mL-1]
280nm; 0.9163
HSL1-BSA 2.5 mg mL-1
277nm; 2.227
HSL1-OVA [2.5 mg mL-1]
269nm; 1.8622
HSL2-BSA [2.5 mg mL-1]
277nm;1.0921
HSL2-OVA [2.5 mg mL-1]
280nm; 1.0127
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Figure 25 UV spectra of HSL4 conjugates  
 
 
  
  
 
Significant shift of peaks and change of the slope have been observed from the HSL4-BSA 
(259 nm) and HSL4-OVA (262 nm) after conjugation (see Figure 25), though the HSL4 itself 
did not show any peak. However, HSL2 and HSL3 conjugates did not have that significant 
difference compared to HSL1 and HSL4 conjugates. HSL2-BSA had a slight shift of 2 nm, 
while HSL2-OVA had the same absorbance wavelength as OVA at 280 nm (Figure 24). The 
shifts of HSL3-BSA and HSL3-OVA compared to the original proteins were both 
approximately 2 nm (Figure 26). But the left peak shoulders of hapten conjugates were less 
steep than the pure proteins in all conjugates. The conjugates were all tested with ELISA in 
HSL4 [0.1 mg mL-1]
BSA [1.25 mg mL-1]
279 nm; 0.5087
OVA [1.25 mg mL-1]
280 nm; 0,4963
HSL4-BSA [1.25 mg mL-1]
259 nm; 1.3681
HSL4-OVA [1.25 mg mL-1]
262 nm; 0,884
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the coating antigen format and the binding of the antibody to the HSL-protein-conjugates was 
thus able to confirm the success of conjugation indirectly (data not shown).  
Figure 26 UV spectra of HSL3 conjugates 
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3.3 Coating antigens and enzyme-tracers selection 
In coating antigen format, all eight HSL-protein conjugates were tested as coating antigens, 
and HSL2-BSA was suitable for almost all antibodies (partly presented in Table 9). 
Additionally following a strategy already employed earlier (Krämer et al., 2010) - conjugates 
with a reduced amount of hapten molecules per protein (HSL2-BSA-r1 and HSL2-BSA-r2) 
were produced and used for optimised assays (production details in Table 5, page 56). They 
both resulted in more sensitive assays than HSL2-BSA due to the reduced HSL2 molecules on 
BSA. 
As enzyme-tracers, the four HSL haptens were conjugated to HRP for their usage in the 
enzyme-tracer format. HSL1- and HSL3-HRP were used as enzyme-tracers in combination 
with HSL1, HSL1/2 and HSL4 antibodies, while with HSL2- and HSL4-HRP it was less 
suitable to obtain an assay in the enzyme-tracer format due to high background (HSL2-HRP) 
or less sensitivity (HSL4-HRP). However, a recent test revealed that the assays could be 
potentially optimised with further diluted HSL4-HRP (data not shown).  
3.4 Antibody screening  
In total, 192 hybridoma culture supernatants (59 with anti-HSL1 and anti-HSL2 antibodies, 
133 with anti-HSL4 antibodies) were tested in the first screening using coating antigen format 
ELISA (procedures present in section 2.11.1, page 60). The affinity and selectivity of the 
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antibodies to the HSL standards, which were presented as % control (formula see 2.11.3, page 
62) inhibition, were the main criteria of screening. With coating antigen format in a second 
round for inhibition with HSLs. HSL3 mAbs are not present in this study, because the 
antibody production and characterisation is not completed yet. 
Figure 27 HSL1/2-2C10 inhibition test against HSL substances in enzyme-tracer format 
After the first screening, two anti-HSL1 mAbs, eleven anti-HSL1/2 mAbs and 15 anti-HSL4 
mAbs were selected for further characterisation (Tables 9 and 10). The antibodies were 
named according to the first screening process, where the haptens were used for antibody 
binding test. For example, HSL1-mAb showed binding to HSL1 and HSL1/2 had binding to 
both HSL1 and HSL2. 
Figure 28 HSL4-5E12 inhibition tests against HSL substances in enzyme-tracer format 
As examples for antibody screening and characterisation, the Figures 27 and 28 present the 
inhibition tests of mAbs against all selected HSLs from C4 to C12 and without or with 3oxo-, 
3-hydroxy substitutions on C3 atom. The OD of PBS was set as 100% and the OD of the 
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Figures 27 and 28 of the HSL substances were calculated (formula described  in section 
2.11.3, page 62). The lower the bars, the better are the recognition of the antibodies to the 
substance, since the assays were competitive. In Figure 27, 28, the hapten HSL1 and HSL4 
were the best recognised substances from all, while HSL2 was very less recognised. The % 
control of each antibody and analyte were taken into consideration for antibody selection and 
further characterisation. The second screening of HSL1, HSL1/2 and HSL4 antibodies are 
listed in Tables 9 and 10. 
Table 9 Selected HSL1 and HSL1/2 antibodies and characterisation with coating antigen format 
Antibody Subclass Coating  HSL 1 HSL 2 
C4-
HSL  
C6-
HSL 
3oxo-
C6-
HSL 
3oxo-
C8-
HSL 
3oxo-
C12-
HSL  
HSL1/2-1F6 IgG-2c HSL1-BSA ++ - - - - + - 
HSL1/2-2C10 IgG-2a HSL2-BSA ++ + - ++ ++ ++ + 
HSL1/2-2G10 IgG-2a HSL2-BSA + + - + - ++ - 
HSL1/2-3C12 IgG-2a HSL2-BSA + - - + - - - 
HSL1/2-4A7 IgG-2a HSL2-BSA ++ - - - + + + 
HSL1/2-4B12 IgG-2a HSL2-BSA ++ - - + - - - 
HSL1/2-4C10 IgG-2a HSL2-BSA + - - + - - + 
HSL1/2-4G11 IgG-2a HSL2-BSA + - - + - - - 
HSL1/2-4H5 IgG-2a HSL2-BSA ++ - - ++ ++ ++ + 
HSL 1/2-8F4 IgG-2c HSL1-BSA - - - - - + - 
HSL1-1A5 IgG-2a HSL2-BSA ++ - + + + ++ + 
HSL1-8E1 IgG-2a HSL2-BSA ++ - - - + ++ + 
In coating antigen format, as a competitive assay, the signal of the assays inversely indicates the affinity of the 
antibodies. The higher the affinity, the lower is the signal and thus lowers % control. Symbols in table: ++: % 
control  30%; +: % control 30%-60%; -: % control  60%. 
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Table 10 Selected HSL4 antibodies and characterisation with coating antigen format 
Antibody Subclass Coating antigen HSL2 C4-
HSL 
3oxo-
C4-
HSL 
3OH-
C4-
HSL 
C6-
HSL 
C6-
3oxo-
HSL 
C8-
HSL 
C8-
3oxo-
HSL 
3OH-
C8-
HSL 
C10-
HSL 
3oxo-
C10-
HSL 
C12-
HSL 
C12-
3oxo-
HSL 
3OH-
C12-
HSL 
HSL4-2F12 IgG-2a HSL2-OVA 2 µg mL
-1
 - + - - - - ++ + - - - - - - 
HSL4-4B5 IgG-2a HSL2-BSA 1 µg/ml - + - - - - ++ + - + - + - - 
HSL4-4B12 IgG-2a HSL2-BSA 1 µg/ml - + - - + - ++ - - ++ + + + - 
HSL4-4C9 IgG-2a HSL2-BSA 1 µg/ml - + - - - - ++ + + + - + - - 
HSL4-5E4 IgG-2a HSL2-BSA 1 µg/ml - + - - + + + + - ++ + + + - 
HSL4-5E12 IgG-2a HSL2-OVA 2 µg/ml - + - - + - ++ + - + + + + - 
HSL4-5H3 IgG-2a HSL2-OVA 2 µg/ml - + + - + + ++ - - ++ - + - - 
HSL4-6D3 IgG-2a HSL2-BSA 1 µg/ml - + - - + + ++ + - ++ + + + + 
HSL4-6H8 IgG-2c HSL2-OVA 2 µg/ml - ++ - - - - + - - - - - - - 
HSL4-8B8 IgG-2a HSL2-OVA 2 µg/ml - + - - + - ++ + - + + + + + 
HSL4-8D8 IgG-2a HSL2-OVA 2 µg/ml + + - - + + ++ + - ++ + + + + 
HSL4-8H10 IgG-2a HSL2-OVA 2 µg/ml - + + - + + ++ + - ++ + + + - 
In coating antigen format, as a competitive assay, the signal of the assays inversely indicates the affinity of the antibodies. The higher the affinity, the lower is the signal and thus 
lowers % control. Symbols in table: ++: % control  30%; +: % control 30%-60%; -: % control  60%. 
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3.5 Antibody subclass determination and purification 
Most HSL1, HSL1/2 and HSL4 mAbs were IgG-2a antibodies and a few of them were IgG-2c 
(reported in Tables 9 and 10) antibodies. Within the purified antibodies, only a part of HSL1-
1A5 was processed with protein A affinity column, the rest were all purified with protein G 
columns. However, the immunoassays did not show any difference between protein A and G 
processed HSL1-1A5 antibody (data not shown). The purified antibodies are listed in Table 
11. 
Table 11 Purified HSL antibodies 
Antibody Concentration 
[mg mL
-1
] 
Purified with 
HSL1-1A5 1.4 Protein A 
2.4 Protein G 
6.3 Protein A 
HSL1-8E1 0.8 Protein G 
unknown Protein G 
HSL1/2-2C10 0.7 Protein G 
1.5 Protein G 
2.8 Protein G 
HSL1/2-4H5 0.8 Protein G 
HSL1/2-4G11 0.4 Protein G 
HSL4-4C9 1.3 Protein G 
HSL4-5E12 3.0 Protein G 
HSL4-5H3 1.0 Protein G 
HSL4-6D3 2.0 Protein G 
3.6 Anti-HSL antibody characterisation with ELISAs 
With the selected antibodies standard curves for twelve HSL and four HS compounds of the 
four HSL haptens were carried out in the coating antigen and/or in the enzyme-tracer format. 
The CRs for all HSL and HS compounds with the selected antibodies are listed in Table 12 
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(coating antigen format) and Table 13 (enzyme-tracer format). The assay conditions e.g. 
antibody concentration, tracer dilution, coating antigens etc. are given in Table 14 (coating 
antigen format) and Table 15 (enzyme-tracer format). The bold written analyte (3oxo-C10-
HSL and C8 HSL) in the tables were the main analytes for the corresponding assays. Only 
three mAbs were characterised with the enzyme-tracer format, because all other mAbs 
showed either too high background or unacceptable standard deviations within this format. 
The reason for this phenomenon remains unknown. 
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Table 12 Cross reactivity of mAbs in coating antigen format  
 
 
Analyte 
(Short form) 
R1 R2 
MAb 
Cross reactivity % 
HSL1-
1A5 
HSL1-
8E1 
HSL1/2-
2C10 
HSL1/2-
4H5 
HSL4-
4C9 
HSL4-
5E12 
HSL4-
5H3 HSL4-6D3 
Coating Antigen   HSL2-BSA-r2 
 
C4-HSL H CH3 8 6 14 21 9 39 13 19 
3-oxo-C4-HSL O CH3 13 3 12 12 8 11 34 3 
3-OH-C4-HSL OH CH3 5 0 8 0 3 15 0 6 
C8-HSL H (CH2)4CH3 17 10 73 110 100 100 100 100 
3-oxo-C8-HSL O (CH2)4CH3 44 54 89 76 12 46 16 46 
3-OH-C8-HSL OH (CH2)4CH3 8 5 23 20 0 14 9 10 
C10-HSL H (CH2)6CH3 14 4 55 27 37 38 70 100 
3-oxo-C10-HSL O (CH2)6CH3 100 100 100 100 5 117 38 29 
3-OH-C10-HSL OH (CH2)6CH3 16 0 38 61 5 24 3 31 
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C12-HSL H (CH2)8CH3 2 5 23 3 9 8 41 30 
3-oxo-C12-HSL O (CH2)8CH3 18 34 43 35 4 33 14 44 
3-OH-C12-HSL OH (CH2)8CH3 8 2 26 20 4 17 4 12 
C8-HS 
O
N
H
O
OH
OH
 
511 258 1587 843 1360 714 - - 
3-oxo-C8-HS OH
N
H
O O
OH
O  
630 1021 1052 782 584 178 - - 
C10-HS 
O
N
H
O
OH
OH
 
545 39 498 869 566 1838 1517 5239 
3-oxo-C10-HS 
O
N
H
O
OH
OH
O
 
1935 1760 1780 1140 837 905 317 909 
HSL1 O (CH2)8COOH 143 159 315 166 5 78 22 120 
HSL2 H (CH2)2COOH <0.1 <0.1 3 <0.1 1 3 72 33 
HSL3 OH (CH2)8COOH 21 4 51 9 1 27 5 10 
HSL4 H (CH2)6COOH 70 20 354 151 73 259 67 167 
“-” means not determined; assay conditions listed in Table 14. Published results (Chen et al., 2010 a) 
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Table 13 Cross reactivity of mAbs in enzyme- tracer format 
 
 
 
 
 
Analyte (short form) R1 R2 
MAb 
Cross reactivity % 
HSL1/2-2C10 HSL1/2-4H5 HSL4-5E12 
Enzyme Tracer   HSL1-HRP HSL3-HRP HSL3-HRP 
C4-HSL H CH3 13 11 12 
3-oxo-C4-HSL O CH3 8 7 4 
3-OH-C4-HSL OH CH3 5 11 4 
C8-HSL H (CH2)4CH3 71 156 100 
3-oxo-C8-HSL O (CH2)4CH3 79 70 19 
3-OH-C8-HSL OH (CH2)4CH3 16 18 6 
C10-HSL H (CH2)6CH3 41 56 46 
3-oxo-C10-HSL O (CH2)6CH3 100 100 39 
3-OH-C10-HSL OH (CH2)6CH3 39 33 15 
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C12-HSL H (CH2)8CH3 34 12 71 
3-oxo-C12-HSL O (CH2)8CH3 39 52 14 
3-OH-C12-HSL OH (CH2)8CH3 18 24 11 
C8-HS 
O
N
H
O
OH
OH
 
3820 1119 4183 
3-oxo-C8-HS OH
N
H
O O
OH
O  
383 - - 
C10-HS 
O
N
H
O
OH
OH
 
1531 2268 841 
3-oxo-C10-HS 
O
N
H
O
OH
OH
O
 
1813 1667 1053 
HSL1 O (CH2)8COOH 263 191 37 
HSL2 H (CH2)2COOH 4 6 4 
HSL3 OH (CH2)8COOH 22 30 9 
HSL4 H (CH2)6COOH 362 292 68 
“-” means not determined; assay conditions listed in Table 15. Published results (Chen et al., 2010 a) 
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Table 14 Test midpoints (IC50) of main analytes using coating antigen format  
 
Main Analyte 
(short form) mAb Concentration Coating Antigen Conc. Secondary Ab Conc. IC50[µg L
-1
] STD [µg L
-1
] n 
3oxo-C10-HSL HSL1-1A5 [200 ng mL
-1
] HSL2-BSA-r2 [2 µg mL
-1
] GAR-HRP [20 µg mL
-1
] 455 213 12 
3oxo-C10-HSL HSL1-8E1 [800 ng mL
-1
] HSL2-BSA-r2 [2 µg mL
-1
] GAR-HRP [20 µg mL
-1
] 1278 519 12 
3oxo-C10-HSL HSL1/2-2C10 [400 ng mL
-1
] HSL2-BSA-r2 [1 µg mL
-1
] GAR-HRP [20 µg mL
-1
] 669 182 18 
3oxo-C10-HSL HSL1/2-4H5 [100 ng mL
-1
] HSL2-BSA-r1 [1 µg mL
-1
] GAR-HRP [40 µg mL
-1
] 1377 435 20 
C8-HSL HSL4-4C9 [200 ng mL
-1
] HSL2-BSA-r1 [2 µg mL
-1
] GAR-HRP [40 µg mL
-1
] 518 218 22 
C8-HSL HSL4-5E12 [400 ng mL
-1
] HSL2-BSA-r2 [2 µg mL
-1
] GAR-HRP [40 µg mL
-1
] 1478 591 18 
C8-HSL HSL4-5H3 (CS) 1:1000 HSL2-BSA-r2 [2 µg mL
-1
] GAR-HRP [20 µg mL
-1
] 455 113 7 
C8-HSL HSL4-6D3 (CS) 1:200 HSL2-BSA-r2 [2 µg mL
-1
] GAR-HRP [20 µg mL
-1
] 447 197 4 
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Table 15 Test midpoints (IC50) of main analytes using enzyme-tracer format 
 
Main Analyte 
(Short form) mAb Concentration Enzyme-Tracer Dilution IC50 [µg L
-1
] STD [µg L
-1
] n 
3oxo-C10-HSL HSL1/2-2C10 [400 ng mL
-1
] HSL1-HRP 1:1000 134 30 53 
3oxo-C10-HSL HSL1/2-4H5 [200 ng mL
-1
] HSL3-HRP 1:400 253 44 19 
C8-HSL HSL4-5E12 [400 ng mL
-1
] HSL3-HRP 1:400 646 114 19 
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3.6.1 Comparison of ELISA in the coating antigen and in the enzyme-
tracer formats 
Although the design of both ELISA formats is different (schemata see Figure 14, page 61 and 
15, page 62) and although the haptens in the conjugates differ (HSL2 in the coating antigen 
format, HSL1 or HSL3 in the enzyme-tracer format), the assays showed generally similar 
results. This reflects the recognition of the mAbs, which should not differ, even if the 
competition within the assays is changed. As illustrated in Figures 29 and 30, the IC50 values 
revealed the same recognition pattern in both assay formats: 3-oxo-C10-HS<C10-HS<3-oxo-
C10-HSL<C10-HSL.  
Figure 29 HSL1/2-2C10 coating antigen format standard curves 
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Standard curves for C10-HSL, 3-oxo-C10-HSL, C10-HS and 3-oxo-C10-HS using mAb HSL1/2-2C10 and 
HSL2-BSA-r2. Assay conditions: HSL1/2-2C10 400 ng mL
-1
, HSL2-BSA-r2 1 µg mL
-1
, GAR-HRP 40 ng mL
-1
. 
Four parameter curve-fitting data are given in parentheses: red circles C10-HSL (A 97.9, B 1.17, C 1169 µg L
-1
, 
D -1.58, R
2 
0.998), yellow green inverted triangles 3-oxo-C10-HSL (A 100.2, B 0.98, C 672.7 µg L
-1
, D -1.7, R
2 
0.999), brown squares C10-HS (A 98.2 , B 1.05, C 119.5 µg L
-1
, D -0.95, R
2 
0.999), and orange rhombuses 3-
oxo-C10-HS (A 99.4, B 0.88, C 32.6 µg L
-1
, D -1.37, R
2 
0.997). 
However, all three antibodies, tested with both assay formats, presented lower test midpoints 
for the corresponding main analyte in the enzyme-tracer format than in the coating antigen 
format (Tables 12 and 13). For example, mAb HSL1/2-2C10 had an IC50 of 134±30 µg L
-1
 
(n=53) in the enzyme-tracer format and an IC50 of 669±182 µg L
-1 
(n=18) in the coating 
antigen format. 
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Figure 30 HSL1/2-2C10 enzyme-tracer format standard curve 
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Standard curves for C10-HSL, 3-oxo-C10-HSL, C10-HS and 3-oxo-C10-HS using mAb HSL1/2-2C10 and 
HSL1-HRP. Assay conditions: HSL1/2-2C10 400 ng mL
-1
, HSL1-HRP 1:1000, Protein G 2 µg mL
-1
. Four 
parameter curve-fitting data are given in parentheses: red circles C10-HSL (A 100.9, B 1.16, C 270.5 µg L
-1
, D 
3.1, R
2 
0.998), yellow green inverted triangles 3-oxo-C10-HSL (A 97.7, B 0.93, C 111.7 µg L
-1
, D -1.2, R
2 
0.998), brown squares C10-HS (A 94.8, B 1.18, C 12.2 µg L
-1
, D 0.95, R
2 
0.998), and orange rhombus 3-oxo-
C10-HS (A 93.2, B 0.76, C 5.7 µg L
-1
, D -1.8, R
2 
0.993). 
3.6.2 Difference in selectivities of anti-HSL1-, anti-HSL1/2-, and anti-
HSL4 mAbs to HSL compounds 
The selected antibodies showed different selectivities against the HSL compounds, which 
differ in the side chain length and in the functional group on the C3 position. For better 
comparability, the assays described in this paragraph were all carried out in the coating 
antigen format. Similar to mAb HSL1/2-2C10, anti-HSL1 mAb HSL1-1A5 had a higher 
affinity to HSLs with the 3oxo-group in the C3 position, but the difference in CR between 
with or without 3oxo-group was more significant (Table 12, Figures 29 and 31).  
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Figure 31 HSL1-1A5 coating antigen format standard curves 
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Standard curves for C10-HSL, 3-oxo-C10-HSL, C10-HS, and 3-oxo-C10-HS using mAb HSL1-1A5 and HSL2-
BSA-r2. Assay conditions: HSL1-1A5 200 ng mL
-1
, HSL2-BSA-r2 2 µg mL
-1
, GAR-HRP 40 ng mL
-1
. Four 
parameter curve-fitting data are given in parentheses: red circles C10-HSL (A 99.7, B 1.32, C 3840 µg L
-1
, D -
3.2, R
2 
0.997); yellow green inverted triangles 3-oxo-C10-HSL (A 105, B 1.29, C 561 µg L
-1
, D -1.8, R
2 
0.994); 
brown squares C10-HS (A 104, B 1.2, C 142 µg L
-1
, D -0.54, R
2 
0.998), and orange rhombuses 3-oxo-C10-HS 
(A 104, B 1.21, C 34 µg L
-1
, D 0.08, R
2 
0.998. 
For HSL1 and HSL1/2 antibodies, 3oxo-C10-HSL was used as the main analyte for cross 
reactivity tests (described in section 2.11.6, page 65). C10-HSL had a CR of 14% for mAb 
HSL1-1A5, while 55% to mAb HSL1/2-2C10 (Table 12). In contrast to anti-HSL1 and anti-
HSL1/2 mAbs, anti-HSL4 mAbs showed higher sensitivity against HSLs without the oxo-
group in the C3 position. For example, using mAb HSL4-5H3 C10-HSL had a CR of 70% 
and 3oxo-C10-HSL a CR of 38%. Here, C8-HSL was used as the main analyte (Table 12 and 
Figure 32). Additionally, after hydrolysis, the recognition of HS with or without 3oxo- group 
of mAbs remained the same trend as for their original HSL forms for most mAbs (exception: 
mAb HSL4-4C9, the antibody with the highest selectivity, standard curves see attachments). 
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Figure 32 HSL4-5H3 coating antigen format standard curves 
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Standard curves for C10-HSL, 3-oxo-C10-HSL, C10-HS, and 3-oxo-C10-HS with the coating antigen format, 
using mAb HSL4-5H3 and HSL2-BSA-r2. Assay conditions: HSL4-5H3 culture supernatant 1:1000, HSL2-
BSA-r2 2 µg mL
-1
, GAR-HRP 40 ng mL
-1
. Four parameter curve-fitting data are given in parentheses: red 
circles C10-HSL (A 100.9, B 1.38, C 1303 µg L
-1
, D -2.3, R
2 
0.999), yellow green inverted triangles 3-oxo-C10-
HSL (A 100.4, B 1.3, C 3674 µg L
-1
, D -3.7, R
2 
0.997), brown squares C10-HS (A 103.2, B 1.33, C 39.4 µg L
-1
, 
D 2.3, R
2 
0.99), and orange rhombuses 3-oxo-C10-HS (A 105.3, B 1.14, C 152.9 µg L
-1
, D 2.4, R
2 
0.986). 
3.6.3 Recognition of HSL and HS 
Interestingly, all our HSL mAbs proved to be more sensitive against homoserines (HSs, 
hydrolysed HSLs) than HSLs, no matter which analyte and which assay format were used. 
For example, 3oxo-C10-HS has a CR of 1935% and C10-HS has a CR of 545% to mAb 
HSL1-1A5 in the coating antigen format and similar trends were observed for other anti-HSL 
mAbs. The detection of tested HSs is in the low µg L
-1
 range in all assays (e.g., 3oxo-C10-HS 
had an IC50 of 5.7 µg L
-1 
using mAb
 
HSL1/2-2C10 in enzyme-tracer format, Figure 30). 
Probably, the HSL antigens used for immunisation were hydrolysed to the HS-form at the 
physiological conditions in the rat. 
3.6.4 Recognition of HSL side chain length 
The side chain length of HSLs plays an important role for the antibodies recognition. When 
the functional group on the C3 position is not taken into account, all antibodies showed the 
best recognition of HSLs with side chain length of C8 or C10, the shorter chain length (C4) 
and longer chain length (C12) were comparatively less recognised by the HSL mAbs. Most 
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HSL1 and HSL1/2 mAbs recognised 3oxo-C10-HSL the best, and most HSL4 mAbs had best 
affinity towards C8-HSL (Tables 13 and 14). That was also the reason why they were chosen 
as main analytes for CR assays. As shown in Figure 33, the assay with mAb HSL1/2-2C10 
has the lowest IC50 for 3oxo-C10-HSL, followed by 3oxo-C12-HSL, and then 3oxo-C4-HSL. 
Anti-HSL4 mAbs were slightly better than HSL1 and HSL1/2 mAbs for short chain HSL 
recognition. This trend was observed from other mAbs as well; despite there were small 
differences between different antibodies. 
Figure 33 HSL1/2-2C10 recognition of different chain length  
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Standard curves for HSL compounds with different chain length: 3-oxo-C4-HSL, 3-oxo-C10-HSL and 3-oxo-
C12-HSL using mAb HSL1/2-2C10 and HSL2-BSA-r2. Assay conditions: HSL1/2-2C10 400 ng mL
-1
, HSL2-
BSA-r2 1 µg mL
-1
, GAR-HRP 40 ng mL
-1
. Four parameter curve-fitting data are given in parentheses: black 
circles 3-oxo-C4-HSL (A 98.4, B 0.99, C 4293 µg L
-1
, D -2.1, R
2 
0.999), red inverted triangles 3-oxo-C10-HSL 
(A 100.3, B 0.98, C 671.5 µg L
-1
, D -1.7, R
2 
0.999), and green squares 3-oxo-C12-HSL (A 98.9, B 1.17, C 1487 
µg L
-1
, D -1.3, R
2 
0.999). 
3.6.5 Recognition of haptens 
All four haptens (HSL1, HSL2, HSL3 and HSL4, Figure 23) were tested also as analytes with 
all assays to characterise the antibodies. HSL2 and HSL3 were generally less recognised than 
HSL1 and HSL4 for all tested mAbs. In addition, all mAbs could clearly distinguish between 
HSL1 and HSL3, which have the identical chain length and differ only in the C3 position 
(oxo- versus hydroxyl group). The best discrimination of the functional group in this position 
is shown with mAb HSL1-8E1, which recognises the oxo- group 40 times better than the 
hydroxyl group. HSL1 mAbs had CRs in the order HSL1>HSL4>HSL3>HSL2, and the CR 
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of HSL1 was about 150% and for HSL2 below 0.1%. Similarly, as described in section 3.6.2, 
the anti-HSLl antibodies were able to distinguish the side chain length and functional group in 
the C3 position significantly. Slightly differently, HSL1/2 antibodies had nearly identical high 
CRs to HSL1 and HSL4. Again HSL2 was the least recognised. The CR from HSL1 to HSL3 
dropped also significantly. As expected, all anti-HSL4 mAbs showed best recognition for 
HSL4. This was followed by the recognition of HSL1. Interestingly, the mAbs HSL4-5E12, 
HSL4-5H3 and HSL4-6D3 showed relatively higher CR to HSL2 compared to all other mAbs 
(Tables 13 and 14). This special property of these HSL4 antibodies offers better binding 
opportunity to short chain HSLs than other mAbs. (The standard curves of mAbs HSL1-8E1, 
HSL4-4C9 HSL4-5E12 and HSL4-6D3 are supplied in Attach. 5-8, page 155-158). 
3.7 HSL detection in biological samples  
In this study, three kinds of biological samples were selected for HSL detection in the 
bacterial supernatant with the developed immunoassays. They were Burkholderia cepacia 
LA3, TCB degradation bacterial community, and Pseudomonas putida (wild type IsoF, 
mutant F117 and negative strain KT2440). 
3.7.1 Burkholderia cepacia isolate LA3 
3.7.1.1 Matrix effects in ABC medium 
For B. cepacia LA3 samples, the matrix effects were determined by comparing the 3oxo-C10-
HSL standard curves in 40 mM PBS buffer and ABC medium. A slight OD increase (about 
0.2) in ABC medium was observed for both ELISAs, but the signal was still in an acceptable 
range in both buffers. In addition, a shift of standard curves to the right (to higher 
concentration) was clearly visible and is shown in Figure. 34. Both ELISAs performed with a 
lower sensitivity in ABC medium than in PBS buffer. The ABC/PBS factor of IC50 for 3oxo-
C10-HSL is 3.1 using mAb HSL1/2-2C10 and 2.5 using mAb HSL1/2-4H5. Noticing this 
matrix effect, the standard curve of 3oxo-C10-HSL was set up in ABC medium as a reference 
for culture supernatant samples. The working range was taken from 15% to 85% control of 
the standard curve (Brady, 1995). According to the standard curves it was 21–585 μg L−1 (78–
2,170 nM) in the assay with PBS buffer and 50–1,500 μg L−1 (186– 5,576 nM) in the assay 
with ABC medium (Figure 34; mAb HSL1/2-2C10, enzyme tracer HSL3-HRP). This implies 
for the assay in ABC medium, that this assay has the lowest relative error between 50 and 
1,500 μg L−1 and correspondingly lower accuracy outside of this range (Harrison et al., 1989). 
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Figure 34 Matrix effects in ABC medium. 
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Standard curves for 3oxo-C10-HSL with mAbs HSL1/2-2C10 and HSL1/2-4H5 in PBS buffer and in ABC 
medium using HSL3-HRP as enzyme-tracer. Assay conditions: Protein G 2 µg mL
-1
; HSL1/2-2C10 400 ng mL
-1
, 
HSL3-HRP 1:600; HSL1/2-4H5 200 ng mL
-1
, HSL3-HRP 1:400. Four parameter curve fitting data are given in 
parentheses: red circles 3oxo-C10-HSL in PBS with HSL1/2-2C10 (A 0.834, B 1.1, C 120 µg L
-1
, D 0.006, R
2 
0.991); yellow green inverted triangles 3oxo-C10-HSL HSL in ABC medium with HSL1/2-2C10 (A 0.956 , B 
1.25, C 373 µg L
-1
, D 0.015, R
2 
0.989); brown squares 3oxo-C10-HSL in PBS with HSL1/2-4H5 (A 0.977, B 
1.04, C 243 µg L
-1
, D -0.017, R
2 
0.979); orange rhombus 3oxo-C10-HSL in ABC medium with HSL1/2-4H5 (A 
1.29, B 1.45, C 601 µg L
-1
, D 0.054, R
2 
0.992). Published results (Chen et al., 2010 b) 
3.7.1.2 Assay comparison with two mAbs and two setups with B. cepacia LA3 
culture supernatants 
Our previous work of this study had confirmed that the mAbs HSL1/2-2C10 and HSL1/2-4H5 
have a very similar specificity pattern to HSLs and HSs (CRs see Tables 12 and 13). As listed 
in Table 15, mAb HSL1/2-2C10 has a lower IC50 for 3oxo-C10-HSL (134 µg L
-1
) than 
HSL1/2-4H5 (253 µg L
-1
), and the recognition of C8-HSL and C10-HSL was slightly 
different as well. In general, these antibodies showed significantly better recognition of the 
hydrolysed form of HSLs (HSs). Using mAb HSL1/2-2C10, C8-HS has a CR of about 
3820%, C10-HS of 1531%, and 3oxo-C10-HS of 1813%. The similar high recognition for 
HSs was revealed with mAb HSL1/2-4H5. 
Doctoral thesis, Xiao Chen, 2011 
 
101 
 
Figure 35 Comparison of two ELISAs with different antibodies and set A and B of undiluted B. cepacia 
culture supernatants.  
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MAb HSL1/2-2C10 (400 ng mL
-1
) and enzyme-tracer HSL3-HRP (1:600): set A red circles; set B orange 
inverted triangles. MAb HSL1/2-4H5 (200 ng mL
-1
), HSL3-HRP (1:400): setup A yellow-green squares; setup 
B green rhombus. Published results (Chen et al., 2010 b) 
Undiluted B. cepacia culture supernatants were then analysed individually in set A and set B 
(in two different flasks set up in parallel) by ELISAs in the enzyme-tracer format using both 
mAbs, respectively. Although C8- and C10-HSL were expected to be the main HSLs for B. 
cepacia, in these experiments 3oxo-C10-HSL was used as the reference standard (= main 
analyte in our optimised assays), and results were then expressed as 3oxo-C10-HSL 
equivalents. All four assays (2 mAbs, 2 sets) showed very similar results for these B. cepacia 
culture supernatants (Figure 35). In summary, no HSLs were detected from samples taken 
from cultures grown less than 12h, and the HSL concentrations increased continuously from 
12h to 48h. The maximum concentration of about 3500 µg L
-1
 of 3oxo-C10-HSL equivalent 
was detected at 48h. Due to the fact that these two setups and two assays had reproducible 
results, the further experiments were performed only with mAb HSL1/2-2C10 and set A. 
Figure 36 presents the UPLC-MS measurement results of the parallel prepared sample. C10-
HSL was the most detected signal molecule and followed by C8-HSL. To compare the ELISA 
results a summary of the both HSLs was additionally present (green curve). Very similar to 
ELISAs, almost no HSL was found before 12 h and the HSL concentration increased with the 
inoculation time (12 h-48h). However, the absolute concentrations, even the summarised 
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values, of detected HSLs were a lot lower than those from ELISAs. The max. HSL 
concentration detected in ELISA was about at 48h with 3500 µg L
-1
 (Figure 35) but the max. 
value from UPLC-MC was less than 500 µg L
-1 
(Figure 36). 
Figure 36 HSLs detected with UPLC-MS in B. cepacia LA3 culture supernatant 
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Green curve presents the summary of C8-HSL and C10-HSL, UPLC-MS measurement results supplied from 
Fekete 2010, unpublished. 
3.7.1.3 Dilution control of B. cepacia LA3 culture supernatants 
As mentioned before, the maximum concentration detected in B. cepacia LA3 culture 
supernatants at 48h was about 3500 µg L
-1
 3oxo-C10-HSL equivalents. This was outside the 
assay’s working range. Therefore the samples were diluted 1:5, 1:10, and 1:20 in ABC 
medium for the HSL determinations. Samples diluted 1:5 had the highest concentrations, and 
the 1:10 and 1:20 diluted samples showed correspondingly lower concentrations (Figure 37). 
Again, it was noticed that the LOD range of the assays had an effect on the accuracy of the 
detection, particularly the samples with higher concentrations. Thus, attention had to be paid 
to sample dilutions with careful consideration of the detection ranges of the assays. From the 
results shown in Figure 37, the 1:10 dilution was selected to be the most suitable for these 
measurements, because most of the values were within the working range. Additionally, the 
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samples with hydrolysing treatment were also diluted with the same factors as described for 
the untreated ones, and the final results were very well comparable (data not shown). 
Figure 37 Dilution controls in ELISA using mAb HSL1/2-2C10 (400 ng mL
-1
) and enzyme-tracer HSL3-
HRP (1:600) 
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1:5 dilution: black circles; 1:10 dilution: red inverted triangles; 1:20 dilution: green squares. Published results 
(Chen et al., 2010b) 
3.7.1.4 Hydrolysis and spiking experiments 
In natural environments, HSLs could be at least partially hydrolysed and HSs would be 
produced due to the lactone ring opening. However, analytic using mAbs and ELISA for 
HSLs in B. cepacia LA3 culture supernatants could not distinguish HSLs from HSs directly. 
In order to find out, whether HSLs of B. cepacia were already hydrolysed in the culture 
supernatants, measurements were carried out with the original sample and after effective 
hydrolysis. In addition, the hydrolysed samples were then spiked with 50 µg L
-1
 of 3oxo-C10-
HS. Figure 38 shows only the 1:10 dilution of culture supernatants; but the dilutions 1:5 and 
1:20 provided comparable results. The green curve (squares) in Figure 38 illustrates the 
concentration of hydrolysed samples which were spiked with 50 µg L
-1
 of 3oxo-C10-HS, 
respectively. The spike of 50 µg L
-1
 of 3oxo-C10-HS resulted in an average concentration of 
1497±60 µg L
-1
 of 3oxo-C10-HSL equivalents (0 to 12h). This higher determination reflects 
the higher CR to 3oxo-C10-HS. For control purpose, the whole process was repeated with a 
Doctoral thesis, Xiao Chen, 2011 
 
104 
 
spiking concentration of 25 µg L
-1
 of 3oxo-C10-HS. Here, the spiked concentration of 25 µg 
L
-1
 of 3oxo-C10-HS was analysed as an average concentration of 669±76 µg L
-1
 of 3oxo-C10-
HSL equivalents (0 to 12h). 
Figure 38 Hydrolysis and spiking experiments with 1:10 diluted B. cepacia culture supernatants.  
 
 
ELISA with mAb HSL1/2-2C10 400 ng mL
-1
 and enzyme-tracer HSL3-HRP 1:600. Black circles: 1:10 diluted 
culture supernatants. Red inverted triangles: 1:10 diluted culture supernatants after hydrolysis of HSLs. Green 
squares: 1:10 diluted culture supernatants after hydrolysis of HSLs and with a spiked concentration of 50 µg L
-1
 
of 3oxo-C10-HS to each sample, the grey dash lines with arrows indicate the increasing of the detected 3oxo-
C10-HSL signals due to the addition of 50 µg L
-1
 3oxo-C10-HS. Published results (Chen et al., 2010 b) 
Assuming that C8- and C10-HSL were present in the B. cepacia LA3 culture supernatants 
(after 12h), the spiked concentration of 3oxo-C10-HS was still clearly visible (Figure 38). The 
spike of 50 µg L
-1
 of 3oxo-C10-HS resulted here in an average concentration of 1149±131 µg 
L
-1
 of 3oxo-C10-HSL equivalents (difference between measurements of 1:10 diluted culture 
supernatants after hydrolysis, without and with spike, 24-48h). The determined concentrations 
though were probably slightly influenced by the presence of C8-HS and C10-HS. 
Although we could not give the distribution of HSLs and HSs in the B. cepacia culture 
supernatants, a clear increase of both compounds during the bacterial growth could be 
followed over time (12h to 48 h).  
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3.7.2 HSL detection in Pseudomonas putida cultural supernatant 
In P. putida culture supernatants, the highest AHL concentration was detected from the 
wildtype IsoF and then followed by the negative mutant F117 and negative control KT2440. 
No signal was detected in the blank control samples (Figure 39). However the AHL 
concentration of the negative supernatant was in quite low level compared to the positive 
supernatant. The diluted samples showed comparable proportional factors (Figure 39). 
Figure 39 P. putida supernatants HSL detection with 24h inoculation time 
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3.7.3 HSL detection in TCB degradation bacterial community  
In Figure 40 it is shown that the blank samples had only very low values. These values were, 
thought to be backgrounds. All samples showed an increase from day 7 to day 14. Not like the 
further increasing of S and E, the C samples showed slight decrease after two weeks. 
Interestingly, a particular high concentration of AHLs was detected of S sample of the day 1, 
which was different from all other sample series. The samples were also analysed by UPLC-
MS and some HSLs were detected but the detailed evaluations are still not available at the 
moment (unpublished results, Fekete, 2010).  
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Figure 40 HSL detection TCB degrading bacterial communities supernatant  
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B: blank; C: community; S: sterilised clay; E: established biofilm on clay 
3.8  AOS results of mAb HSL1/2-2C10 
For comparison with ELISA, the mAb HSL1/2-2C10 was also characterised with AOS. Due 
to limited available sensor chips, no other mAb has been characterised with AOS. As 
discussed previously, the mAb HSL1/2-2C10 was well characterised with ELISA using both 
formats.  
As an example, Figure 41 shows the directly measured and evaluated results of the AOS for 
the antibody HSL1/2-2C10 without analyte. The slope value of the second middle peak, 
which used the coating of 2 mg mL
-1
 of HSL2-BSA-r2, was obtained for further evaluation. 
As the competitive principle coating antigen format, the peaks become smaller (lower slope) 
with the increasing of the analyte concentration (data see Attach.9, page 159 and Attach.10, 
page 160).  
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Figure 41 AOS peaks of Oyster-645 labelled mAb HSL1/2-2C10 without analyte  
 
 
 
Assay condition: mAb HSL1/2-2C10 labelled with Oyster-645 (label degree 1:2), 48 ng mL
-1
; spotting with 
HSL2-BSA-r2 in 50 mM carbonate buffer, pH = 9.6 + 0.05% (v/v) Tween 20, [3 mg mL
-1
] for peak left, [2 mg 
mL
-1
] for peak middle and [1 mg mL
-1
] for peak right. Zero analyte addition.  Slope value: peak left= 8.341 
mV/s, peak middle= 9.036 mV/s (value in the figure), and peak right= 9.622 mV/s. 
 
The Figure 42 and 43 are the standard curves for 3oxo-C10-HS and C10-HS measured by 
AOS using the antibody HSL1/2-2C10. No significant difference was observed between the 
coating concentrations of 1, 2 or 3 mg mL
-1
 in both curves. The IC50 of 3oxo-C10-HS was 
38.8 µg L-1, which is slightly lower than the IC50 of C10-HS (54.3 µg L
-1
). 
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Figure 42 Standard curves of 3oxo-C10-HS with AOS 
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AOS standard curves for 3oxo-C10-HS with different concentration of spotting antigen HSL2-BSA-r2, using 
mAb HSL1/2-2C10. Assay conditions: Oyster-645 labelled HSL1/2-2C10 (label degree 2), 48 ng mL
-1
. Four 
parameter curve-fitting data are given in parentheses: black circles HSL2-BSA-r2, 3 mg mL
-1
,  (A 98.6, B -0.63, 
C 44.6 µg L
-1
, D -14.5, R
2 
0.979), red inverted triangles HSL2-BSA-r2, 2 mg mL
-1
,  (A 97.7, B -1.04, C 38.8 µg 
L
-1
, D -1.93, R
2 
0.996), and green squares HSL2-BSA-r2, 1 mg mL
-1
,  (A 99.9, B -9.23, C 31.8 µg L
-1
, D -4.68, 
R
2 
0.997). 
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Figure 43 Standard curves of C10-HS with AOS 
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AOS standard curves for C10-HS with different concentration of spotting antigen HSL2-BSA-r2, using mAb 
HSL1/2-2C10. Assay conditions: Oyster-645 labelled HSL1/2-2C10 (label degree 2), 48 ng mL
-1
. Four 
parameter curve-fitting data are given in parentheses: black circles HSL2-BSA-r2, 3 mg mL
-1
,  (A 105.8, B -
1.18, C 56.2 µg L
-1
, D 5.46, R
2 
0.989), red inverted triangles HSL2-BSA-r2, 2 mg mL
-1
,  (A 105.6, B -1.30, C 
54.3 µg L
-1
, D 6.94, R
2 
0.972), and green squares HSL2-BSA-r2, 1 mg mL
-1
,  (A 104.9, B -1.27, C 55.8 µg L
-1
, 
D 6.03, R
2 
0.967). 
3.9  Fluorophore labelled antibodies  
It is possible that the chemical properties of antibodies are changed in some manners through 
the labelling with dyes. To obtain good fluorescence immunoassays, two aspects must be 
taken into consideration. First, a good affinity of the antibodies is still required for target 
analytes; secondly, the fluorescence signal should be strong enough to be detected. Using 
Oyster645-NHS as fluorescent dye for HSL antibodies, different label degrees and reaction 
times have been tested.  
The increase of antibody-dye reaction time resulted in a slightly higher fluorescent signals 
(Figure 44) but reduced binding to the coating antigen (Figure 45), however, the difference 
was not very high.  
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Figure 44 AOS affinity determination of HSL1-1A5 after fluorescent labelling  
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A representative figure for Oyster645 labelled HSL-mAb binding determined by AOS. Assay conditions: coating 
antigen HSL2-BSA-r2, 3 mg mL
-1
 in 50 mM Carbonate-Puffer + 0.05 % (v/v) Tween 20; HSL1-1A5+Oyster 
645, 48 ng L
-1
 (measured by Miss Mandy Starke, 082009, IEC) 
Interestingly, a strong influence to antibody affinities of label degrees has been observed from 
both methods. The antibody binding on coating antigen was almost completely inhibited with 
label degrees of 10 or 20 (results not shown) and only very small amount of binding was 
shown at label degree of 5 (Figures 44 and 45). The antibody-antigen binding sites could 
probably be blocked by the relative large amount of dye. Thus the reduced label rate resulted 
in significant increase of binding signal in AOS and more effective inhibition in ELISA. 
Based on the results discussed above, the antibodies with label degree of 2 and reaction time 
of 20 min were chosen for further applications, e.g. in situ experiments.  
In addition to the fluorophore labelling protocol of Denovo Biolabels, the DMF volume was 
varied depending upon the dye amount needed for conjugations. Basically, the dye solution 
needed for individual antibody should be more than 1 µL, which is aimed to reduce pipette 
error. This is particular important at small amount conjugations. Another important point was 
found to have enough glycine for complete blocking of activated ester on dye. A double or 
higher amount of glycine as dye is recommended to avoid unspecific binding of activated 
NHS.  
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Figure 45 Inhibition 2D tests of HSL1-1A5+Oyster645 with coating antigen format ELISA 
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A representative figure evaluation of Oyster645-labelled HSL-mAb using two dimensional inhibition tests with 
the coating antigen format ELISA. Assay conditions: coating antigen HSL2-BSA-r2, 2 µg mL
-1
; HSL1-
1A5+Oyster 645, 400 ng mL
-1
. The green bars are the OD without inhibition (only PBS), the orange and yellow 
bars are the OD with additional 3oxo-C10-HSL as competitor of the binding to coating antigen. The more the 
difference to PBS, the better is the inhibition and the better is the sensitivity of the assay. 
3.10  In situ experiments 
 
The in situ experiments of bacterial biofilms on ibidi slides (Figure 46) and of bacterial 
colonisation of plant roots (Figure 47) were difficult due to the interference of the specific 
fluorophore label with the matrix autofluorescence and unspecific binding of the labelled 
antibodies. Figure 46 is showing biofilms/colonies of B. cepacia LA3 on ibidi slides. It is 
apparent, that without blocking with 10% glycine (0.5% glycine in final antibody solution) 
the Oyster645-staining binds un-specifically (Fig. 46B and 46C). Using Oyster-labelled 
HSL1/2-2C10 binding of the labelled antibody was visible (Fig. 46D) and less in Fig. 46F 
when less Ab-concentration was applied. However, low binding of Oyster645-labelled anti-
DDT (as negative control) demonstrates still some degree of unspecific binding, which need 
to be reduced further by alternative blocking and more intense washing. 
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Figure 46 LSM-images of Oyster labeled mAb on B. cepacia LA3 biofilm in ibidi slide 
BA
DC
FE
 
 
Experiment conditions: biofilm of B.cepacia LA3, mAb HSL1/2-2C10 labelled with Oyster645 in 40 mM PBS. 
A: only biofilm, no glycine; B: biofilm incubated with Oyster 645 solution, no glycine; C: biofilm incubated 
with 0.5% glycine treated Oyster 645; D: biofilm treated with Oyster 645-labelled HSL1/2-2C10, 0.3 mg mL
-1
, 
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with 0.5% glycine E: biofilm treated with Oyster 645 labelled HSL1/2-2C10, 0.2 mg mL
-1 
, with 0.5% glycine; 
F: biofilm with Oyster645-labelled anti-DDT-mAb, with 0.5% glycine. Pictures from Rotballer, 2010. 
 
In Figure 47 LSM-images of root surfaces of barley inoculated with gfp-labelled 
Pseudomonas putida IsoF are shown. The preincubation of 3% BSA was efficient to reduce 
drastically the unspecific background labeling with Oyster-645-labelled HSL ½-2C10 
antibody (Fig. 47 B and C). In the presence of AHL-producing bacteria on the root surface, a 
strong “blue” antibody labeling was visible (Fig. 47D) – especially of the plant cell wall and 
intercellular spaces (upper left corner of 47D). 
 
Figure 47 LSM-images of barley roots inoculated with P. putida IsoF and labelled with Oyster 645-
labelled HSL1/2-2C10 
 
The Oyster645 labelled antibody solutions were all treated with glycine (0.5% in final solution); A: root with 
GFP-labelled bacteria; B: uninoculated root, incubated with labelled antibody after blocking (then washed out) 
with 3% BSA; C: inoculated root treated with labelled antibody, without BSA blocking; D: inoculated root 
treated with labelled antibody after blocking (then washed out) with 3% BSA. Pictures from Buddrus-Schiemann 
, 2010. 
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4 Discussion 
4.1 Selection of HSL haptens  
Immunogens are structurally complex high molecular weight materials which cause an 
immune response in host animals (vertebrates) leading to antibody production. The hapten 
design is the most crucial step of immunoassay, because the properties of the haptens directly 
influence the antibody quality (more information see section 1.4.2.2 and 1.4.2.3). The HSL 
based haptens (Figure 23, page 76) selected in this study were aimed to obtain antibodies, 
which could distinguish the AHL side chain length, and the substitutions (oxo-, OH- or only 
hydrogen) on the C3 atom. Furthermore, the antibodies showed different selectivities to the D 
and L isomers of the HSL substances (Attach. 11, page 161). But a proper comparison was 
difficult because there are no pure D-form HSLs available and the experiments were only 
performed using Lisomeric HSLs and DL mixed HSLs. 
4.2 Hapten conjugation and conjugates characterisation 
Small molecules (MW<1000 Da) are usually not sufficient to trigger a vertebrates’ immune 
system. In this study, the HSL molecules are too small (MW<1000 Da) and must be 
conjugated to carrier proteins to enable an immune response and consequently antibody 
production. Albumin (typically BSA and OVA) and keyhole limpet hemocyanin (KLH) are 
two very common carrier proteins. BSA is well suited as a carrier protein due to its high 
solubility in various buffers, moderate molecular weight (BSA, 66 kDa), and high content of 
available primary amines. Immunogens based on KLH have been frequently used; however, 
they are difficult to characterise due to poor solubility, variable mass of the starting protein, 
and inconsistencies in the purity. Thus BSA and OVA (45 kDa) were used as carrier proteins 
and confirmed to be a suitable choice for the resulting immunoassays. The haptens used for 
this work were produced with modification of a carboxyl functional group at the end of the 
HSL carbon side chain (Figure 24).  
Several methods have been used to determine the hapten-protein conjugation. The UV 
absorbance spectrum of the synthesised conjugate is commonly used when the hapten or 
linker has a strong chromophore which differs from the carrier protein. Electrophoresis and 
fluorescence methods were also suggested to be very useful in detecting hapten-protein cross-
linking while matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) 
and spectrophotometric detection provided qualitatively comparable hapten density 
(Adamczyk et al., 1994, Singh et al., 2004). In this study, the UV spectra of HSL haptens, 
BSA, OVA, and the conjugates were obtained to confirm the success of conjugation. 
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Unfortunately, HSL1 was the only hapten, which showed a peak in the UV spectra and no 
significant UV signal was detected of the rest three haptens (Figure 24-26). However, the shift 
of the peaks of BSA/OVA proteins after the conjugation indicated the success of the 
experiments. But the determination of the exact number of the HSL haptens per protein was 
not possible using this technology. MALDI-MS was tried to determine the hapten conjugate, 
but the experiment was not successfully because the detected molecular weight of proteins 
after coupling was very similar or even smaller compared to non-conjugated protein. The 
reason might be that the change of protein molecular weight caused by coupling of the small 
HSLs (MW<500) was not large enough for the instrumental sensitivity. MALDI-TOF-MS 
might be a more suitable method to the HSL conjugates characterisation for the BSA/OVA 
molecular size. 
4.3 HSL-protein and HSL-HRP conjugates selection for ELISAs 
The results of antibody screening and antibody characterisation showed that HSL2-BSA-r1 
and HSL2-BSA-r2 with reduced hapten number had a higher sensitivity than HSL2-BSA with 
higher hapten number in the coating antigen format. The hapten amount per BSA molecule 
had the order of HSL2-BSA>HSL2-BSA-r1>HSL2-BSA-r2, and the sensitivity of the assays 
increased with the reduced hapten number. Marco et al. (II, 1995) and Raem & Rauch (2007) 
described that the hapten-protein ratio plays different roles for immunisation as compared to 
the immunoassay as coating antigen. A high hapten-protein ratio is commonly required to 
reach a high strength and specificity of the immune response, but for coating antigen assay 
(the HSLs on immunogen compete with the HSL in free solution for the antigen-binding sites 
of the antibody) a lower number is more desirable to obtain sensitive assays. In general, when 
the amount of hapten in the competitor (hapten-protein conjugate) is reduced, less analyte in 
solution is required to compete for the specific binding to mAb. However, a too low hapten-
protein ratio could not be used as competitor since the binding to the antibody is too weak and 
therefore not sufficient for assays. From the four HSL-HRPs, HSL1-HRP and HRL3-HRP 
showed the best enzyme-tracer format assays and HSL2-HRP generally had very low or 
instable signals. Thus variable hapten-protein ratios for coating antigens and enzyme-tracers 
should be prepared to obtain most sensitive assays. 
4.4 Antibody screening  
Sensitivity, selectivity and signal intensity were the main criteria for antibody screening. For 
further characterisation of sub-cloned mAbs in culture supernatants or  in purified solutions, 
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two-dimensional titrations were carried out and standard curves were used to check the 
combination which gave the highest sensitivity (lowest IC50) and the lowest background with 
an acceptable binding signal (optical density>0.3). The selectivity of antibodies against HSLs 
was also carefully considered to gain diverse antibodies. In the end, two HSL1 mAbs, two 
HSL1/2 mAbs and four HSL4 mAbs were chosen for purification regarding  the results of 
optimised coating antigen and enzyme-tracer formats. 
4.5 Comparison of coating antigen and enzyme-tracer format 
assays 
All antibodies tested in this study showed less sensitivity in the coating antigen format than in 
the enzyme-tracer format, although similar tendency of cross-reactivity pattern was observed  
in general (Tables 12 and 13, page 88-90). This phenomenon of lower test midpoints in the 
enzyme-tracer format was already demonstrated in former ELISA developments (e.g., Krämer 
et al., 2004, 2010). One explanation originates in the immunochemical reaction which is 
based on the law of mass action. As it was discussed above, more hapten molecules (per 
protein) will need more analyte molecules (higher concentration) in the competitive reaction 
to reveal the same signal. This implies particularly in applications when the same hapten is 
used for the coating antigen and for the enzyme-tracer conjugates and when mAbs are utilized 
in the assays (Krämer et al., 2010). Generally, from six lysines in the HRP molecule, a 
maximum of three molecules show surface accessibility (Krämer et al., 2004). The BSA 
molecule on the other hand has 59 lysine residues, 30-35 of which have primary amines 
capable of reacting with a conjugation reagent. Assuming that all accessible 30-35 lysine 
residues were occupied with haptens during our ‘normal’ conjugation process, the hapten-
BSA conjugate with reduced hapten molecules, for which only half of the hapten quantity for 
conjugation was used (Table 5, page 56), approximately 15 hapten molecules per protein 
molecule are expected. This will lead to a less favourable inhibition for HSL compounds in 
the coating antigen format in comparison to the enzyme-tracer format. 
4.6 Comparison of ELISA and AOS  
The coating antigen format was used for both ELISA and AOS, however, there are a few 
differences between the two methods. The most important difference was the fluorophore 
labelling of the antibodies for AOS, while the antibodies for ELISA were unlabelled. The 
other differences referred to the incubation conditions (e.g. time, temperature, and 
concentrations) and immobilisation surface. These are the factors, which might affect the 
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sensitivity of the assays. As mentioned in the previous section of fluorophore conjugation 
(1.4.6.2, page 41), the antibody could be changed in some manner after conjugation with a 
fluorophore. The tendency of cross-reactivity pattern of the assays remained similar: the 
assays recognised 3oxo-C10-HS better than C10-HS. However, the AOS was slightly more 
sensitive than ELISA compared to the IC50 values of the analytes (Table 16). Another 
interesting point is that the ELISA distinguished the HS with or without –oxo group more 
significantly than AOS. In general, they are both very comparable characterisation methods 
for antibodies. But individual assay for different antibody and analyte is strongly 
recommended, because all molecules have their unique nature. 
 
Table 16 IC50 and LOD comparison of ELISA and AOS  
 ELISA 
Coating antigen format 
AOS 
Coating antigen format 
Coating antigen HSL2-BSA-r2 [1 µg mL
-1
] HSL2-BSA-r2 [2 mg mL
-1
] 
mAb HSL1/2-2C10 
 
[400 ng mL
-1
] 
HSL1/2-2C10 labelled with 
Oyster-645 
[48 ng mL
-1
] 
Analyte IC50 [µg L
-1
] LOD [µg L
-1
] IC50 [µg L
-1
] LOD [µg L
-1
] 
C10-HS 131±16, n=2 14±3, n=2 53±5, n=3 14±1, n=3 
3oxo-C10-HS 37±6, n=2 4.7±3.5, n=2 38±6, n=3 2.4±1.4, n=3 
4.7 Antibody recognition of homoserine lactone (HSL) and 
homoserine (HS) compounds 
The selected antibodies showed distinguishing selectivities to the HSLs with varied chain 
length and functional groups on the C3 position corresponding to the immunised haptens. All 
antibodies showed best recognition of chain lengths of C8 or C10 and very low recognition of 
the hydroxy group on the C3 atom. HSL1 mAbs could significantly distinguish the HSLs with 
or without oxo- on C3 position, and long chain HSLs were preferred. HSL1/2 mAbs had very 
broad recognitions of HSLs with slightly better affinity for oxo- containing HSLs. In contrast 
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the HSL4 antibodies showed higher affinity to the HSL without any substitution on C3 
position and the HSL4-4C9 was very specific to C8-HSL and showed much less recognition 
of other HSLs. The affinities of the antibodies to the HSL haptens showed very similar trends 
as obtained from HSL standards. These specificities of the antibodies confirmed a successful 
hapten design for targeting HSL molecules. 
An unusual phenomenon was observed with six out of eight HSL-antibodies. The recognition 
of HSL2 was extremely low (CR<0.1 to 3%) although the HSL2-BSA conjugate was selected 
as the best coating antigen, meaning that HSL2 must have been recognised by the antibodies. 
One explanation for this might be that the linkage of HSL2 to the lysine group of the protein 
leads to an extension of the chain length. It seems that the peptide bond formed during 
covalent attachment of the HSL2 hapten to lysine is not so critical for recognition, and 
therefore the antibodies recognise a longer chain length than originally from HSL2. This is 
supported also by the good recognition seen of HSL4 and the very poor affinity of the HSL2 
compound. 
In this study, the newly developed anti-HSL mAbs were proven being more sensitive against 
homoserines (HSs, hydrolysed HSLs) than HSLs in both ELISA formats and biosensors. The 
initial goal of the study was to produce specific anti-HSL mAbs, which are relevant for 
quorum sensing. One explanation for this high specificity to HSs compounds might be that 
the HSLs were already hydrolysed during conjugation and immunisation processes which had 
pH 7 and consequently, the antibodies were mostly developed to hydrolysed HSLs. Former 
publications have already stated the occurrence of abiotic hydrolysis of HSLs (lactone ring 
opens) under different conditions (Yates et al., 2002; Frommberger et al., 2005; Kaufmann et 
al., 2006; Englmann et al., 2007). Yates et al., (2002) particularly revealed the mammalian 
physiological conditions (22°C or 37°C, pH 7) of hydrolysis in a temperature, pH and chain 
length dependent manner. The hydrolysis enhanced with increased temperature and pH, but 
decreased chain length. 
However, in order to distinguish HSLs and HSs in samples, the assay conditions were 
carefully considered. This could be accomplished, for example, by the measurements of a 
sample before and after chemical hydrolysis of the HSLs (using alkaline conditions, 
lactonolysis). Also, the preliminary analysis of the samples with a conventional method prior 
to the screening of corresponding samples by immunoassay will give information about the 
distribution of HSLs and potential appearance of HSs. This method was successfully applied 
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for the analysis of HSLs in Burkholderia cepacia culture supernatants with the established 
immunoassays.  
Furthermore a few of HSL/HS analogues (Figure 17, page 64), including serine, methionine 
and fatty acids with different chain length, were tested against HSL1/2-2C10. None of the 
tested substances showed binding in assays. This result can prove the specificity of the 
antibodies, that they recognise HSL/HS but not some degradation products, even serine. Of 
course it is still difficult to confirm with 100% security, because so many other analogues 
were not determined. 
4.8 Biological relevance of HSL and HS 
Regarding the affinity and selectivity of the antibodies, the developed immunoassays were 
used for the detection of HSLs and HSs in bacterial cultural supernatants. But the broad 
recognition of HSLs and even higher sensitivity of HSs were the main factors, which needed 
to be considered. Similar to bioreporter assays, the immunoassays are not able to distinguish 
single individual molecules, but only report the sum of all the HSLs and HSs. The challenging 
question is what and how exactly could we see with the immunoassays? Taking the 10% 
control of the standard curves as LODs, the values ranged from low µM to nM depending on 
assay format and antibody. This sensitivity is enough for most HSLs in real samples reported 
with other analytical methods e.g. with UPLC, LC-MS (Li et al., 2006; Fekete et al., 2010). 
The LODs of HSs could even come down to pM, e.g. 3oxo-C10-HS had an LOD of ca. 250 
pM in enzyme-tracer format assay with mAb HSL1/2-2C10.  
Though the HSLs are the known quorum sensing molecules, the co-appearance of HSLs and 
HSs were reported in many publications (Englmann et al., 2007; Uroz et al., 2009; Fekete et 
al., 2010). Fekete et al., (2010) demonstrated the dynamic curves of production and 
degradation of C10-HSL and C10-HS in P. putitda IsoF cultural supernatant (see Figure 4, 
page 23). In B. cepacia LA3 cultural supernatant, 6.33 µM C10-HSL and 3 µM C10-HS were 
determined in the same sample using UPLC. As one of the main degradation pathways of 
HSLs, hydrolysis seems to have not fully discovered meaning of the QS regulation. In a 
recent review of quorum quenching (Uroz et al., 2009), the QS inhibition mechanisms and the 
potential biological applications were extensively discussed, which included the therapeutic 
strategies against QS related disease. Beside the abiotic hydrolysis, a few lactone-degrading 
enzymes (named lactonase) were identified for hydrolysis of HSLs in natural environments 
and a few bacteria (e.g. Agrobacterium) owned HSL synthase and lactonase as well (Dong et 
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al., 2000; Uroz et al., 2009). Thus, the significant sensitivity against HSs of these newly 
developed mAbs allows the detection of HSs at low concentrations and may help to reveal 
quorum quenching processes. On the other hand, the assay conditions must be carefully 
considered, due to the high CRs to HSs. 
4.9 Development of QQ innovative biological tools 
4.9.1 Immunotherapy 
The 3oxo-C12-HSL has been shown not only to mediate bacterial QS, but also to exert 
cytotoxic effects on mammalian cells. These findings allowed the development of new 
strategies to combat microbial infections by targeting the QS signalling molecules. Kaufmann 
et al. (2006, 2008) reported an immunopharmacotherapeutic approach for the attenuation of 
AHL-dependent QS in the Gram-negative human pathogen P. aeruginosa. Monoclonal 
antibodies (mAbs) raised against the 3oxo-C12-HSL hapten demonstrated an affinity (Kd 
range between 150 nM and 5 mM) in vitro for 3oxo-C12-HSL, and may exhibited high 
specificity as these antibodies did not recognise any of the short-chain 3oxo-AHLs. These 
mAbs exerted a clear inhibitory effect on the production of phyocyanin by P. aeruginosa, a 
QS-controlled virulence factor. More recently, Park et al. (2007) have reported a similar 
immunotherapeutic approach for the attenuation of QS in the Gram-positive human pathogen 
Staphylococcus aureus. Remarkably, the antibody that was raised against the peptidic QS 
signal suppressed S. aureus pathogenicity in an abscess-formation mouse model in vivo, and 
provided complete protection against an otherwise lethal S. aureus challenge. These findings 
provide a strong foundation for further investigations of immunotherapy for the treatment of 
bacterial infections in which QS controls the expression of virulence factors.  
4.9.2 QQ bacterial strains as biocontrol agents 
When expressed in a heterologous system, such as Burkholderia glumae, Pectobacterium 
carotovora, Pseudomonas aeruginosa or Agrobacterium tumefaciens, some of the known 
AHL-degrading enzymes have been shown to limit or abolish the accumulation of AHL in the 
environment. As a consequence, this process also significantly reduces the expression of QS-
regulated functions of the host bacterium (Uroz et al., 2008). Therefore, in these systems, the 
expression of an AHL-degradation enzyme by an AHL-producing strain led to the same 
phenotype as a luxI null-mutation. However, this approach is barely exploitable in biological 
control experiments. A more suitable approach is based upon the selection of bacteria that are 
naturally able to degrade AHL or AHL analogues either as single isolates or as consortia. Co-
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inoculation experiments involving the AHL-producing pathogen and the AHL-degrading 
quencher(s) revealed that this approach is often able to significantly reduce, and in some cases 
abolish, the expression of the QS-regulated function of the pathogens (Uroz et al., 2003; 
Cirou et al., 2007). AHL-degrading strains might therefore have great potential as biocontrol 
agents to protect plants from pathogens (Uroz et al., 2009). 
4.10  Comparison of the current methods for HSL and HS analysis 
Compared to conventional analysis, the developed immunoassays are faster, more cost-
effective, and easier to carry out. Another valuable advantage is the low sample volume 
requirement, which is lower than 1 mL. A comparison of different analytical methods for 
HSLs is presented in Table 17. It has to be pointed out though that a proper assessment of 
these different methods is not easy. Conventional methods on the one hand use, for example, 
a well-adapted sample pretreatment before the analytical procedure. On the other hand 
bioreceptor-based assays often use long incubation times, have an internal amplification 
system, and need specialised laboratories (genetically modified organisms) for their 
execution. Considering the sample pretreatment, the volume of sample needed, the analysis 
time and costs, and the ease of operation, immunoassays are certainly a truly competitive 
analytical method for HSLs.  
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Table 17 Comparison of analytical methods for HSL compounds  
 
Analytical 
method 
Description Analyte Samples extraction 
and  
pre-concentration  
Real sample volume 
[mL] 
Limit of detection 
[nM] 
Working range 
[nM] 
Reference 
 
Immunoassay mAb HSL1/2-2C10 /  
enzyme-tracer format 
3-oxo-C10-HSL no 0.5 
(1)
 31 31-3200 
 
This study  
mAb HSL4-4C9 /  
coating antigen format 
C8-HSL no 0.5 
(1)
 476 476-12500 This study  
mAb RS2-1G9 /  
coating antigen format 
3-oxo-C12-HSL 
3-oxo-C6-HSL 
no 
 
Not reported 
 
15
 (2)
 
>10000 
(2)
 
15-1500 
(2)
 
Not reported 
(Kaufmann 
et al., 2006) 
Conventional 
methods 
 
GC-MS 3-oxo-C12-HSL 
3-oxo-C10-HSL 
yes 2 67 
(3)
 
74 
(3)
 
Not reported 
Not reported 
(Charlton et 
al., 2000) 
GC/EI-MS C10-HSL 
C6-HSL 
yes 50 
 
3600 
5100 
Not reported 
Not reported 
(Cataldi et 
al., 2007) 
SPE,UPLC, FT-ICR-MS C10-HSL 
C8-HSL 
yes 10-50 
 
400 
400 
400-90000 
400-90000 
(Li et al., 
2006) 
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UPLC, FT-ICR-MS, 
SDME 
L-C10-HSL 
L-C8-HSL 
yes 
(4)
 2 
 
391 
439 
Not reported 
Not reported 
(Malik  et 
al., 2009) 
Bioreporter assay Agrobacterium 
tumefaciens A 136 
(pMV26)(pCF218) 
3-oxo-C10-HSL 
C10-HSL 
yes 0.05-0.5 0.00002 
25 
Not reported 
Not reported 
(Chambers 
et al., 2005) 
(5)
 
Escherichia coli JM109 
(pSB1075) 
C12-HSL 
C4-HSL 
no 0.3 
(6)
 
 
1 
100 
1-10000 
100-100000 
(Kumari et 
al., 2006) 
Escherichia coli ROlux2 3-oxo-C6-HSL no 2 3 3-390 (Yan, et al. 
2007) 
(1)
 For quadruplicate determination 
(2)
 Not given, working range was calculated as a factor of 10 below and above the IC50. 
(3)
 Not given, calculated from the lowest detected HSL (1 ng tube
-1
), sample volume (50 µL tube
-1
) and molecular weight of HSL compound. 
(4)
 Extraction and pre-concentration was included in the process of SDME. 
(5)
 Concentration measured is from the extracted and pre-concentrated sample. 
(6)
 For triplicate determination 
Published results (Chen et al,, 2010 a) 
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4.11  Matrix effects 
Initially, the assays were developed in a specific buffer system. Biological samples though 
have usually very different background substances, called matrix, which can contribute to 
changes in assay performance. The matrix of a sample can interfere with antibodies and 
enzymes (in the enzyme-tracer) and have an influence on the antibody-analyte binding. Thus, 
the matrix effects must be considered carefully for any biological samples determination in 
immunoassays. In extreme cases, the matrix effects could entirely inhibit the immunoassay 
(Krotzky & Zeeh, 1995). 
Table 18 Matrix effects of different media 
Assay  Buffer/medium OD IC50 of 3oxo-C10-
HSL [µg L
-1
] 
Medium OD/PBS 
OD 
Medium 
IC50/PBS IC50 
1 40 mM PBS 0.83 120 
1.15 3.11 
ABC medium 0.96 373 
2 40 mM PBS 1.51 99 
1.16 3.20 
Mineral medium +TCB 1.75 316 
3 40 mM PBS 1.09 143 
1.32 2.79 
M9 medium 1.44 399 
4 40 mM PBS 1.18 103 
0.14 - 
NB medium* 0.17  - 
Due to the standard deviation between the plates, the matrix effect was compared in one plate with PBS and the 
corresponding medium. * The test in NB medium obtained almost no binding signals, thus the IC50 in NB was 
not given. 
In Table 18, the matrix effects of 4 media were present compared to PBS buffer. Except NB 
medium, all these 3 media showed increased OD and reduced sensitivity (increased IC50). But 
the changing factors are slightly different (listed in Table 18). Differently, NB medium 
showed much lower OD (0.17) compared to PBS (1.18) and it was not possible to obtain 
evaluable assay. This phenomenon might be due to the high interfering with the contents in 
NB medium (detailed composition of buffer/medium, see Attach. 2, page 143). 
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4.12 Possible problems and suggestions of immunoassays  
There are a few key facts which should be pointed out while working with these 
immunoassays: 
A) The matrix interference with assays of the biological samples should be tested and 
optimised before real sample determination. In some cases, sample preparation procedures 
like extraction might be required to reduce or avoid the matrix effect. 
B) Broad recognition HSLs and HSs, but the affinities are very dependent on the individual 
antibodies and HSL molecular structures. A suitable combination of antibodies and analytes is 
essential for good assays. 
C) The antibodies are unable to distinguish HSLs and HSs in a mixture, but it is possible to 
check the relative presence of HSLs through the hydrolysis treatment due to their dramatically 
higher sensitivity for HSs. 
D) Identification of individual molecules is basically not possible with immunoassays and 
must be performed by using chemical analysis such as HPLC, MS, NMR and etc. 
E) The antibodies recognition might be influenced by some unknown AHL-mimic substances, 
which cannot be absolutely excluded. 
4.13 Difficulties and solutions of fluorescence based in situ 
experiments 
The aim of the in situ tests was to visualise the localisation of HSL molecules on QS regulated 
biofilms. Different to planctonic cell culture, biofilms are understood as highly complex 
structures. Within them the accumulated HSLs can reach particularly high concentrations on 
some spots (Charlton et al., 2000). 
Initially, there were two strategies for in situ experiments. One was with HSL QS regulated 
biofilms on plastic flow chambers (ibidi slides), and the other was on living plant roots 
inoculated with HSL producing bacteria. Two types of fluorescence labels were used for these 
two experiments. The first type was fluorophore Oyster-645 which was labelled to anti-HSL 
mAbs and these directly labelled mAbs were used for most experiments. Later on, the Cy3-
TSA system (Perkin Elmer, Boston, USA) was employed in order to get enhanced 
fluorescence signals. With this method, fluorescent signals could be catalysed and amplified 
by the HRP on secondary goat anti rat antibody (schema see Figure 21, page 73). 
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In both experimental setups, the occurrence of background signals was unfortunately the main 
problem of the tests. It is quite well known that fluorophores could react with environmental 
matrices and possibly cause unspecific signals. However, this interference can be inhibited by 
using appropriate quenching solutions. A lot of factors could influence the fluorescent 
performance, e.g. hydrophobicity, temperature, viscosity, salt content, pH value in the 
corresponding environment. It was reported that a conjugation of fluorescent dye to protein 
would change the fluorescent behaviour and would not be identical to free dye (Raem & 
Rauch, 2007). Additionally, the common existing auto-fluorescence in many biological 
samples could disturb the targeted fluorescent signals as well. In this study, strong auto-
fluorescence was observed on barley root at different wavelengths under the laser scanning 
microscope (Figure 46, page 112 and Figure 47, page 113). AHL molecules are low 
molecular compounds, which lead to the consequence of being easily removed during 
washing steps. Even assuming that the HSL molecules are immobilised somewhere on 
biofilm or plant root structures, the fluorophore labelled antibodies might not be able to reach 
the targeted location due to their big molecular size. All these aspects must be taken into 
consideration for in situ HSL detection. The searching of other new suitable visualising signal 
systems may help to enable the in situ idea in the future. 
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5 Summary 
Quorum Sensing (QS) is a process that enables bacteria to communicate via chemical 
signalling molecules, which are called autoinducers (AI). When a threshold concentration of 
QS molecules is reached, the bacteria start their QS regulated gene expression e.g. 
bioluminescence (Vibrio fischeri), virulence factor secretion (Pseudomonas aeruginosa), 
biofilm formation (Burkholderia cepacia), sporulation, and mating. It was found that many 
Gram-negative bacteria use acylated homoserine lactones (AHLs or HSLs) as autoinducers. 
Due to the broad biological functions of HSLs, the interest in detection and analysis of HSLs 
is increasing for medical, biotechnological and agricultural applications. In the past years, 
numerous analytical methods have been developed for HSLs. Conventional analysis, which 
usually combines chromatography, mass spectrometry (MS), and nuclear magnetic resonance 
(NMR) has been very successfully applied for identification and quantification of HSLs. But 
normally, conventional analysis requires many steps of sample preparation, e.g. extraction, 
pre-concentration and optimisation of conditions to separate individual HSL molecules. In 
addition, many sensitive bioreporter assays have been developed using different LuxR 
responsive promoters, which contain LuxR family functional proteins but lack the HSL 
synthase. A combination of different bioassays is strongly recommended, since no bioreporter 
is sensitive to all HSLs.  
Alternatively, in this study, an anti-HSL antibody based immunochemical detection method 
has been successfully developed and established. HSL molecules consist of a homoserine 
lactone ring and an acyl side chain (4-18 carbon atoms), and they differ only from side chain 
length and substitution at C3 atom. Regarding the variation of the molecule structures, four 
HSL haptens, named HSL1, HSL2, HSL3 and HSL4, were designed for antibody and assay 
development. HSL1 and HSL3 have a long chain (C11-COOH), but HSL1 has an -oxo and 
HSL3 has an –OH functional group at the C3 position. In comparison, HSL2 (C5-COOH) and 
HSL4 (C9-COOH) have shorter side chains and no substitution on the C3 atom. The haptens 
were synthesised and were covalently coupled to the C-terminal COOH-group of the NH2-
residues (lysines) of the carrier proteins (BSA/OVA). Using these HSL hapten-conjugates, rat 
and mouse anti-HSL monoclonal antibodies (mAbs) were produced, screened and further 
characterised with enzyme-linked immunosorbent assays (ELISAs). Corresponding to hapten 
structures, the antibodies showed different selectivities to HSLs with different substitution on 
C3 position and chain length.  
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Eight mAbs (HSL1-1A5, HSL1-8E1, HSL1/2-2C10, HSL1/2-4H5, HSL4-4C9, HSL4-5H3, 
HSL4-5E12 and HSL4-6D3) were selected from about 200 mAbs and characterised in detail 
using coating antigen and enzyme tracer formats. It was demonstrated that the new assays 
have HSL detection ranges from nM to low µM, which is sensitive enough for detection of 
HSLs in natural samples according to literature. Interestingly but not surprisingly, AHLs 
mAbs have at least 20 times higher sensitivity against hydrolysed HSLs (named HSs) than 
original HSLs, because the conjugation and immunisation conditions, e.g. pH and 
temperature, for mAb development resulted in HSL hydrolysis. This property of antibodies 
additionally offers a new sensitive method to detect quorum quenching (QQ) relevant 
homoserines (HSs), which are important degradation products of HSLs. Comparable results 
have been obtained by Biacore and Aqua-Optosensor biosensors for HS (L) characterisation. 
Based on these properties of the mAbs, a detection method of HSLs and HSs in biological 
samples has been developed and optimised. With the comparison of the real samples before 
and after hydrolysis treatment, the assays could simply present the relative HSL- and HS- 
contents in the samples. Similar to bio-reporters, the identification or quantitation of single 
HSL molecules is not possible only using immunoassay due to the broad recognition of HSLs 
and HSs. For this purpose, a combination with conventional chemical analysis is a must. 
However, as a novel sensitive HSL and HS detection method, the developed immunoassays 
have the advantages of being fast, cost effective and having low sample volume requirement.  
Using the direct or indirect fluorescence signals of fluorophore labelled anti-HSL mAbs, the 
in situ experiments with modified Burkholderia cepacia biofilm on ibidi slide (plastic flow 
chamber from ibidi GmbH) and Pseudomonas putida inoculated barley root have been carried 
out. Unfortunately, the in situ tests were not successful, mainly due to remaining unspecific 
background signals. Nevertheless, a few steps, e.g. fluorophore labelling, biofilm formation, 
and surface blocking have been optimised. The door of HSL in situ tests with the antibodies is 
still open, if a suitable specific visualising detection method could be found in the future. 
Certainly, the antibodies can also be broadly applied for many other immunochemical 
techniques, such as immunosensors or immunoaffinity columns for characterisation or pre-
screening of HSLs/HSs, as have been demonstrated successfully. 
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6 Zusammenfassung 
Quorum Sensing (QS) ist ein Prozess, welcher es den Bakterien ermöglicht, miteinander 
durch Signalmoleküle zu kommunizieren. Die Signalmoleküle werden auch als Autoinducer 
(AI) bezeichnet. Wenn eine bestimmte Konzentration der QS-Moleküle erreicht ist, starten die 
QS-Bakterien die Regulation mit einer Genexpression, was z.B. zur Biolumineszenz (Vibrio 
fischeri), zur Virulenzfaktorensekretion (Pseudomonas aeruginosa) oder zur Ausbildung von 
Biofilmen (Burkholderia cepacia) führt. Es wurde für einen Großteil der Gram-negativen 
Bakterien nachgewiesen, dass N-acylierte Homoserinlaktone (abgekürzt als AHL oder HSL) 
als Autoinducer verwendet werden. Aufgrund der vielfältigen biologischen Funktion der 
HSL-Moleküle ist das Interesse an der Detektion und der Analyse von HSL für medizinische, 
biotechnologische und agrarwissenschaftliche Anwendungen deutlich angestiegen. Während 
der letzten Jahre sind viele unterschiedliche Methoden zur HSL-Analyse entwickelt worden. 
Konventionelle analytische Methoden kombinieren häufig die Chromatographie mit der 
Massenspektroskopie (MS) und der kernmagnetischen Resonanzspektroskopie (NMR) und 
werden sehr erfolgreich für die Identifizierung und Quantifizierung der HSL angewandt. 
Hierbei sind jedoch viele Probenvorbereitungsschritte, wie z.B. die Probenextraktion, die 
Vorkonzentrierung und die Optimierung der individuellen HSL-Trennung, notwendig. 
Weiterhin wurden viele sensitive Bioreporter-Assays entwickelt, welche mit dem Einsatz der 
unterschiedlichen LuxR-ansprechbaren Promoter arbeiten. Diese funktionellen Proteine der 
LuxR-Familie besitzen aber keine HSL-Produzenten. Eine Kombination von mehreren 
Bioassays ist empfehlenswert, weil kein einziger Bioreporter für alle HSL ausreichend 
sensitiv und selektiv ist. 
Als eine Alternative zu den genannten Methoden werden in dieser Arbeit auf anti-HSL 
monoklonalen Antikörpern (mAk) basierende immunochemische Detektionsmethoden 
erfolgreich eingeführt. Es wurde berücksichtigt, dass HSL-Moleküle aus einem 
Homoserinlacton-Ring bestehen und eine Seitenkette (mit 4 bis 18 Kohlenstoffatomen) 
besitzen, welche sich nur durch die Kettenlänge und die Substitution am C3-Atom 
unterscheiden. Auf dieser Grundlage wurden vier HSL-Derivate, die als HSL1, HSL2, HSL3 
und HSL4 bezeichnet wurden, synthetisiert und für die Antikörper- und die Assay-
Entwicklungen eingesetzt. HSL1 und HSL3 besitzen dieselbe Kettenlänge (C11-COOH); 
HSL1 zeichnet sich jedoch durch eine oxo- und HSL3 durch eine OH-Gruppe an der C3-
Position aus. Im Vergleich dazu haben HSL2 (C5-COOH) und HSL4 (C9-COOH) eine 
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kürzere Kettenlänge und besitzen keine Substitution am C3-Atom. Diese Haptene (HSL 
Derivate) wurden synthetisiert und über ihre C-terminale COOH-Gruppe mit der NH2-(Lysin) 
Gruppe der Trägerproteine (BSA/OVA) kovalent gekoppelt. Mit den HSL-Hapten-Protein-
Konjugaten wurden Ratten und Mäuse immunisiert. Dadurch wurden die anti-HSL mAk 
produziert, welche weiter mit Hilfe von Enzyme-linked Immunosorbent Assays (ELISAs) 
‚gescreent’ und charakterisiert wurden. Im Zusammenhang mit den Hapten-Strukturen 
können die entsprechenden Antikörper die unterschiedlichen Substitutionen an der C3-
Position und die Kettenlänge erkennen. 
Von ca. 200 monoklonalen Antikörpern wurden acht ausgewählt (mAk HSL1-1A5, HSL1-
8E1, HSL1/2-2C10, HSL1/2-4H5, HSL4-4C9, HSL4-5H3, HSL4-5E12 und HSL4-6D3) und 
detailliert mittels ELISA im Coating Antigen und Enzym Tracer Format charakterisiert. Der 
Detektionsbereich der neuen Assays befindet sich im nM bis unterem µM Bereich; dieser ist 
sensitiv genug für den Nachweis der HSL-Moleküle in Realproben. Interessanterweise weisen 
die HSL mAk eine mindestens 20-mal höhere Sensitivität gegenüber hydrolysierten HSL 
(Homoserine genannt) als den orginalen HSL auf. Die Bedingungen während der Konjugation 
und der Immunisierung, z.B. die Temperatur und der pH Wert, könnte die Hydrolysierung der 
HSL-Moleküle verursacht haben. Diese Eigenschaft der Antikörper bietet eine neue sensitive 
Methode für Quorum Quenching (QQ) der relevanten Homoserine (HS), welche eine der 
wichtigsten Abbauprodukte der HSL sind. Außer mit ELISA wurden vergleichbare 
Ergebnisse für die HSL-Charakterisierung mit Hilfe der Biosensoren Biacore und Aqua-
Optosensor erzielt. 
Aufgrund der gefundenen Eigenschaften der Antikörper wurde eine Nachweismethode der 
HSL- und HS- Moleküle in biologischen Proben entwickelt und optimiert. Mit dem Vergleich 
der Realproben vor und nach der Hydrolysebehandlung konnten die Assays den relativen 
HSL- und HS- Inhalt aufzeigen. Ähnlich wie bei den Bioreporter Assays ist es nicht möglich 
die Identifizierung und Quantifizierung für einzelne Moleküle allein mit dem ELISA 
durchzuführen. Die immunochemische Analyse muss mit konventionellen chemischen 
Analysen kombiniert werden, weil die Assays breitere Erkennungen von HSL und HS 
besitzen. Die neu entwickelten Assays stellen aber eine sensitive Detektionsmethode für 
HSL/HS dar, welche schnell und kostengünstig mit einer geringen Probenmenge durchgeführt 
werden kann. 
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Mithilfe der direkten oder indirekten Fluoreszenzsignale der an anti-HSL mAk konjugierten 
Fluorophore wurden in situ Tests entweder mit einem modifizierten Burkholderia cepacia-
Biofilm an Ibidi Slides oder an einer mit Pseudomonas putida inokulierten Weizenwurzel 
durchgeführt. Leider waren die in situ Experimente nicht erfolgreich, hauptsächlich aufgrund 
der noch verbliebenen unspezifischen Hintergrundsignale. Trotzdem konnten einige Schritte 
wie die Fluorophor-Koppelungsrate an mAk, die Biofilmausbildung und die Absättigung der 
Oberfläche optimiert werden. Die Möglichkeit der HSL in situ Detektion ist immer noch 
gegeben, wenn ein passender Signalstoff gefunden wird. Die Antikörper können für viele 
weitere immunochemische Techniken verwendet werden, wie z.B. für Immunosensoren und 
Immunoaffinität für die Charakterisierung und das ‚ Screening’ der HSL/HS. 
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10 Attachments 
Attach. 1 Chemicals for synthesis 
Chemicals MW MF Company 
Sodium cyanoborohydride  62.8 NaBH3CN Sigmal aldrich,Steinheim Germany 
Potassium hydroxide 56.1 KOH Fluka,Steinheim Germany 
Toluene 92.1 C7H8 Fluka,Steinheim Germany 
Benzyl bromide 171.0 C7H7Br Fluka,Steinheim Germany 
Tetrabutylammonium bromide 322.4 C10H36BrN Fluka,Steinheim Germany 
Sebacid acid 202.3 C10H18O4 Fluka,Steinheim Germany 
Ethyl acetate 88.1 C4H8O2 Riedel de Haen, Seelze, Germany 
Meldrum's acid 144.1 C6H8O4 Fluka,Steinheim Germany 
Dichloromethane (dry) 84.93 CH2Cl2 Fluka,Steinheim Germany 
4-Dimethylaminopyridine 122.2 C7H10N2 Fluka,Steinheim Germany 
Cyclohexane 84.2 C6H12 Riedel de Haen, Seelze, Germany 
Hydrochloric acid 32% 36.5 HCl Merck, Darmstadt, Germany 
Sodium chloride 58.4 NaCl Merck, Darmstadt, Germany 
Sodium hydrogen carbonate 84.0 NaHCO3 Merck, Darmstadt, Germany 
Ammonium chloride 53.5 NH4Cl Riedel de Haen, Seelze, Germany 
Triethylamine 101.2 C6H15N Fluka,Steinheim Germany 
Acetonitrile 41.1 C2H3N Fluka,Steinheim Germany 
(S)-2-Amino-4-butyrolactone hydrobromide 182.0 C4H7NO2.HBr Fluka,Steinheim Germany 
Acetonitrile Chromasolv 34851 41.1 C2H3N Riedel de Haen, Seelze, Germany 
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Attach. 2 Buffers and media used in this study 
 
Buffer/medium pH Composition for 1 L buffer 
40 mM PBS  7.6 NaH2PO4  0.689 g 
Na2HPO4  6.23 g 
NaCl  5.84 g 
MilliQ H2O  1000 mL 
 
200 mM PBS  7.5-7.8 NaH2PO4  3.45 g 
Na2HPO4  31.15 g 
NaCl  5.84 g 
MilliQ H2O  1000 mL 
 
20 mM PBS dialysis buffer 7.8 200 mM PBS 100 mL 
MilliQ H2O  900 mL 
 
4 mM PBST wash buffer 7.8 40 mM PBS 100 mL 
Tween 20 500 µL 
MilliQ H2O  900 mL 
 
50 mM carbonate coating 
buffer 
9.6-9.8 Na2CO3  1.59 g 
NaHCO3  2.94 g 
MilliQ H2O  1000 mL 
 
100 mM sodiumacetat 
substrate buffer 
5.5 C2H3NaO2 8.2  g 
adjust with 1% (w/v) citric acid to pH 5.5  ca. 100 mL 
MilliQ H2O  1000 mL (final 
volume) 
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10 mM HEPES with  2.5 
mM CaCl2 
7.4 1M HEPES 10 mL 
0.5M CaCl2 Solution 5 mL 
adjust with 0.1M NaOH to pH 7.4  variable 
MilliQ H2O filled 1000 mL (final 
volume) 
 
10 mM HEPES 7.4 1M HEPES 10 mL 
adjust with 0.1M NaOH to pH 7.4  variable  
MilliQ H2O filled 1000 mL (final 
volume) 
 
 
volume) 
 
1 mM HEPES washbuffer 7.4 10 mM HEPES (with or without CaCl2) 100 mL 
Tween 20 500 µL 
MilliQ H2O  900 mL 
 
0.2 M borate buffer 7.8 0.2 M boric acid 250 mL 
0.05 M borax 24.5 mL 
MilliQ H2O 1000 mL (final 
volume) 
 
ABC medium 
modified from (Clark & 
Maaloe, 1967) 10 mL 
6.8 A  (NH4)2SO4                          2 g 100 mL 
Na2HPO4                            6 g 
KH2PO4                              3 g 
NaCl                                   3 g 
H2Odest                         100 mL 
 
B  1 M MgSO4 x 6 H2O      2 mL 900 mL 
0.5 M CaCl2 x 2 H2O   0.2 mL 
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0.01 M FeCl3 x 6 H2    0.3 mL 
H2Odest                         900 mL 
 
C  1M sodium citrate for P. putida 10 mL 
20 % (W/V) glucose for B. cepacia 10 mL 
 
Mineral medium  
 
 
7.0 
 
 
Na2HPO4•2H2O  2.9 g 
KH2PO4  1.5 g 
NH4NO3 1g 
MgSO4•7H2O 100 mg 
Ca(NO3)2•4H2O 50 mg 
MilliQ H2O 1000 mL (final 
volume) 
 
M9 medium  
 
6.9 
 
1M KH2PO4 22 mL 
10% (W/V) NH4Cl 10mL 
1M CaCl2  100 µL 
1M MgSO4 2 mL 
20 % (W/V) glucose 9 mL 
MilliQ H2O 1000 mL (final 
volume) 
 
NB (nutrient broth) medium 
 
7.0 Pepton 5 g 
 Meatextract 3 g 
 MilliQ H2O 1000 mL 
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Attach. 3 First screening of HSL1 and HSL1/2 antibodies with coating antigen format 
No. Mabs Coating 
antigen [1 µg 
mL
-1
] 
Analyte  
HSL 1 HSL 2 C4-
HSL  
C6-
HSL 
3oxo-
C6-HSL 
3oxo-C8-
HSL 
3oxo-C12-
HSL  
1 HSL1/2-1A5 HSL 1-BSA - -  - - - - 
   HSL 2-BSA - -  - - - - 
2 HSL1/2-1C7 HSL 1-BSA - -  - - - - 
    HSL 2-BSA - -  - - - - 
3 HSL1/2-1D5 HSL 1-BSA - -  - - - - 
    HSL 2-BSA - -  - - - - 
4 HSL1/2-1D12 HSL 1-BSA - -  - - - - 
    HSL 2-BSA - -  - - - - 
5 HSL1/2-1E6 HSL 1-BSA - -  - - - - 
   HSL 2-BSA - -  - - - - 
6 HSL1/2-1F6 HSL 1-BSA ++ -  - - + - 
    HSL 2-BSA - -  - - - - 
7 HSL1/2-1F10 HSL 1-BSA - -  - - - - 
    HSL 2-BSA - -  - - - - 
8 HSL1/2- 1G4 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
9 HSL1/2- 2A9 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
10 HSL1/2-2A10 HSL 1-BSA - -  - - - - 
    HSL 2-BSA - -  - - - - 
11 HSL1/2-2C1 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
12 HSL1/2-2C10 HSL 1-BSA + - - - - + - 
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    HSL 2-BSA ++ + - ++ ++ ++ + 
13 HSL1/2-D11 HSL 1-BSA - -  - - - - 
    HSL 2-BSA - -  - - - - 
14 HSL1/2-2E2 HSL 1-BSA - -  - - - - 
    HSL 2-BSA - -  - - - - 
15 HSL1/2-2E5 HSL 1-BSA - -  - - - - 
    HSL 2-BSA - -  - - - - 
16 HSL1/2-2F6 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
17 HSL1/2-2G8 HSL 1-BSA - -  - - - - 
    HSL 2-BSA - -  - - - - 
18 HSL1/2-2G10 HSL 1-BSA - -  - - + - 
    HSL 2-BSA + +  + - ++ - 
19 HSL1/2-3A5 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
20 HSL1/2-3A7 HSL 1-BSA - - - - - - - 
    HSL 2-BSA + - - - - - - 
21 HSL1/2-3A11 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
22 HSL1/2-3A12 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
23 HSL1/2-3B11 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
24 HSL1/2-3C4 HSL 1-BSA - - - - - - - 
    HSL 2-BSA + - - - - - - 
25 HSL1/2-3C11 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
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26 HSL1/2-3C12 HSL 1-BSA - - - - - - - 
    HSL 2-BSA + - - + - - - 
27 HSL1/2-3D2 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
28 HSL1/2-3E7 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
29 HSL1/2-3F10 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
30 HSL1/2-4A2 HSL 1-BSA - - - - - - - 
    HSL 2-BSA + - - - - - - 
31 HSL1/2-4A7 HSL 1-BSA - - - - - - - 
    HSL 2-BSA ++ - - - + + + 
32 HSL1/2-4B12 HSL 1-BSA - - - - - - - 
    HSL 2-BSA ++ - - + - - - 
33 HSL1/2-4C3 HSL 1-BSA - - - - - - - 
    HSL 2-BSA + - - - - - - 
34 HSL1/2-4C10 HSL 1-BSA - - - - - - - 
    HSL 2-BSA + - - + - - + 
35 HSL1/2-4E6 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
36 HSL1/2-4G6 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
37 HSL1/2-4G7 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
38 HSL1/2-4G11 HSL 1-BSA - - - - - - - 
    HSL 2-BSA + - - + - - - 
39 HSL1/2-4H1 HSL 1-BSA - - - - - - - 
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    HSL 2-BSA - - - - - - - 
40 HSL1/2-4H5 HSL 1-BSA + - - - - - - 
    HSL 2-BSA ++ - - ++ ++ ++ + 
41 HSL1/2-6C5 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
42 HSL1/2-6D6 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
43 HSL1/2-7A8 
 
HSL 1-BSA - - - - - - - 
    HSL 2-BSA + - - - - - - 
44 HSL1/2-7B2 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
45 HSL1/2-8C6 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
46 HSL1/2-8E5 HSL 1-BSA - - - - - - - 
    HSL 2-BSA + - - - - - - 
47 HSL1/2-8F4 HSL 1-BSA - - - - - + - 
    HSL 2-BSA - - - - - - - 
48 HSL1/2-10E1 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
49 HSL1/2-11D10 
11D10 
HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
50 HSL1/2-12C7 HSL 1-BSA - - - - - - - 
    HSL 2-BSA + - - - - - - 
51 HSL1/2-12E6 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
52 HSL1-1A5 HSL 1-BSA - - - - - - - 
    HSL 2-BSA ++ - + + + ++ + 
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53 HSL1-3D6 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
54 HSL1-8A7 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
55 HSL1-8E1 HSL 1-BSA - -  - - - - 
    HSL 2-BSA ++ -  - + ++ + 
56 HSL1-9E9 HSL 1-BSA - -  - - - - 
    HSL 2-BSA - -  - - - - 
57 HSL1-11D1 HSL 1-BSA - -  - - - - 
    HSL 2-BSA - -  - - - - 
58 HSL1-11F9 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
59 HSL1-12E6 HSL 1-BSA - -  - - - - 
    HSL 2-BSA - -  - - - - 
60 HSL2-10A6 HSL 1-BSA - - - - - - - 
    HSL 2-BSA - - - - - - - 
The symbols in table: ++: % control  30%; +: % control 30%-60%; -: % control  60%. 
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Attach. 4 Characterisation of selected HSL4 mAbs with enzyme-tracer format 
Antobody Enzyme-Tracer C4-HSL C8-HSL 3oxo-C8-
HSL 
C10-HSL 
HSL4-2F12 
  
  
  
HSL1-HRP 1:500 - + - + 
HSL1-HRP 1:1000 - + - + 
HSL3-HRP 1:500 - - - - 
HSL3-HRP 1:1000 - - - + 
HSL4-4B5 
  
  
  
HSL1-HRP 1:500 - - - + 
HSL1-HRP 1:1000 - - - + 
HSL3-HRP 1:500 - - - - 
HSL3-HRP 1:1000 - - - - 
HSL4-4B12 
  
  
  
  
  
  
  
HSL1-HRP 1:500 - - - - 
HSL1-HRP 1:1000 - - - - 
HSL3-HRP 1:500 - - - - 
HSL3-HRP 1:1000 - - - - 
HSL1-HRP 1:2000 - - - + 
HSL1-HRP 1:4000 - + - + 
HSL3-HRP 1:2000 - - - + 
HSL3-HRP 1:4000 - + - + 
HSL4-4C9 HSL1-HRP 1:500 + + + + 
  
  
  
HSL1-HRP 1:1000 - + - + 
HSL3-HRP 1:500 - + - + 
HSL3-HRP 1:1000 - + - + 
HSL4-5D6 
  
  
  
  
  
  
  
HSL1-HRP 1:500 - - - - 
HSL1-HRP 1:1000 - - - - 
HSL3-HRP 1:500 - - - - 
HSL3-HRP 1:1000 - - - - 
HSL1-HRP 1:2000 - - - + 
HSL1-HRP 1:4000 - + - + 
HSL3-HRP 1:2000 - - - - 
HSL3-HRP 1:4000 - - - - 
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HSL4-5D7 
  
  
  
HSL1-HRP 1:500 - - - - 
HSL1-HRP 1:1000 - - - + 
HSL3-HRP 1:500 - - - + 
HSL3-HRP 1:1000 - - - + 
HSL4-5E4 
  
  
  
HSL1-HRP 1:500 - - - - 
HSL1-HRP 1:1000 - - - - 
HSL3-HRP 1:500 - - - - 
HSL3-HRP 1:1000 - - - - 
HSL4-5E12 
  
  
  
  
  
  
  
HSL1-HRP 1:500 - - - - 
HSL1-HRP 1:1000 - - - - 
HSL3-HRP 1:500 - - - - 
HSL3-HRP 1:1000 - - - - 
HSL1-HRP 1:2000 - - - + 
HSL1-HRP 1:4000 - + - + 
HSL3-HRP 1:2000 - - - - 
HSL3-HRP 1:4000 - - - + 
HSL4-5H3 
  
  
  
HSL1-HRP 1:500 - + - - 
HSL1-HRP 1:1000 - + - + 
HSL3-HRP 1:500 + + - + 
HSL3-HRP 1:1000 + + - + 
HSL4-6D3 
  
  
  
  
  
  
  
HSL1-HRP 1:500 - - - + 
HSL1-HRP 1:1000 - + - + 
HSL3-HRP 1:500 - - - - 
HSL3-HRP 1:1000 - - - - 
HSL1-HRP 1:2000 - + - + 
HSL1-HRP 1:4000 - + - + 
HSL3-HRP 1:2000 - + - + 
HSL3-HRP 1:4000 - + - + 
HSL4-6F6 
  
HSL1-HRP 1:500 - + - + 
HSL1-HRP 1:1000 - + - + 
HSL3-HRP 1:500 - - - + 
Doctoral thesis, Xiao Chen, 2011 
 
154 
 
  
  
HSL3-HRP 1:1000 - + - + 
HSL4-6H8 
  
  
  
HSL1-HRP 1:500 + + + - 
HSL1-HRP 1:1000 - - - + 
HSL3-HRP 1:500 + - + + 
HSL3-HRP 1:1000 + + + + 
HSL4-8B8 
  
  
  
  
  
  
  
HSL1-HRP 1:500 - - - - 
HSL1-HRP 1:1000 - - - - 
HSL3-HRP 1:500 - - - - 
HSL3-HRP 1:1000 - - - - 
HSL1-HRP 1:2000 - - - + 
HSL1-HRP 1:4000 - + - + 
HSL3-HRP 1:2000 - - - - 
HSL3-HRP 1:4000 - - - - 
HSL4-8D8 
  
  
  
  
  
  
  
HSL1-HRP 1:500 + - - - 
HSL1-HRP 1:1000 - - - + 
HSL3-HRP 1:500 - - - - 
HSL3-HRP 1:1000 + - - - 
HSL1-HRP 1:2000 - + - + 
HSL1-HRP 1:4000 - - - + 
HSL3-HRP 1:2000 - - - + 
HSL3-HRP 1:4000 - + - + 
HSL4-8E2 
  
  
  
  
  
  
  
HSL1-HRP 1:500 - - - - 
HSL1-HRP 1:1000 - - - - 
HSL3-HRP 1:500 - - - - 
HSL3-HRP 1:1000 - - - + 
HSL1-HRP 1:2000 - - - - 
HSL1-HRP 1:4000 - - - - 
HSL3-HRP 1:2000 - - - - 
HSL3-HRP 1:4000 - - - - 
HSL4-8H10 HSL1-HRP 1:500 - - - - 
HSL1-HRP 1:1000 - - - - 
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HSL3-HRP 1:500 - - - - 
HSL3-HRP 1:1000 - - - - 
HSL1-HRP 1:2000 - - - + 
HSL1-HRP 1:4000 - - - + 
HSL3-HRP 1:2000 - - - - 
HSL3-HRP 1:4000 - - - - 
Coating with 2 µg mL
-1
 protein G, antibody cultural supernatant was 1:50 or 1:100 diluted in PBS, the symbols 
in table: ++: % control  30%; +: % control 30%-60%; -: % control  60%. 
 
Attach. 5 HSL1-8E1 coating antigen format standard curves 
Analyte [µg L-1]
10 100 1000 10000
%
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Standard curves for 3-oxo-C10-HSL, C12-HSL, 3-oxo-C12-HSL, and 3-OH-C12-HSL with the coating antigen 
format, using mAb HSL1-8E1 and HSL2-BSA-r2. Assay conditions: HSL1-8E1 800 ng mL
-1
, HSL2-BSA-r2 2 
µg mL
-1
, GAR-HRP 40 ng mL
-1
. Four parameter curve-fitting data are given in parentheses: red circles 3-oxo-
C10-HSL (A 103.7, B -1.36, C 1112 µg L
-1
, D 0.84, R
2 
0.996), yellow green inverted triangles C12-HSL (A 
107.1, B -1.36, C 19250 µg L
-1
, D 10.8, R
2 
0.992), brown squares 3-oxo-C12-HSL (A 103.9, B -1.18, C 2886 µg 
L
-1
, D -2.35, R
2 
0.999), and orange rhombuses 3-OH-C12-HSL (A 105.8, B -1.46, C 39292 µg L
-1
, D 35.3, R
2 
0.974). 
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Attach. 6 HSL4-5E12 coating antigen format standard curves 
Analyte [µg L-1]
10 100 1000 10000
%
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Standard curves for C8-HSL, 3-oxo-C8-HSL, 3-OH-C8-HSL, and C4-HSL with the coating antigen format, 
using mAb HSL4-5E12 and HSL2-BSA-r1. Assay conditions: HSL4-5E12 400 ng mL
-1
, HSL2-BSA-r1 2 µg 
mL
-1
, GAR-HRP 20 ng mL
-1
. Four parameter curve-fitting data are given in parentheses: red circles C8-HSL (A 
102.1, B -1.25, C 1829 µg L
-1
, D 4.04, R
2 
0.999), yellow green inverted triangles 3-oxo-C8-HSL (A 94.4, B -
1.57, C 5054 µg L
-1
, D 5.23, R
2 
0.996), brown squares 3-OH-C8-HSL (A 96.1, B -1.08, C 22214 µg L
-1
, D -1.68, 
R
2 
0.988), and orange rhombuses C4-HSL (A 102.2, B -1.42, C 1577 µg L
-1
, D 5.78, R
2 
0.997). 
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Attach. 7 HSL4-6D3 coating antigen format standard curves 
Analyte [µg L-1]
10 100 1000 10000
%
 C
o
n
tr
o
l
0
20
40
60
80
100
120
C8-HSL 
C4-HSL 
3oxo-C4-HSL 
3OH-C4-HSL 
0
 
Standard curves for C8-HSL, C4-HSL, 3-oxo-C4-HSL, and 3-OH-C4-HSL with the coating antigen format, 
using mAb HSL4-6D3 and HSL2-BSA-r2. Assay conditions: HSL4-6D3 cultural supernatant 1:200, HSL2-
BSA-r2 2 µg mL
-1
, GAR-HRP 20 ng mL
-1
. Four parameter curve-fitting data are given in parentheses: red 
circles C8-HSL (A 94.4, B -0.78, C 451.5 µg L
-1
, D -5.23, R
2 
0.993), yellow green inverted triangles C4-HSL (A 
92.9, B -0.95, C 2267 µg L
-1
, D -1.05, R
2 
0.976), brown squares 3-oxo-C4-HSL (A 105.0, B -0.88, C 8421 µg L
-
1
, D -6.65, R
2 
0.987), and orange rhombuses 3-OH-C4-HSL (A 100.5, B -1.38, C 7175 µg L
-1
, D 12.8, R
2 
0.985). 
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Attach. 8 HSL4-4C9 coating antigen format standard curves 
Analyte [µg L-1]
10 100 1000 10000
%
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0
 
Standard curves for C8-HSL, 3-oxo-C8-HSL, 3-OH-C8-HSL, and C10-HSL with the coating antigen format, 
using mAb HSL4-4C9 and HSL2-BSA-r1. Assay conditions: HSL4-4C9 200 ng mL
-1
, HSL2-BSA-r1 2 µg mL
-1
, 
GAR-HRP 40 ng mL
-1
. Four parameter curve-fitting data are given in parentheses: red circles C8-HSL (A 103.4, 
B -1.29, C 476 µg L
-1
, D 0.71, R
2 
0.998), yellow green inverted triangles 3-oxo-C8-HSL (A 106.0, B -1.25, C 
6227 µg L
-1
, D -5.16, R
2 
0.997), brown squares 3-OH-C8-HSL (A 100.0, B -0.80, C 10349 µg L
-1
, D 0, R
2 
0.986), and orange rhombuses C10-HSL (A 102.4, B -1.10, C 1807 µg L
-1
, D 0.32, R
2 
0.999
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Attach. 9 AOS peaks of Oyster-645 labelled mAb HSL1/2-2C10 with analyte 3oxo-C10-HS concentration 
of [55.5 µg L
-1
] 
 
Assay condition: mAb HSL1/2-2C10 labelled with Oyster-645 (label degree 1:2), 48 ng mL
-1
; spotting with 
HSL2-BSA-r2 in 50 mM carbonate buffer, pH = 9.6 + 0.05% (v/v) Tween 20, [3 mg mL
-1
] for peak left, [2 mg 
mL
-1
] for peak middle and [1 mg mL
-1
] for peak right; analyte 3oxo-C10-HS, 55 µg L
-1
. Slope value: peak left= 
3.050 mV/s, peak middle 4.279 mV/s (value in the figure), and peak right= 4.337 mV/s. 
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Attach. 10 AOS peaks of Oyster-645 labelled mAb HSL1/2-2C10 with analyte 3oxo-C10-HS concentration 
of [123.3 µg L
-1
] 
 
 
Assay condition: mAb HSL1/2-2C10 labelled with Oyster-645 (label degree 1:2), 48 ng mL
-1
; spotting with 
HSL2-BSA-r2 in 50 mM carbonate buffer, pH = 9.6 + 0.05% (v/v) Tween 20, [3 mg mL
-1
] for peak left, [2 mg 
mL
-1
] for peak middle and [1 mg mL
-1
] for peak right; analyte 3oxo-C10-HS, 123.3 µg L
-1
. Slope value: peak 
left= 1.447 mV/s, peak middle 1.603 mV/s (value in the figure), and peak right= 1.515 mV/s. 
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Attach. 11 HSL antibody recognition of DL and L HSL isomers in coating antigen format ELISA 
mAb HSL1-1A5, 200 ng mL-1
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mAb HSL4-4C9, 200 ng mL-1
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A: mAb HSL1-1A5 200 ng mL
-1
, B: mAb HSL4-4C9 200 ng mL
-1
, C: HSL1/2-2C10 400 ng mL
-1
, D: HSL4-5E12 400 ng mL
-1
.General assay condition: coating with HSL2-
BSA-r2 2 µg mL
-1
, GAR-HRP 20 ng mL
-1
, all analytes 2000 µg L
-1 
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Attach. 12 P. putida IsoF and strain KT2440 supernatants HSL detection with different sampling time 
Inoculation time [h]
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ELISA results with mAb HSL1/2-2C10 400 ng mL
-1
 in enzyme-tracer format. 
 
Attach. 13 HSL detection in extracted soil samples with inoculated TCB community  
Inoculation time [day]
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B: blank, S: sterilised clay: S:; E: established biofilm 
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 Attach. 14 LSM images of TSA and HSL mAb treated B. cepacia LA3 biofilm in ibidi slide 
A B
 
 
A: biofilm incubated with 1:50 diluted TSA without HRP and HSL mAb; B: TSA signals on the biofilm with 
HSL1/2-2C10 but without GAR-HRP treatment. Pictures captured from Dr. Michael Rotballer. 
 
Attach. 15 HSL3 antibody list 
Antibody Animal for immunisation Subclass 
HSL3-1D2 rat IgG-2a 
HSL3-2D11 rat IgG-2a  
HSL3-2F4 rat IgG-2a 
HSL3-8F6 rat IgG-2c 
HSL3-13F8 rat IgG-2a 
HSL3-2C4 mouse IgG-2b 
HSL3-4A1 mouse IgG-2a 
HSL3-4F7 mouse IgG-2a 
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